[{"symbol": "AMGN", "publishedDate": "2021-03-29 12:10:03", "title": "Week 13 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge", "image": "https://cdn.snapi.dev/images/v1/s/9/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5892632fdata-analyticsjpgw700opresize-743366.jpg", "site": "Seeking Alpha", "text": "Two new breakout stocks for Week 13 of 2021 with better than 10% short-term upside potential. This past week one selection gained over 10% with KIRK +16.2% in the early part of the week before giving back all its gains and more.", "url": "https://seekingalpha.com/article/4416609-week-13-mda-breakout-stocks-april-2021-short-term-picks-to-give-you-edge"}, {"symbol": "AMGN", "publishedDate": "2021-03-29 08:35:50", "title": "Hunting For Recession-Proof Bargains: 10 Picks As Prey", "image": "https://cdn.snapi.dev/images/v1/f/f/ff02222-742842.", "site": "Seeking Alpha", "text": "In the following article, I present 10 recession-proof stocks that are undervalued right now. Including companies from the healthcare sector like Gilead Sciences, Amgen, Novo Nordisk, Walgreens Boots Alliance, CVS Health, Cardinal Health and Bayer.", "url": "https://seekingalpha.com/article/4416566-recession-proof-bargains-10-picks"}, {"symbol": "AMGN", "publishedDate": "2021-03-28 07:00:00", "title": "Like Dividends? I Bet You'll Love These 3 Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038462fstock-chart-getty-62717jpgw700opresize-qbawc5cgqa-705783-742161.jpg", "site": "The Motley Fool", "text": "The combination of growing earnings and generous payouts makes these companies attractive.", "url": "https://www.fool.com/investing/2021/03/28/like-dividends-i-bet-youll-love-these-3-stocks/"}, {"symbol": "AMGN", "publishedDate": "2021-03-26 14:49:00", "title": "7 Big Pharmaceutical Stocks for Bigger Income", "image": "https://cdn.snapi.dev/images/v1/s/t/stocksnetapp1-741545.jpg", "site": "Kiplinger", "text": "Pharmaceutical stocks with stable, substantial dividends can hold their own in almost any environment, making them ideal for long-term income investors.", "url": "https://www.kiplinger.com/investing/stocks/dividend-stocks/602509/big-pharmaceutical-stocks-bigger-income"}, {"symbol": "AMGN", "publishedDate": "2021-03-24 14:39:13", "title": "Prime Time's Revival a Lesson for Biotech Investors", "image": "https://cdn.snapi.dev/images/v1/i/s/biotech21-737950.jpg", "site": "GuruFocus", "text": "In Amgen Inc.'s (NASDAQ:AMGN) recent agreement to buy small cancer drug developer Five Prime Therapeutics Inc. (NASDAQ:FPRX) for nearly $2 billion, there seems to be a message for investors in other small biotechs: stay the course.", "url": "https://www.gurufocus.com/news/1388283/prime-times-revival-a-lesson-for-biotech-investors"}, {"symbol": "AMGN", "publishedDate": "2021-03-22 04:13:41", "title": "Week 12 MDA Breakout Stocks - March 2021: Short-Term Picks To Give You An Edge", "image": "https://cdn.snapi.dev/images/v1/a/u/biotech33-732862.jpg", "site": "Seeking Alpha", "text": "Two new breakout stocks for Week 12 of 2021 with better than 10% short-term upside potential.", "url": "https://seekingalpha.com/article/4415311-week-12-mda-breakout-stocks-march-2021-short-term-picks-to-give-you-edge"}, {"symbol": "AMGN", "publishedDate": "2021-03-19 14:29:29", "title": "Though Potential Bidders Moved Away, Amgen's Bid For Five Prime Outlasted 15 Suitors", "image": "https://cdn.snapi.dev/images/v1/e/w/handshake-cash-1-731958.jpg", "site": "Benzinga", "text": "Earlier this month, biotech giant\u00a0Amgen Inc\u00a0(NASDAQ:\u00a0AMGN)\u00a0announced a $1.9 billion buyout\u00a0of\u00a0Five Prime Therapeutics Inc\u00a0(NASDAQ:\u00a0FPRX) that outlasted around 15 potential collaborators. Background:\u00a0Amgen's interest in FPRX goes back to 2019 when it, alongside others (not named in\u00a0the SEC filing), tried to bet on FPRX's pipeline.", "url": "https://www.benzinga.com/general/biotech/21/03/20258498/though-potential-bidders-moved-away-amgens-bid-for-five-prime-outlasted-15-suitors"}, {"symbol": "AMGN", "publishedDate": "2021-03-18 07:25:06", "title": "Amgen: Powerful Growth Platform Built To Reward Dividend Growth Investors", "image": "https://cdn.snapi.dev/images/v1/3/b/biotech38-729102.jpg", "site": "Seeking Alpha", "text": "Amgen rewarded investors by producing a five-year CAGR of 10.2% in total returns and 15.2% in dividend increases. Biosimilars' threat has been converted into a business opportunity by becoming a dominant player in the biosimilars market.", "url": "https://seekingalpha.com/article/4414713-amgen-powerful-growth-platform-dividend-growth-investors"}, {"symbol": "AMGN", "publishedDate": "2021-03-16 20:33:07", "title": "Amgen, Inc. (AMGN) Presents at Oppenheimer Healthcare Broker Conference Call - (Transcript)", "image": "https://cdn.snapi.dev/images/v1/h/0/transcript50-726851.jpg", "site": "Seeking Alpha", "text": "Amgen, Inc. (AMGN) Presents at Oppenheimer Healthcare Broker Conference Call - (Transcript)", "url": "https://seekingalpha.com/article/4414418-amgen-inc-amgn-presents-oppenheimer-healthcare-broker-conference-call-transcript"}, {"symbol": "AMGN", "publishedDate": "2021-03-13 08:32:00", "title": "Why the Growth Isn't Over for This Best-in-Breed Biotech Stock", "image": "https://cdn.snapi.dev/images/v1/i/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6172152fgetty-lab-tech-vialsjpgw700opresize-722321.jpg", "site": "The Motley Fool", "text": "It's not getting much attention lately, but the future for Amgen looks strong.", "url": "https://www.fool.com/investing/2021/03/13/why-the-growth-isnt-over-for-this-best-in-breed-bi/"}, {"symbol": "AMGN", "publishedDate": "2021-03-11 16:00:00", "title": "Amgen To Present At The Oppenheimer 31st Annual Healthcare Conference", "image": "https://cdn.snapi.dev/images/v1/p/a/conf13-720093.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., March 11, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the virtual Oppenheimer 31st Annual Healthcare Conference at 2:30 p.m.", "url": "https://www.prnewswire.com/news-releases/amgen-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-301246017.html"}, {"symbol": "AMGN", "publishedDate": "2021-03-11 15:00:00", "title": "Why You Should Own Biotech Stocks Now", "image": "https://cdn.snapi.dev/images/v1/p/o/podc12-720033.jpg", "site": "The Motley Fool", "text": "The confluence of healthcare and technology will send many biotech stocks soaring over the next decade.", "url": "https://www.fool.com/investing/2021/03/11/why-you-should-own-biotech-stocks-now/"}, {"symbol": "AMGN", "publishedDate": "2021-03-05 16:12:13", "title": "Amgen: 10-12% Upside Going Into March", "image": "https://cdn.snapi.dev/images/v1/b/f/biotech12-711159.jpg", "site": "Seeking Alpha", "text": "Amgen has come back down from a period of slight capital appreciation which saw the company's forward expected returns deteriorate to levels I found unappealing.", "url": "https://seekingalpha.com/article/4411903-amgen-upside-going-march"}, {"symbol": "AMGN", "publishedDate": "2021-03-05 12:11:58", "title": "Amgen (AMGN) to Add Stomach Cancer Drug With Five Prime Buyout", "image": "https://cdn.snapi.dev/images/v1/n/w/biotech7-710799.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) inks a $1.9-billion deal to acquire clinical-stage biotech, Five Prime Therapeutics, to boost its oncology pipeline.", "url": "https://www.zacks.com/stock/news/1274257/amgen-amgn-to-add-stomach-cancer-drug-with-five-prime-buyout"}, {"symbol": "AMGN", "publishedDate": "2021-03-05 10:40:07", "title": "ETFs to Tap Amgen's Drive for Cancer Deal", "image": "https://cdn.snapi.dev/images/v1/a/g/biotech2-710517.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) has agreed to buy Five Prime Therapeutics (FPRX) for $1.9 billion.", "url": "https://www.zacks.com/stock/news/1274182/etfs-to-tap-amgens-drive-for-cancer-deal"}, {"symbol": "AMGN", "publishedDate": "2021-03-04 23:27:16", "title": "Amgen Inc. (AMGN) Management Presents at Cowen 41st Annual Healthcare Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/5/j/transcript18-709817.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) Management Presents at Cowen 41st Annual Healthcare Conference (Transcript)", "url": "https://seekingalpha.com/article/4411660-amgen-inc-amgn-management-presents-cowen-41st-annual-healthcare-conference-transcript"}, {"symbol": "AMGN", "publishedDate": "2021-03-04 19:07:43", "title": "FPRX Stock Price Increases 78.74% On Amgen Acquisition News", "image": "https://cdn.snapi.dev/images/v1/k/a/biotech27-709666.jpg", "site": "Pulse2", "text": "The stock price of Five Prime Therapeutics Inc (NASDAQ: FPRX) increased by 78.74% today. This is why it happened.", "url": "https://pulse2.com/fprx-stock-price-nasdaq-five-prime-therapeutics-increases-78-74-on-amgen-acquisition-news/"}, {"symbol": "AMGN", "publishedDate": "2021-03-04 16:12:01", "title": "Amgen: One Of The Few Bargains In This Market", "image": "https://cdn.snapi.dev/images/v1/g/v/biotech19-709241.jpg", "site": "Seeking Alpha", "text": "Amgen: One Of The Few Bargains In This Market", "url": "https://seekingalpha.com/article/4411530-amgen-bargain-in-this-market"}, {"symbol": "AMGN", "publishedDate": "2021-03-04 13:00:00", "title": "Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6166332fmaking-a-deal-gettyjpgw700opresize-708808.jpg", "site": "The Motley Fool", "text": "The big biotech wants to bolster its late-stage pipeline with a potential new stomach cancer treatment.", "url": "https://www.fool.com/investing/2021/03/04/amgens-to-buy-oncology-startup-five-prime-therapeu/"}, {"symbol": "AMGN", "publishedDate": "2021-03-04 12:09:26", "title": "Amgen (AMGN) Down 5.5% Since Last Earnings Report: Can It Rebound?", "image": "https://cdn.snapi.dev/images/v1/d/v/biotech38-708657.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/1273417/amgen-amgn-down-55-since-last-earnings-report-can-it-rebound"}, {"symbol": "AMGN", "publishedDate": "2021-03-04 11:45:00", "title": "Why Five Prime Therapeutics Stock Is Skyrocketing Today", "image": "https://cdn.snapi.dev/images/v1/6/f/dodlk2222-708579.jpg", "site": "The Motley Fool", "text": "Amgen is paying a premium to buy the small biotech.", "url": "https://www.fool.com/investing/2021/03/04/why-five-prime-therapeutics-stock-is-skyrocketing/"}, {"symbol": "AMGN", "publishedDate": "2021-03-04 11:44:28", "title": "FPRX Stock: The Huge Takeover News That Has Five Prime Therapeutics Shares Blasting Higher", "image": "https://cdn.snapi.dev/images/v1/p/i/biotech36-708585.jpg", "site": "InvestorPlace", "text": "Five Prime Therapeutics (FPRX) stock is soaring higher on Thursday following news that Amgen (AMGN) is acquiring the company. The post FPRX Stock: The Huge Takeover News That Has Five Prime Therapeutics Shares Blasting Higher appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/03/fprx-stock-the-huge-takeover-news-that-has-five-prime-therapeutics-shares-blasting-higher/"}, {"symbol": "AMGN", "publishedDate": "2021-03-04 11:35:40", "title": "Amgen Pays $1.9B For Five Prime Therapeutics Acquisition", "image": "https://cdn.snapi.dev/images/v1/2/i/biotech35-708564.jpg", "site": "Benzinga", "text": "Amgen Inc\u00a0(NASDAQ:\u00a0AMGN)\u00a0has agreed to acquire\u00a0Five Prime Therapeutics Inc\u00a0(NASDAQ:\u00a0FPRX) for $38 per share in cash, representing an equity value of approximately $1.9 billion. The offer price of $38 represents a whopping 79% premium on the last close price of $21.26 on Wednesday.", "url": "https://www.benzinga.com/general/biotech/21/03/20007289/amgen-pays-1-9b-for-five-prime-therapeutics-acquisition"}, {"symbol": "AMGN", "publishedDate": "2021-03-04 08:43:56", "title": "Amgen to buy Five Prime Therapeutics in a deal valued at $1.9 billion to boost cancer treatment portfolio", "image": "https://cdn.snapi.dev/images/v1/g/s/biotech20-707955.jpg", "site": "Market Watch", "text": "Amgen Inc. announced Thursday an agreement to buy biotechnology company Five Prime Therapeutics Inc. in a cash deal valued at $1.9 billion. Five Prime shares were halted for news until 9 a.m.", "url": "https://www.marketwatch.com/story/amgen-to-buy-five-prime-therapeutics-in-a-deal-valued-at-19-billion-to-boost-cancer-treatment-portfolio-2021-03-04"}, {"symbol": "AMGN", "publishedDate": "2021-03-03 16:00:00", "title": "Amgen Announces 2021 Second Quarter Dividend", "image": "https://cdn.snapi.dev/images/v1/g/l/press3-706720.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., March 3, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.76 per share dividend for the second quarter of 2021. The dividend will be paid on June 8, 2021, to all stockholders of record as of the close of business on...", "url": "https://www.prnewswire.com/news-releases/amgen-announces-2021-second-quarter-dividend-301240017.html"}, {"symbol": "AMGN", "publishedDate": "2021-02-26 12:35:47", "title": "AstraZeneca/Amgen's Tezepelumab Reduces Asthma Exacerbations, Phase 3 Trial Shows", "image": "https://cdn.snapi.dev/images/v1/s/5/biotech11-698703.jpg", "site": "Benzinga", "text": "AstraZeneca Plc\u00a0(NASDAQ:\u00a0AZN) and its partner\u00a0Amgen Inc\u00a0(NASDAQ:\u00a0AMGN) have\u00a0announced positive results\u00a0from\u00a0NAVIGATOR Phase 3 trial\u00a0evaluating tezepelumab in severe asthma. Results were presented at the American Academy of Asthma Allergy & Immunology Annual Meeting.", "url": "https://www.benzinga.com/general/biotech/21/02/19881192/astrazenecaamgens-tezepelumab-reduces-asthma-exacerbations-phase-3-trial-shows"}, {"symbol": "AMGN", "publishedDate": "2021-02-25 16:53:43", "title": "Prometheus Biosciences Starts $125 Million IPO Plan", "image": "https://cdn.snapi.dev/images/v1/0/c/drugs24-697042.jpg", "site": "Seeking Alpha", "text": "Prometheus Biosciences Starts $125 Million IPO Plan", "url": "https://seekingalpha.com/article/4409134-prometheus-biosciences-starts-125-million-ipo-plan"}, {"symbol": "AMGN", "publishedDate": "2021-02-25 07:00:00", "title": "Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates", "image": "https://cdn.snapi.dev/images/v1/s/4/press8.jpg", "site": "Business Wire", "text": "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna reports fourth quarter and fiscal year 2020 financial results and provides business updates.", "url": "https://www.businesswire.com/news/home/20210225005514/en/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2020-Financial-Results-and-Provides-Business-Updates/"}, {"symbol": "AMGN", "publishedDate": "2021-02-23 10:59:15", "title": "Why Turning Point Is Turning Heads", "image": "https://cdn.snapi.dev/images/v1/i/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6146302fgetty-lung-cancerjpgw700opresize.jpg", "site": "The Motley Fool", "text": "This oncology biotech is up over 450% since its April 2019 IPO. Are there still gains to come, or should investors turn away?", "url": "https://www.fool.com/investing/2021/02/23/why-turning-point-is-turning-heads/"}, {"symbol": "AMGN", "publishedDate": "2021-02-14 07:26:21", "title": "Week 7 MDA Breakout Stocks - February 2021: Short-Term Picks To Give You An Edge", "image": "https://cdn.snapi.dev/images/v1/z/r/computer-electronic5.jpg", "site": "Seeking Alpha", "text": "Week 7 MDA Breakout Stocks - February 2021: Short-Term Picks To Give You An Edge", "url": "https://seekingalpha.com/article/4406009-week-7-mda-breakout-stocks-february-2021-short-term-picks-to-give-you-edge"}, {"symbol": "AMGN", "publishedDate": "2021-02-09 17:24:19", "title": "Primecap Management's Top Trades of the 4th Quarter", "image": "https://cdn.snapi.dev/images/v1/t/a/software10.jpg", "site": "GuruFocus", "text": "PRIMECAP Management ( Current Portfolio ) has revealed its portfolio for the fourth quarter. Major trades include a new buy in Morgan Stanley (NYSE:MS) and reductions in Qualcomm Inc. (NASDAQ:QCOM), Adobe Inc. (NASDAQ:ADBE), Microsoft Corp. (NASDAQ:MSFT) and Alphabet Inc. (NASDAQ:GOOG).", "url": "https://www.gurufocus.com/news/1354803/primecap-managements-top-trades-of-the-4th-quarter"}, {"symbol": "AMGN", "publishedDate": "2021-02-08 17:00:31", "title": "Coherus Deal Signals Pivot to New and Crowded Market", "image": "https://cdn.snapi.dev/images/v1/f/w/drugs46.jpg", "site": "GuruFocus", "text": "Shares of Redwood City, California-based Coherus BioSciences Inc. (NASDAQ:CHRS) are up about 13% just a week after announcing it has cut a $150 million deal with Chinese drugmaker Junshi Biosciences Co. Ltd. (HKSE:01877).", "url": "https://www.gurufocus.com/news/1352992/coherus-deal-signals-pivot-to-new-and-crowded-market"}, {"symbol": "AMGN", "publishedDate": "2021-02-06 13:03:19", "title": "Week 6 MDA Breakout Stocks - February 2021: Short-Term Picks To Give You An Edge", "image": "https://cdn.snapi.dev/images/v1/r/w/computer-electronic32.jpg", "site": "Seeking Alpha", "text": "Week 6 MDA Breakout Stocks - February 2021: Short-Term Picks To Give You An Edge", "url": "https://seekingalpha.com/article/4404108-week-6-mda-breakout-stocks-february-2021-short-term-picks-to-give-you-edge"}, {"symbol": "AMGN", "publishedDate": "2021-02-05 15:54:03", "title": "How Will Biotech ETFs React to These Q4 Earnings Releases?", "image": "https://cdn.snapi.dev/images/v1/c/x/biotech33.jpg", "site": "Zacks Investment Research", "text": "Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.", "url": "https://www.zacks.com/stock/news/1258543/how-will-biotech-etfs-react-to-these-q4-earnings-releases"}, {"symbol": "AMGN", "publishedDate": "2021-02-05 13:03:53", "title": "3 Dividend Stocks for Market-Beating Yields and High Growth", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks121---weh8a2livg.jpg", "site": "InvestorPlace", "text": "Sure, dividends are a nice, reliable revenue stream, but they're not the only thing these three dividend stocks have to offer. The post 3 Dividend Stocks for Market-Beating Yields and High Growth appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/02/3-dividend-stocks-for-market-beating-yields-and-high-growth/"}, {"symbol": "AMGN", "publishedDate": "2021-02-03 09:51:22", "title": "Amgen (AMGN) Q4 Earnings & Sales Top, 2021 Outlook Dull", "image": "https://cdn.snapi.dev/images/v1/b/v/biotech38---fwaicosbk3.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) beats Q4 estimates for both earnings and sales. Shares decline in after-hours trading.", "url": "https://www.zacks.com/stock/news/1256638/amgen-amgn-q4-earnings-sales-top-2021-outlook-dull"}, {"symbol": "AMGN", "publishedDate": "2021-02-03 09:39:00", "title": "With Clock Ticking on Humira, Amgen Plans for 2021 Growth", "image": "https://cdn.snapi.dev/images/v1/a/5/im-294234.jpg", "site": "Barrons", "text": "AbbVie guided for 2021 earnings that slightly exceeded the consensus.", "url": "https://www.barrons.com/articles/with-clock-ticking-on-humira-amgen-plans-for-2021-growth-51612363196"}, {"symbol": "AMGN", "publishedDate": "2021-02-03 06:04:00", "title": "Why Amgen's Q4 Earnings Beat Didn't Impress Investors", "image": "https://cdn.snapi.dev/images/v1/i/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6111592fscientist-in-lab-looking-through-microscopejpgw700opresize.jpg", "site": "The Motley Fool", "text": "The big biotech's near-term growth prospects aren't as great as shareholders would like.", "url": "https://www.fool.com/investing/2021/02/03/why-amgens-q4-earnings-beat-didnt-impress-investor/"}, {"symbol": "AMGN", "publishedDate": "2021-02-02 21:26:03", "title": "Amgen Inc. (AMGN) CEO Bob Bradway on Q4 2020 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/a/w/transcript9---iipkirifzo.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) CEO Bob Bradway on Q4 2020 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4402916-amgen-inc-amgn-ceo-bob-bradway-on-q4-2020-results-earnings-call-transcript"}, {"symbol": "AMGN", "publishedDate": "2021-02-02 18:56:14", "title": "Amgen (AMGN) Q4 Earnings and Revenues Beat Estimates", "image": "https://cdn.snapi.dev/images/v1/a/o/biotech14.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) delivered earnings and revenue surprises of 13.39% and 0.86%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/1256366/amgen-amgn-q4-earnings-and-revenues-beat-estimates"}, {"symbol": "AMGN", "publishedDate": "2021-02-02 18:00:00", "title": "Amgen Earnings Meet Expectations, but Its 2021 Outlook Doesn't Inspire", "image": "https://cdn.snapi.dev/images/v1/w/d/im-293978.jpg", "site": "Barrons", "text": "The biotech firm grew sales by 9% in 2020, and earnings by 12%. Its guidance for 2021 sales growth is roughly flat.", "url": "https://www.barrons.com/articles/amgen-stock-earnings-2021-outlook-51612306786"}, {"symbol": "AMGN", "publishedDate": "2021-02-02 16:42:00", "title": "Earnings Results: Amgen posts mixed results, cites COVID-19 impact", "image": "https://cdn.snapi.dev/images/v1/r/w/biotech12---3bpt4atrpc.jpg", "site": "Market Watch", "text": "Amgen Inc. posted mixed fourth-quarter results as its revenue rose but profit fell, with the company saying its business continued to feel the effects of the COVID-19 pandemic.", "url": "https://www.marketwatch.com/story/amgen-posts-mixed-results-cites-covid-19-impact-11612302148"}, {"symbol": "AMGN", "publishedDate": "2021-02-02 16:27:21", "title": "Recap: Amgen Q4 Earnings", "image": "https://cdn.snapi.dev/images/v1/q/u/biotech11---y9lxduyijt.jpg", "site": "Benzinga", "text": "Shares of Amgen (NASDAQ:AMGN) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 4.67% year over year to $3.81, which beat the estimate of $3.39.", "url": "https://www.benzinga.com/news/earnings/21/02/19453911/recap-amgen-q4-earnings"}, {"symbol": "AMGN", "publishedDate": "2021-02-02 16:21:00", "title": "Amgen fourth-quarter profit rises, 2021 outlook below Street view", "image": "https://cdn.snapi.dev/images/v1/w/p/m02d20210202t2i1550057598w940fhfwllplsqrlynxmpeh111mb.jpg", "site": "Reuters", "text": "Amgen Inc on Tuesday reported a higher-than-expected quarterly profit as sales of newer drugs offset lower revenue from older off-patent medications, but the biotech company forecast 2021 earnings below Wall Street estimates.", "url": "https://www.reuters.com/article/us-amgen-results/amgen-fourth-quarter-profit-rises-2021-outlook-below-street-view-idUSKBN2A22UU"}, {"symbol": "AMGN", "publishedDate": "2021-02-02 13:53:38", "title": "Bolt Biotherapeutics Aims For $150 Million U.S. IPO", "image": "https://cdn.snapi.dev/images/v1/e/g/drugs40---cng5gy0w3e.jpg", "site": "Seeking Alpha", "text": "Bolt Biotherapeutics has filed proposed terms for a $150 million IPO. The firm is developing antibody conjugate treatments for various cancers.", "url": "https://seekingalpha.com/article/4402758-bolt-biotherapeutics-aims-for-150-million-u-s-ipo"}, {"symbol": "AMGN", "publishedDate": "2021-02-02 09:00:00", "title": "Upcoming Ex-Dividend Dates: February 3-12, 2021", "image": "https://cdn.snapi.dev/images/v1/a/m/computer-electronic36.jpg", "site": "Seeking Alpha", "text": "Upcoming Ex-Dividend Dates: February 3-12, 2021", "url": "https://seekingalpha.com/article/4402625-upcoming-ex-dividend-dates-february-3minus-12-2021"}, {"symbol": "AMGN", "publishedDate": "2021-02-01 10:03:37", "title": "Amgen's Earnings Outlook", "image": "https://cdn.snapi.dev/images/v1/x/k/biotech8---djj9cyklzg.jpg", "site": "Benzinga", "text": "On Tuesday, February 02, Amgen (NASDAQ:AMGN) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.", "url": "https://www.benzinga.com/news/earnings/21/02/19421377/amgens-earnings-outlook"}, {"symbol": "AMGN", "publishedDate": "2021-02-01 04:16:53", "title": "Week 5 MDA Breakout Stocks - February 2021: Short-Term Picks To Give You An Edge", "image": "https://cdn.snapi.dev/images/v1/m/j/fe212-2.jpg", "site": "Seeking Alpha", "text": "Two new breakout stocks for Week 5 of 2021 with better than 10% short-term upside potential. This past week all 4 stocks gained over 10% with NBSE and QDEL gaining over 20% before pulling back on Friday to close with average +3.77% gains this week.", "url": "https://seekingalpha.com/article/4402369-week-5-mda-breakout-stocks-february-2021-short-term-picks-to-give-you-edge"}, {"symbol": "AMGN", "publishedDate": "2021-01-28 11:17:30", "title": "What's in the Cards for Amgen (AMGN) This Earnings Season?", "image": "https://cdn.snapi.dev/images/v1/f/j/biotech17---zc9cnlabys.jpg", "site": "Zacks Investment Research", "text": "Whether Amgen's (AMGN) sales recovery from the COVID-19 effect continued in the fourth quarter is what remains to be seen when the company reports results.", "url": "https://www.zacks.com/stock/news/1253310/whats-in-the-cards-for-amgen-amgn-this-earnings-season"}, {"symbol": "AMGN", "publishedDate": "2021-01-24 05:04:50", "title": "Week 4 MDA Breakout Stocks - January 2021: Short-Term Picks To Give You An Edge", "image": "https://cdn.snapi.dev/images/v1/n/y/computer-electronic39.jpg", "site": "Seeking Alpha", "text": "Two new breakout stocks for Week 4 of 2021 with better than 10% short-term upside potential. This past week 3 out of 4 stocks gained over 10% in a short trading week but gave back most of their gains closing for an avg loss of -4.1%. 2021 MDA portfolio returns are on record pace up +36.3% in the first three weeks with 10 out of 12 picks gaining more than 10% in less than a week.", "url": "https://seekingalpha.com/article/4400583-week-4-mda-breakout-stocks-january-2021-short-term-picks-to-give-you-edge"}, {"symbol": "AMGN", "publishedDate": "2021-01-22 17:56:35", "title": "3 Buffett-Munger Stocks Expected to Show Strong Growth", "image": "https://cdn.snapi.dev/images/v1/2/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5406972fmagnifying-glass-with-stock-chartsjpgw700opresize.jpg", "site": "GuruFocus", "text": "\"It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price,\" Warren Buffett (Trades, Portfolio) famously said in his 1989 letter to the shareholders of Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B).", "url": "https://www.gurufocus.com/news/1338716/3-buffettmunger-stocks-expected-to-show-strong-growth"}, {"symbol": "AMGN", "publishedDate": "2021-01-19 15:28:59", "title": "Motorhome Retirement:\u00a0Amgen - Wait For A Better Price", "image": "https://cdn.snapi.dev/images/v1/n/j/biotech15.jpg", "site": "Seeking Alpha", "text": "Motorhome Retirement:\u00a0Amgen - Wait For A Better Price", "url": "https://seekingalpha.com/article/4399724-motorhome-retirement-amgen-wait-for-better-price"}, {"symbol": "AMGN", "publishedDate": "2021-01-19 09:05:12", "title": "Invest Like A Billionaire With High Yield: THW", "image": "https://cdn.snapi.dev/images/v1/m/g/drugs10---qzacpqqvmc.jpg", "site": "Seeking Alpha", "text": "Invest Like A Billionaire With High Yield: THW", "url": "https://seekingalpha.com/article/4399114-invest-like-billionaire-high-yield-thw"}, {"symbol": "AMGN", "publishedDate": "2021-01-19 03:54:59", "title": "DIA: Time For The Dow To Shine This Year", "image": "https://cdn.snapi.dev/images/v1/f/e/fe212-2---z6kohsbvbe.jpg", "site": "Seeking Alpha", "text": "The Dow Jones Industrial Average (DIA) index has lagged significantly behind other flagship large cap indices over the past several years. DIA and Dow Jones Transportation index broke out to fresh all-time highs in November together, which is a long-term bullish signal.", "url": "https://seekingalpha.com/article/4399574-dia-time-for-dow-to-shine-this-year"}, {"symbol": "AMGN", "publishedDate": "2021-01-18 16:05:33", "title": "Dogs Of The Dow: Best And Worst Breeds", "image": "https://cdn.snapi.dev/images/v1/8/k/dogs-of-the-dow-best-and-worst-breeds.jpg", "site": "Forbes", "text": "The Dogs of the Dow is a venerable strategy. But some dogs are better than others.", "url": "https://www.forbes.com/sites/kenberman/2021/01/18/dogs-of-the-dow-best-and-worst-breeds/"}, {"symbol": "AMGN", "publishedDate": "2021-01-18 13:52:03", "title": "Dividend Growth Pharmaceuticals For 2021", "image": "https://cdn.snapi.dev/images/v1/h/i/stocks151-65.jpg", "site": "Seeking Alpha", "text": "Merck and Amgen are major pharmaceuticals that experienced slowing sales in the mid 2010s due to patent expirations and biosimilar competition. However, Merck recently experienced strong bottom line growth due to their expanding oncology and vaccine divisions.", "url": "https://seekingalpha.com/article/4399528-dividend-growth-pharmaceuticals-for-2021"}, {"symbol": "AMGN", "publishedDate": "2021-01-17 05:43:41", "title": "Week 3 MDA Breakout Stocks - January 2021: Short-Term Picks To Give You An Edge", "image": "https://cdn.snapi.dev/images/v1/m/2/computer-electronic12.jpg", "site": "Seeking Alpha", "text": "Week 3 MDA Breakout Stocks - January 2021: Short-Term Picks To Give You An Edge", "url": "https://seekingalpha.com/article/4399342-week-3-mda-breakout-stocks-january-2021-short-term-picks-to-give-you-edge"}, {"symbol": "AMGN", "publishedDate": "2021-01-16 05:51:00", "title": "The 5 Most Important Dow Stocks in 2021", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6082432fnyse-wall-street-trading-new-york-financial-stock-market-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Hint: Apple didn't even come close to making the list.", "url": "https://www.fool.com/investing/2021/01/16/the-5-most-important-dow-stocks-in-2021/"}, {"symbol": "AMGN", "publishedDate": "2021-01-13 08:09:00", "title": "3 Top Biotech Picks for January", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6079282fdna-genetics-science-biology-3jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Buy these three biotech stocks before they take off.", "url": "https://www.fool.com/investing/2021/01/13/3-top-biotech-picks-for-january/"}, {"symbol": "AMGN", "publishedDate": "2021-01-11 23:39:07", "title": "The Dogs Of The Dow: My Plan To Improve On The Market Beating Strategy", "image": "https://cdn.snapi.dev/images/v1/u/q/stocks-this-week-sell-short-amgen-and-kraft-heinz.jpg", "site": "Seeking Alpha", "text": "Data indicates The Dogs of the Dow outperform over long time frames. I contend the Dogs provide a good risk/reward profile for Dividend Growth investors.", "url": "https://seekingalpha.com/article/4398433-dogs-of-dow-plan-to-improve-on-market-beating-strategy"}, {"symbol": "AMGN", "publishedDate": "2021-01-11 21:30:35", "title": "Amgen Inc. (AMGN) CEO Robert Bradway Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/t/0/transcript16.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) CEO Robert Bradway Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)", "url": "https://seekingalpha.com/article/4398425-amgen-inc-amgn-ceo-robert-bradway-presents-39th-annual-jpmorgan-virtual-healthcare-conference"}, {"symbol": "AMGN", "publishedDate": "2021-01-11 16:45:00", "title": "Amgen To Achieve Carbon Neutrality By 2027", "image": "https://cdn.snapi.dev/images/v1/1/c/press6---kmr8wgzbka.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Jan. 11, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of a new seven-year environmental sustainability plan, which includes a commitment to achieve carbon neutrality, while also reducing water use by 40% and waste disposed by 75%. \"As a...", "url": "https://www.prnewswire.com/news-releases/amgen-to-achieve-carbon-neutrality-by-2027-301205666.html"}, {"symbol": "AMGN", "publishedDate": "2021-01-10 09:37:00", "title": "Dogs Of The Dow 2021: Buy, Hold Or Sell These 10 Dividends?", "image": "https://cdn.snapi.dev/images/v1/l/b/dogs-of-the-dow-2021-buy-hold-or-sell-these-10-dividends.jpg", "site": "Forbes", "text": "For income investors, dividend strategies don't come any easier than the \u201cDogs of the Dow.\u201d", "url": "https://www.forbes.com/sites/brettowens/2021/01/10/dogs-of-the-dow-2021-buy-hold-or-sell-these-10-dividends/"}, {"symbol": "AMGN", "publishedDate": "2021-01-10 04:45:13", "title": "Week 2 MDA Breakout Stocks - January 2021: Short-Term Picks To Give You An Edge", "image": "https://cdn.snapi.dev/images/v1/w/3/computer-electronic15.jpg", "site": "Seeking Alpha", "text": "Week 2 MDA Breakout Stocks - January 2021: Short-Term Picks To Give You An Edge", "url": "https://seekingalpha.com/article/4398052-week-2-mda-breakout-stocks-january-2021-short-term-picks-to-give-you-edge"}, {"symbol": "AMGN", "publishedDate": "2021-01-07 15:23:27", "title": "Moderna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine Marketing", "image": "https://cdn.snapi.dev/images/v1/y/b/syringe-1884779-1920-24.jpg", "site": "Benzinga", "text": "Moderna Inc (NASDAQ: MRNA), which received the fourth regulatory nod for its investigational coronavirus vaccine with the conditional approval granted Wednesday by the European Union, is leaving no stone unturned in its commercialization efforts. What Happened: Boston, Massachusetts-based Moderna said it has hired biopharma industry veteran Corinne Le Goff as chief commercial officer effective Jan. 19.", "url": "https://www.benzinga.com/general/biotech/21/01/19061313/moderna-hires-amgen-executive-as-chief-commercial-officer-to-bolster-vaccine-marketing"}, {"symbol": "AMGN", "publishedDate": "2021-01-07 11:05:15", "title": "Moderna hires Amgen executive as chief commercial officer", "image": "https://cdn.snapi.dev/images/v1/k/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5663602fhand-holding-vial-with-bloodjpgw700opresize.jpg", "site": "Market Watch", "text": "Shares of Moderna Inc. were down 0.2% in trading on Thursday after the company said it had hired an Amgen executive to run commercial operations as it rolls out the first doses of its COVID-19 vaccine, in the U.S. and elsewhere. Corinne Le Goff, a pharmacist by trade and the former president of the U.S. business at Amgen Inc. , will begin her role as chief commercial officer on Jan. 19, reporting to CEO St\u00e9phane Bancel.", "url": "https://www.marketwatch.com/story/moderna-hires-amgen-executive-as-chief-commercial-officer-2021-01-07"}, {"symbol": "AMGN", "publishedDate": "2021-01-07 10:32:19", "title": "The Dogs of the Dow Didn't Hunt in 2020, and 2021 Isn't Looking Much Better", "image": "https://cdn.snapi.dev/images/v1/w/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5915492fnyse-wall-street-trading-new-york-financial-stock-market-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "This not-so-old strategy of identifying undervalued blue chip stocks has had its moments -- but not enough of them.", "url": "https://www.fool.com/investing/2021/01/07/dogs-of-the-dow-didnt-hunt-2020-2021-no-better/"}, {"symbol": "AMGN", "publishedDate": "2021-01-06 15:05:00", "title": "Dogs of the Dow 2021: 10 Dividend Stocks to Watch", "image": "https://cdn.snapi.dev/images/v1/n/c/dogs-of-the-dow-2021.jpg", "site": "Kiplinger", "text": "The Dogs of the Dow were flea-bitten last year, but this simple dividend-investing strategy will try to return to greatness in 2021.", "url": "https://www.kiplinger.com/investing/stocks/dividend-stocks/602033/dogs-of-the-dow-2021-10-dividend-stocks-to-watch"}, {"symbol": "AMGN", "publishedDate": "2021-01-05 12:32:52", "title": "From the Impatient to the Patient", "image": "https://cdn.snapi.dev/images/v1/x/p/biotech7.jpg", "site": "GuruFocus", "text": "\"The stock market is a device which transfers money from the impatient to the patient.\" \u2014Warren Buffett (Trades, Portfolio)", "url": "https://www.gurufocus.com/news/1323868/from-the-impatient-to-the-patient"}, {"symbol": "AMGN", "publishedDate": "2021-01-05 07:07:00", "title": "Meet the 2021 Dogs of the Dow", "image": "https://cdn.snapi.dev/images/v1/s/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6070662fdogs-getty-smilingjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here are the newest stocks to join the portfolio for those using this easy-to-follow strategy.", "url": "https://www.fool.com/investing/2021/01/05/meet-the-2021-dogs-of-the-dow/"}, {"symbol": "AMGN", "publishedDate": "2021-01-04 14:55:54", "title": "Sand In My Shoes - December Update", "image": "https://cdn.snapi.dev/images/v1/8/2/computer-electronic29.jpg", "site": "Seeking Alpha", "text": "Sand In My Shoes - December Update", "url": "https://seekingalpha.com/article/4397263-sand-in-shoes-december-update"}, {"symbol": "AMGN", "publishedDate": "2021-01-01 08:30:00", "title": "3 No-Brainer Stocks to Buy in Healthcare", "image": "https://cdn.snapi.dev/images/v1/3/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6064922fgettyimages-1224454909jpgw700opresize.jpg", "site": "The Motley Fool", "text": "If you're worried about another market crash, don't pass up these three unstoppable healthcare stocks.", "url": "https://www.fool.com/investing/2021/01/01/3-no-brainer-stocks-to-buy-in-healthcare/"}, {"symbol": "AMGN", "publishedDate": "2021-01-01 07:12:02", "title": "2021's Dogs of the Dow", "image": "https://cdn.snapi.dev/images/v1/e/h/biotech10.jpg", "site": "24/7 Wall Street", "text": "In the 10 days since we posted our preliminary list of 2021's Dogs of the Dow, more than 23,000 Americans have died from causes related to the COVID-19 pandemic.", "url": "https://247wallst.com/investing/2021/01/01/2021s-dogs-of-the-dow/"}, {"symbol": "AMGN", "publishedDate": "2020-12-30 09:47:23", "title": "Wall Street Stories That Hit Headlines in 2020", "image": "https://cdn.snapi.dev/images/v1/w/m/computer-electronic31.jpg", "site": "Zacks Investment Research", "text": "With super-easy policies and vaccination, small-cap stocks like Liquidity Services (LQDT) and cyclical stocks like Nexstar Media (NXST), Deere & Company (DE) and BHP Billiton (BBL) are expected to benefit the most.", "url": "https://www.zacks.com/stock/news/1235105/wall-street-stories-that-hit-headlines-in-2020"}, {"symbol": "AMGN", "publishedDate": "2020-12-30 06:12:43", "title": "2 Top Picks - Safe High Dividend Biotechs For 2021", "image": "https://cdn.snapi.dev/images/v1/i/d/drugs8.jpg", "site": "Seeking Alpha", "text": "2 Top Picks - Safe High Dividend Biotechs For 2021", "url": "https://seekingalpha.com/article/4396693-2-top-picks-safe-high-dividend-biotechs-for-2021"}, {"symbol": "AMGN", "publishedDate": "2020-12-28 09:16:00", "title": "2 Top Stocks for Retirees", "image": "https://cdn.snapi.dev/images/v1/7/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6032052fgettyimages-1174295678jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Dividends are only part of the story for these two high-yielders.", "url": "https://www.fool.com/investing/2020/12/28/2-top-stocks-for-retirees/"}, {"symbol": "AMGN", "publishedDate": "2020-12-27 04:30:00", "title": "Amgen's Competition Heated Up in 2020. What's Ahead for the Stock.", "image": "https://cdn.snapi.dev/images/v1/a/w/im-251205.jpg", "site": "Barrons", "text": "Hopes for growth hinge on continued expansion for new products, as well as a pipeline of drugs in clinical trials.", "url": "https://www.barrons.com/articles/amgens-competition-heated-up-in-2020-whats-ahead-for-the-stock-51609061400"}, {"symbol": "AMGN", "publishedDate": "2020-12-24 06:54:55", "title": "Amgen: Now Is A Great Time To Buy This Cash Cow", "image": "https://cdn.snapi.dev/images/v1/1/w/biotech20.jpg", "site": "Seeking Alpha", "text": "Amgen has seen strong revenue and earnings growth, as supported by its strong stable of drugs. It also has a fast-growing biosimilar practice, and a promising pipeline.", "url": "https://seekingalpha.com/article/4396098-amgen-now-is-great-time-to-buy-this-cash-cow"}, {"symbol": "AMGN", "publishedDate": "2020-12-24 06:00:00", "title": "10 Dividend Growth Stocks For December 2020", "image": "https://cdn.snapi.dev/images/v1/i/q/the-mirage-within-the-market-a-current-snapshot.jpg", "site": "Seeking Alpha", "text": "In my monthly series of 10 Dividend Growth Stocks, I rank a selection of dividend growth stocks in Dividend Radar and present the 10 top-ranked stocks for consideration. To rank stocks, I use DVK Quality Snapshots to get quality scores and sort them in descending order, breaking ties with additional metrics.", "url": "https://seekingalpha.com/article/4396091-10-dividend-growth-stocks-for-december-2020"}, {"symbol": "AMGN", "publishedDate": "2020-12-23 11:18:10", "title": "Amgen/AstraZeneca's Asthma Drug Misses Phase III Study Goal", "image": "https://cdn.snapi.dev/images/v1/6/v/biotech3.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) and AstraZeneca (AZN) plan to file regulatory applications for tezepelumab next year.", "url": "https://www.zacks.com/stock/news/1200746/amgen-astrazenecas-asthma-drug-misses-phase-iii-study-goal"}, {"symbol": "AMGN", "publishedDate": "2020-12-23 10:32:13", "title": "Amgen (AMGN) Files for KRAS Inhibitor for Lung Cancer in Europe", "image": "https://cdn.snapi.dev/images/v1/2/1/biotech39.jpg", "site": "Zacks Investment Research", "text": "The regulatory filing for Amgen's (AMGN) sotorasib is based on data from a phase II study, which shows that sotorasib led to durable anticancer activity in advanced NSCLC patients with KRAS G12C mutation.", "url": "https://www.zacks.com/stock/news/1200681/amgen-amgn-files-for-kras-inhibitor-for-lung-cancer-in-europe"}, {"symbol": "AMGN", "publishedDate": "2020-12-22 08:32:45", "title": "Meet the Preliminary Dogs of the Dow for 2021", "image": "https://cdn.snapi.dev/images/v1/s/s/ss922ddd.", "site": "24/7 Wall Street", "text": "Perhaps no year since World War II will be less missed than 2020. The coronavirus pandemic has claimed more than 1.7 million lives so far this year.", "url": "https://247wallst.com/investing/2020/12/22/meet-the-preliminary-dogs-of-the-dow-for-2021/"}, {"symbol": "AMGN", "publishedDate": "2020-12-22 02:00:00", "title": "Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma", "image": "https://cdn.snapi.dev/images/v1/h/g/press11---t7fqyszegj.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Dec. 21, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced the SOURCE trial did not meet the primary endpoint of a statistically significant reduction in the daily oral corticosteroid (OCS) dose, without loss of asthma control, with...", "url": "https://www.prnewswire.com/news-releases/update-on-source-phase-3-trial-for-tezepelumab-in-patients-with-severe-oral-corticosteroid-dependent-asthma-301197136.html"}, {"symbol": "AMGN", "publishedDate": "2020-12-21 15:26:42", "title": "Dividend Changes: December 12-18, 2020", "image": "https://cdn.snapi.dev/images/v1/a/d/adasads2---bqkroynosz.jpg", "site": "Seeking Alpha", "text": "This weekly article series covers dividend changes. A summary table provides relevant data and key statistics of dividend increases.", "url": "https://seekingalpha.com/article/4395705-dividend-changes-december-12minus-18-2020"}, {"symbol": "AMGN", "publishedDate": "2020-12-19 07:30:00", "title": "Forget Apple: Here's a Better Dividend Growth Stock", "image": "https://cdn.snapi.dev/images/v1/0/s/biotech1---a85b4gvqpm.jpg", "site": "The Motley Fool", "text": "In terms of its payouts to shareholders, drugmaker Amgen has better stats than the tech powerhouse.", "url": "https://www.fool.com/investing/2020/12/19/forget-apple-heres-a-better-dividend-growth-stock/"}, {"symbol": "AMGN", "publishedDate": "2020-12-19 07:00:00", "title": "Eli Lilly, Amgen, and 2 Other Companies That Raised Their Dividends This Week", "image": "https://cdn.snapi.dev/images/v1/c/q/im-275385.jpg", "site": "Barrons", "text": "Dividend increases, which were very rare early in the pandemic as plenty of firms cut or suspended their payouts, have become more frequent as 2020 has gone along.", "url": "https://www.barrons.com/articles/eli-lilly-amgen-and-2-other-companies-that-raised-their-dividends-this-week-51608379201"}, {"symbol": "AMGN", "publishedDate": "2020-12-18 14:14:10", "title": "3 Stocks Delivering Over 10% Dividend Increases", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks9-1---zfkijdw8em.jpg", "site": "GuruFocus", "text": "This is an exciting time for dividend growth investors as it seems companies of all sizes and industries are announcing dividend increases. We will highlight three large companies that have provided their shareholders with at least a 10% dividend increase in recent weeks.", "url": "https://www.gurufocus.com/news/1314774/3-stocks-delivering-over-10-dividend-increases"}, {"symbol": "AMGN", "publishedDate": "2020-12-17 16:00:00", "title": "FDA Approves Amgen's RIABNI\u2122 (rituximab-arrx), A Biosimilar To Rituxan\u00ae (rituximab)", "image": "https://cdn.snapi.dev/images/v1/u/r/press12---owjtiowgor.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Dec. 17, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved RIABNI\u2122 (rituximab-arrx), a biosimilar to Rituxan\u00ae (rituximab), for the treatment of adult patients with Non-Hodgkin's Lymphoma (NHL),...", "url": "https://www.prnewswire.com/news-releases/fda-approves-amgens-riabni-rituximab-arrx-a-biosimilar-to-rituxan-rituximab-301195492.html"}, {"symbol": "AMGN", "publishedDate": "2020-12-17 10:32:23", "title": "Amgen (AMGN) Submits NDA for KRAS Inhibitor for Lung Cancer", "image": "https://cdn.snapi.dev/images/v1/p/i/biotech3---9ei5abwf3n.jpg", "site": "Zacks Investment Research", "text": "The NDA filing for Amgen's (AMGN) sotorasib is based on data from a phase II study, which showed that sotorasib led to durable anticancer activity in advanced NSCLC patients with KRAS G12C mutation.", "url": "https://www.zacks.com/stock/news/1176379/amgen-amgn-submits-nda-for-kras-inhibitor-for-lung-cancer"}, {"symbol": "AMGN", "publishedDate": "2020-12-17 06:17:00", "title": "3 Dividend Stocks That Have Doubled Their Payouts in 5 Years", "image": "https://cdn.snapi.dev/images/v1/t/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6049982f100-dollar-billsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "And their dividend payments could continue to climb higher.", "url": "https://www.fool.com/investing/2020/12/17/3-dividend-stocks-that-have-doubled-their-payouts/"}, {"symbol": "AMGN", "publishedDate": "2020-12-16 17:41:14", "title": "Stocks making the biggest moves after the bell: Roku, Amgen & more", "image": "https://cdn.snapi.dev/images/v1/b/m/105839207-1554740286113gettyimages-181766434.jpeg", "site": "CNBC", "text": "These are the stocks posting the largest moves after the bell Wednesday.", "url": "https://www.cnbc.com/2020/12/16/stocks-making-the-biggest-moves-after-the-bell-roku-amgen-more.html"}, {"symbol": "AMGN", "publishedDate": "2020-12-16 17:00:00", "title": "Amgen To Transfer Listing Of Debt Securities To Nasdaq", "image": "https://cdn.snapi.dev/images/v1/i/o/press12---fkh3qtrdsk.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Dec. 16, 2020 /PRNewswire/ -- Amgen Inc. (NASDAQ: AMGN) today announced its intention to transfer the securities exchange listing for its 1.250% Senior Notes due 2022 and 2.00% Senior Notes due 2026 (the \"Debt Securities\") from the New York Stock Exchange to the...", "url": "https://www.prnewswire.com/news-releases/amgen-to-transfer-listing-of-debt-securities-to-nasdaq-301194566.html"}, {"symbol": "AMGN", "publishedDate": "2020-12-16 16:00:00", "title": "Amgen Submits Sotorasib New Drug Application To U.S. FDA For Advanced Or Metastatic Non-Small Cell Lung Cancer With KRAS G12C Mutation", "image": "https://cdn.snapi.dev/images/v1/k/l/press4---lq0gld8sp2.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Dec. 16, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for sotorasib, an investigational KRASG12C inhibitor for the treatment of patients with KRAS G12C-mutated...", "url": "https://www.prnewswire.com/news-releases/amgen-submits-sotorasib-new-drug-application-to-us-fda-for-advanced-or-metastatic-non-small-cell-lung-cancer-with-kras-g12c-mutation-301194511.html"}, {"symbol": "AMGN", "publishedDate": "2020-12-15 15:56:35", "title": "Undervalued Dividend Growth Stocks: December 2020", "image": "https://cdn.snapi.dev/images/v1/a/4/biotech9.jpg", "site": "Seeking Alpha", "text": "I run my KISS Portfolio screen each month to look for buying opportunities. I present here the stocks that passed the KISS screen this month.", "url": "https://seekingalpha.com/article/4394915-undervalued-dividend-growth-stocks-december-2020"}, {"symbol": "AMGN", "publishedDate": "2020-12-15 00:17:00", "title": "This Popular Stock Strategy Got Pounded in 2020. Why 2021 Will Be Different", "image": "https://cdn.snapi.dev/images/v1/t/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6048952fdogs-2-gettyimages-186182291jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Many follow the Dogs of the Dow, which look poised for a rebound in the coming year.", "url": "https://www.fool.com/investing/2020/12/15/this-popular-stock-strategy-got-pounded-in-2020-wh/"}, {"symbol": "AMGN", "publishedDate": "2020-12-14 05:31:06", "title": "The 7 Best Dow Jones Stocks to Buy Now As You Ready for the Coming Year", "image": "https://cdn.snapi.dev/images/v1/8/a/fe212-2.jpg", "site": "InvestorPlace", "text": "For those who are put off by the extreme enthusiasm of this bull market, the usually reliable Dow Jones stocks offer much-needed balance. Here are seven to consider.", "url": "https://investorplace.com/2020/12/7-best-dow-jones-stocks-to-buy-now-ibm-hd-mmm-aapl-msft-wmt-amgn/"}, {"symbol": "AMGN", "publishedDate": "2020-12-11 17:50:11", "title": "Amgen (AMGN) Dips More Than Broader Markets: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/r/l/biotech7.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) closed at $227.40 in the latest trading session, marking a -0.33% move from the prior day.", "url": "https://www.zacks.com/stock/news/1155465/amgen-amgn-dips-more-than-broader-markets-what-you-should-know"}, {"symbol": "AMGN", "publishedDate": "2020-12-10 10:10:07", "title": "Which Big Biotechs Short Sellers Favor Now", "image": "https://cdn.snapi.dev/images/v1/l/9/biotech40.jpg", "site": "24/7 Wall Street", "text": "The short interest data is out for November 30, the most recent settlement date. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.", "url": "https://247wallst.com/healthcare-business/2020/12/10/which-big-biotechs-short-sellers-favor-now/"}, {"symbol": "AMGN", "publishedDate": "2020-12-10 06:11:25", "title": "December Dogs Of The Dow Run Away", "image": "https://cdn.snapi.dev/images/v1/s/j/sju222f.", "site": "Seeking Alpha", "text": "\"The Dow\u00ae [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration.\"- Dow Jones & Co. 30 Dow stocks represent nine of 11 sectors. Dow tracks utilities as a separate index and omits real estate. Broker top 10 target-estimated net gains ranged 11.05%-18.86% topped by MRK 12/7/20.", "url": "https://seekingalpha.com/article/4394003-december-dogs-of-dow-run-away"}, {"symbol": "AMGN", "publishedDate": "2020-12-08 22:03:07", "title": "Amgen Inc. (AMGN) Post ASH 2020 Oncology Update Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/p/o/transcript5---nj7et8lpih.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) Post ASH 2020 Oncology Update Conference (Transcript)", "url": "https://seekingalpha.com/article/4393727-amgen-inc-amgn-post-ash-2020-oncology-update-conference-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-12-07 09:00:00", "title": "Should You Buy Amgen Stock At $225?", "image": "https://cdn.snapi.dev/images/v1/n/r/should-you-buy-amgen-stock-at-225.jpg", "site": "Forbes", "text": "Amgen stock is down 5% since the start of the year and it has gained around 22% from its March lows. We believe that Amgen could offer an upside in the near term, as the company's revenues in the last three quarters have grown by 9%, primarily aided by its new drug Otezla.", "url": "https://www.forbes.com/sites/greatspeculations/2020/12/07/should-you-buy-amgen-stock-at-225/"}, {"symbol": "AMGN", "publishedDate": "2020-12-05 15:00:00", "title": "Amgen To Present First Clinical Data For BCMA-Targeted Half-Life Extended BiTE\u00ae Therapy AMG 701 At ASH 2020", "image": "https://cdn.snapi.dev/images/v1/1/c/conf13.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Dec. 5, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the first presentation of clinical safety and efficacy data from the Phase 1 study of AMG 701 in heavily pre-treated patients with relapsed/refractory multiple myeloma (R/R MM). AMG 701 is an...", "url": "https://www.prnewswire.com/news-releases/amgen-to-present-first-clinical-data-for-bcma-targeted-half-life-extended-bite-therapy-amg-701-at-ash-2020-301186776.html"}, {"symbol": "AMGN", "publishedDate": "2020-12-04 07:48:00", "title": "Dow Jones 30,000: Here's Why It's Still Underperforming the S&P 500 and the Nasdaq", "image": "https://cdn.snapi.dev/images/v1/h/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6024962fgettyimages-177320725jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Coronavirus vaccine news and a Biden presidency are pushing the stock market higher, but certain sectors are contributing most of the gains.", "url": "https://www.fool.com/investing/2020/12/04/dow-jones-30000-heres-why-it-still-underperforming/"}, {"symbol": "AMGN", "publishedDate": "2020-12-04 07:15:00", "title": "Amgen and McKesson Launch Strategic Agreement to Advance Cancer Innovation in Communities", "image": "https://cdn.snapi.dev/images/v1/w/n/press16---iynjmaexga.jpg", "site": "Business Wire", "text": "IRVING, Texas & THOUSAND OAKS, Calif.--(BUSINESS WIRE)--McKesson and Amgen (NASDAQ:AMGN), one of the world's leading biotechnology companies, have signed a strategic agreement to help improve cancer care in community oncology settings. Today, 1 in 5 cancer patients receives an Amgen medicine, while McKesson reaches 20% of U.S. cancer patients. This multi-year agreement bridges the power and reach of the two companies and will focus on reducing gaps in care by optimizing access to innovative pre", "url": "https://www.businesswire.com/news/home/20201204005114/en/Amgen-and-McKesson-Launch-Strategic-Agreement-to-Advance-Cancer-Innovation-in-Communities/"}, {"symbol": "AMGN", "publishedDate": "2020-12-03 11:13:37", "title": "3 Under-Loved Biotech Stocks to Buy for Profits Into 2021", "image": "https://cdn.snapi.dev/images/v1/p/q/biotech10.jpg", "site": "InvestorPlace", "text": "Biotech stocks are vulnerable to headlines, but these three have too much potential to ignore. Own them for a swing trade into 2021.", "url": "https://investorplace.com/2020/12/3-under-loved-biotech-stocks-to-buy-for-profits-into-2021/"}, {"symbol": "AMGN", "publishedDate": "2020-12-01 18:06:03", "title": "Amgen's (AMGN) Management on Evercore ISI 3rd Annual HealthCONx Conference", "image": "https://cdn.snapi.dev/images/v1/0/x/transcript12.jpg", "site": "Seeking Alpha", "text": "Amgen's (AMGN) Management on Evercore ISI 3rd Annual HealthCONx Conference", "url": "https://seekingalpha.com/article/4392409-amgens-amgn-management-on-evercore-isi-3rd-annual-healthconx-conference"}, {"symbol": "AMGN", "publishedDate": "2020-11-30 16:45:00", "title": "World's Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19", "image": "https://cdn.snapi.dev/images/v1/a/e/press5---rawm8qqqfs.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Nov. 30, 2020 /PRNewswire/ -- Three members of the COVID R&D Alliance - Amgen Inc. (NASDAQ: AMGN), Takeda Pharmaceutical Co. Ltd. (NYSE: TAK), and UCB (Euronext BR: UCB) - today announced the first patient enrolled in the COMMUNITY Trial (COVID-19 Multiple Agents...", "url": "https://www.prnewswire.com/news-releases/worlds-leading-life-science-companies-now-enrolling-community-a-global-platform-trial-for-hospitalized-patients-with-covid-19-301181830.html"}, {"symbol": "AMGN", "publishedDate": "2020-11-27 11:31:32", "title": "Amgen (AMGN) Up 1.8% Since Last Earnings Report: Can It Continue?", "image": "https://cdn.snapi.dev/images/v1/m/w/biotech1.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/1115558/amgen-amgn-up-18-since-last-earnings-report-can-it-continue"}, {"symbol": "AMGN", "publishedDate": "2020-11-26 09:10:40", "title": "You Need To Look At Amgen - Right Now", "image": "https://cdn.snapi.dev/images/v1/l/5/biotech7.jpg", "site": "Seeking Alpha", "text": "Amgen is one of the world's largest independent biopharma companies, headquartered in California. The company's focus is recombinant DNA technology, with major product lines being immunostimulation medication, autoimmune diseases and others.", "url": "https://seekingalpha.com/article/4391687-you-need-to-look-amgen-right-now"}, {"symbol": "AMGN", "publishedDate": "2020-11-25 16:00:00", "title": "Amgen To Present At The Evercore ISI Virtual HealthCONx Conference", "image": "https://cdn.snapi.dev/images/v1/t/a/conf9.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Nov. 25, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Evercore ISI Virtual HealthCONx Conference at 1:50 p.m. ET on Tuesday, Dec. 1, 2020. David M. Reese, M.D., executive vice president of Research and Development and Peter H. Griffith, executive...", "url": "https://www.prnewswire.com/news-releases/amgen-to-present-at-the-evercore-isi-virtual-healthconx-conference-301180785.html"}, {"symbol": "AMGN", "publishedDate": "2020-11-25 10:03:19", "title": "Big Biotech Short Sellers Seek Cover", "image": "https://cdn.snapi.dev/images/v1/x/s/biotech34.jpg", "site": "24/7 Wall Street", "text": "The short interest data are out for November 13, the most recent settlement date. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.", "url": "https://247wallst.com/healthcare-business/2020/11/25/big-biotech-short-sellers-seek-cover/"}, {"symbol": "AMGN", "publishedDate": "2020-11-23 07:30:00", "title": "Amgen To Transition Development And Commercial Rights For Omecamtiv Mecarbil And AMG 594 To Cytokinetics", "image": "https://cdn.snapi.dev/images/v1/e/a/press19---voyifiwuqh.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Nov. 23, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Company has provided notice to Cytokinetics of termination of its collaboration and its intention to transition the development and commercialization rights for omecamtiv mecarbil and AMG 594....", "url": "https://www.prnewswire.com/news-releases/amgen-to-transition-development-and-commercial-rights-for-omecamtiv-mecarbil-and-amg-594-to-cytokinetics-301178604.html"}, {"symbol": "AMGN", "publishedDate": "2020-11-18 18:22:04", "title": "Amgen, Inc. (AMGN) Presents at Jefferies Virtual London Healthcare Broker Conference Call - (Transcript)", "image": "https://cdn.snapi.dev/images/v1/o/q/transcript33.jpg", "site": "Seeking Alpha", "text": "Amgen, Inc. (AMGN) Presents at Jefferies Virtual London Healthcare Broker Conference Call - (Transcript)", "url": "https://seekingalpha.com/article/4390157-amgen-inc-amgn-presents-jefferies-virtual-london-healthcare-broker-conference-call-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-11-18 11:36:02", "title": "Amgen Makes Notable Cross Below Critical Moving Average", "image": "https://cdn.snapi.dev/images/v1/o/p/amgen-makes-notable-cross-below-critical-moving-average.jpg", "site": "Forbes", "text": "In trading on Wednesday, shares of Amgen crossed below their 200 day moving average of $231.90, changing hands as low as $230.26 per share. Amgen shares are currently trading down about 0.3% on the day.", "url": "https://www.forbes.com/sites/dividendchannel/2020/11/18/amgen-makes-notable-cross-below-critical-moving-average/"}, {"symbol": "AMGN", "publishedDate": "2020-11-13 16:00:00", "title": "Amgen To Present At The Jefferies Virtual London Healthcare Conference", "image": "https://cdn.snapi.dev/images/v1/j/4/conf9.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Nov. 13, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Jefferies Virtual London Healthcare Conference at 12:00 p.m. ET on Wednesday, Nov. 18, 2020. Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the...", "url": "https://www.prnewswire.com/news-releases/amgen-to-present-at-the-jefferies-virtual-london-healthcare-conference-301172939.html"}, {"symbol": "AMGN", "publishedDate": "2020-11-10 22:13:17", "title": "Elephant Dividends Portfolio Monthly Review:\u00a0October 2020", "image": "https://cdn.snapi.dev/images/v1/t/r/biotech16.jpg", "site": "Seeking Alpha", "text": "The Elephant Dividends portfolio's projected annual dividend income (PADI) is $907.25. Well-constructed charts and graphs are useful tools for monitoring and maintaining a properly diversified dividend portfolio.", "url": "https://seekingalpha.com/article/4387884-elephant-dividends-portfolio-monthly-review-october-2020"}, {"symbol": "AMGN", "publishedDate": "2020-11-10 12:35:45", "title": "5 Leading Healthcare Stocks Surging On Pent-Up Demand", "image": "https://cdn.snapi.dev/images/v1/h/t/biotech38---hxdmyuzpuc.jpg", "site": "Insider Monkey", "text": "As Mr. Valuation, I find myself constantly reminding investors that value investing requires patience. However, value investing also requires the willingness to get your money in front of attractive valuation when it is discovered. Trying to time your purchases perfectly can just as easily cause you to miss out on significant gains as it is to participate in them. More directly stated, significant undervaluation can stimulate strong pent-up demand causing stock prices to rise rapidly. Therefore, if you are not already in front of those advances, you can miss out on a lot of profit and opportunity.", "url": "https://www.insidermonkey.com/blog/5-leading-healthcare-stocks-surging-on-pent-up-demand-889339/"}, {"symbol": "AMGN", "publishedDate": "2020-11-10 09:38:37", "title": "Amgen, AstraZeneca Stocks Pop On 'Best-Case' Outcome For Asthma Drug", "image": "https://cdn.snapi.dev/images/v1/x/3/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5385732fcheering-crowd-of-healthcare-providers-gettyjpgw700opresize.jpg", "site": "Investors Business Daily", "text": "Amgen stock popped Tuesday after the biotech company's AstraZeneca-partnered asthma treatment succeeded in a Phase 3 test. The post Amgen, AstraZeneca Stocks Pop On 'Best-Case' Outcome For Asthma Drug appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/amgen-stock-pops-best-case-outcome-asthma-treatment/"}, {"symbol": "AMGN", "publishedDate": "2020-11-10 02:00:00", "title": "Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma", "image": "https://cdn.snapi.dev/images/v1/t/p/press9.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Nov. 9, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive topline results from the Phase 3 NAVIGATOR trial in which the investigational medicine tezepelumab demonstrated a statistically significant reduction in exacerbations compared...", "url": "https://www.prnewswire.com/news-releases/tezepelumab-navigator-phase-3-trial-met-primary-endpoint-of-a-statistically-significant-and-clinically-meaningful-reduction-in-exacerbations-in-a-broad-population-of-patients-with-severe-asthma-301169291.html"}, {"symbol": "AMGN", "publishedDate": "2020-11-09 20:14:05", "title": "Amgen Inc. (AMGN) Management Presents at Credit Suisse 29th Annual Virtual Healthcare Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/d/k/transcript24.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) Management Presents at Credit Suisse 29th Annual Virtual Healthcare Conference (Transcript)", "url": "https://seekingalpha.com/article/4387327-amgen-inc-amgn-management-presents-credit-suisse-29th-annual-virtual-healthcare-conference"}, {"symbol": "AMGN", "publishedDate": "2020-11-05 23:09:58", "title": "5 Leading Healthcare Stocks Surging On Pent-Up Demand", "image": "https://cdn.snapi.dev/images/v1/9/v/drugs50---7chu6g7nxb.jpg", "site": "Seeking Alpha", "text": "The primary message behind this article is that value is worth waiting for, especially when a dividend is associated. Several high-quality companies in these subsectors posted strong price advances.", "url": "https://seekingalpha.com/article/4385631-5-leading-healthcare-stocks-surging-on-pent-up-demand"}, {"symbol": "AMGN", "publishedDate": "2020-11-05 07:27:00", "title": "Need to Know: These 7 unloved stocks are for the long haul, says contrarian manager", "image": "https://cdn.snapi.dev/images/v1/e/t/etf28---gan7oyd3pn.jpg", "site": "Market Watch", "text": "Our call of the day offers up several stocks that busy, distracted investors have been overlooking. Smead Capital Management's CIO says they are stocks to hold for the long run.", "url": "https://www.marketwatch.com/story/these-7-unloved-stocks-are-for-the-long-haul-says-contrarian-manager-11604579260"}, {"symbol": "AMGN", "publishedDate": "2020-11-04 17:00:00", "title": "Amgen To Present At The 29th Annual Credit Suisse Healthcare Conference", "image": "https://cdn.snapi.dev/images/v1/q/y/conf1.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Nov. 4, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 29th Annual Credit Suisse Virtual Healthcare Conference at 4:15 p.m. ET on Monday, Nov. 9, 2020, in Scottsdale, Ariz. Murdo Gordon, executive vice president of Global Commercial Operations at Amgen...", "url": "https://www.prnewswire.com/news-releases/amgen-to-present-at-the-29th-annual-credit-suisse-healthcare-conference-301166676.html"}, {"symbol": "AMGN", "publishedDate": "2020-11-04 11:23:37", "title": "Health care stocks soar, add more than 350 points to the Dow's price", "image": "https://cdn.snapi.dev/images/v1/t/e/m02d20201010t2i1536923540w940fhfwllplsqrlynxmpeg9813w.jpg", "site": "Market Watch", "text": "Shares of UnitedHealth Group Inc. soared 10.2% in morning trading, enough to pace the Dow Jones Industrial Average's gainers, as the uncertain election outcome is seen as a boon to the health care sector. The stock's price gain of $32.65 was adding about 215 points to the Dow's price, while the Dow was up 547 points, or 2.0%.", "url": "https://www.marketwatch.com/story/health-care-stocks-soar-add-more-than-350-points-to-the-dows-price-2020-11-04"}, {"symbol": "AMGN", "publishedDate": "2020-11-03 16:14:10", "title": "Bristol Myers Squibb Says Its Drug Outperforms Drug It Sold To Amgen", "image": "https://cdn.snapi.dev/images/v1/l/j/biotech16.jpg", "site": "Investors Business Daily", "text": "Bristol Myers Squibb said Phase 3 clinical trial results shows its psoriasis drug candidate outperformed a drug it sold to Amgen last year as part of its Celgene acquisition. BMY stock rose.", "url": "https://www.investors.com/news/technology/bmy-stock-rises-bristol-myers-squibb-reports-positive-trial-results-psoriasis-drug-branch/"}, {"symbol": "AMGN", "publishedDate": "2020-11-03 08:41:10", "title": "Bristol Myers Squibb Says Its Drug Outperforms Drug It Sold To Amgen", "image": "https://cdn.snapi.dev/images/v1/p/0/biotech35.jpg", "site": "Investors Business Daily", "text": "Bristol Myers Squibb said Phase 3 clinical trial results shows its psoriasis drug candidate outperformed a drug it sold to Amgen last year as part of its Celgene acquisition. BMY stock rose.", "url": "https://www.investors.com/news/technology/bmy-stock-rises-bristol-myers-squibb-reports-positive-trial-results-psoriasis-drug/"}, {"symbol": "AMGN", "publishedDate": "2020-10-30 15:34:08", "title": "Bill Nygren Explains How to Look Beyond GAAP Accounting", "image": "https://cdn.snapi.dev/images/v1/k/g/biotech1.jpg", "site": "GuruFocus", "text": "Accounting is the language of investing and finance. As with any language, it is very helpful to have a set of standardized rules and conventions that allow different parties to understand one another.", "url": "https://www.gurufocus.com/news/1271925/bill-nygren-explains-how-to-look-beyond-gaap-accounting"}, {"symbol": "AMGN", "publishedDate": "2020-10-29 10:35:58", "title": "Amgen (AMGN) Losing Altitude Despite Strong Quarter", "image": "https://cdn.snapi.dev/images/v1/o/0/biotech6.jpg", "site": "Investopedia", "text": "Amgen (AMGN) is trading lower after third quarter earnings and could drop another 20 points in coming weeks.", "url": "https://www.investopedia.com/amgen-amgn-losing-altitude-despite-strong-quarter-5084946"}, {"symbol": "AMGN", "publishedDate": "2020-10-29 06:05:00", "title": "Thank Otezla for Amgen's Q3 Revenue and Earnings Beats", "image": "https://cdn.snapi.dev/images/v1/u/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5972042fscientist-in-lab-with-arms-crossedjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Without the purchase of the blockbuster autoimmune disease drug, Amgen's latest results wouldn't have looked nearly as good.", "url": "https://www.fool.com/investing/2020/10/29/thank-otezla-for-amgens-q3-revenue-and-earnings-be/"}, {"symbol": "AMGN", "publishedDate": "2020-10-28 23:30:54", "title": "Amgen Inc. (AMGN) CEO Robert Bradway on Q3 2020 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/t/x/transcript3---yco5fogbjf.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) CEO Robert Bradway on Q3 2020 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4382377-amgen-inc-amgn-ceo-robert-bradway-on-q3-2020-results-earnings-call-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-10-28 16:39:13", "title": "Amgen Earnings, Sales Top Wall Street Views; Hikes Earnings Guidance", "image": "https://cdn.snapi.dev/images/v1/u/d/biotech20.jpg", "site": "Investors Business Daily", "text": "Amgen posted third-quarter earnings and sales that beat Wall Street views and hiked it earnings outlook, and Amgen stock rose after hours after hitting four-month lows in the regular session. The post Amgen Earnings, Sales Top Wall Street Views; Hikes Earnings Guidance appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/amgen-stock-edges-higher-after-company-posts-earnings-beat-hikes-eps-guidance/"}, {"symbol": "AMGN", "publishedDate": "2020-10-28 16:30:35", "title": "Recap: Amgen Q3 Earnings", "image": "https://cdn.snapi.dev/images/v1/m/k/biotech18.jpg", "site": "Benzinga", "text": "Shares of Amgen (NASDAQ:AMGN) were unchanged\u00a0after the company reported Q3 results. Quarterly Results Earnings per share increased 19.40% over the past year to $4.37, which beat the estimate of $3.80.", "url": "https://www.benzinga.com/news/earnings/20/10/18105124/recap-amgen-q3-earnings"}, {"symbol": "AMGN", "publishedDate": "2020-10-28 16:30:28", "title": "Amgen beats EPS and revenue, $6.42B vs. $6.38B, raises full-year guidance", "image": "https://cdn.snapi.dev/images/v1/w/p/amgen-beats-eps-and-revenue-642b-vs-638b-raises-full-year-guidance.jpg", "site": "CNBC Television", "text": "Meg Tirrell joins 'Closing Bell' to report Amgen's quarterly earnings.", "url": "https://www.youtube.com/watch?v=cBSZFkNtaKo"}, {"symbol": "AMGN", "publishedDate": "2020-10-28 16:25:20", "title": "These Two Major Biotechs Are Bouncing Back With Q3 Results", "image": "https://cdn.snapi.dev/images/v1/b/l/biotech17.jpg", "site": "24/7 Wall Street", "text": "Amgen Inc. (NASDAQ: AMGN) and Gilead Sciences Inc.", "url": "https://247wallst.com/healthcare-business/2020/10/28/these-two-major-biotechs-are-bouncing-back-with-q3-results/"}, {"symbol": "AMGN", "publishedDate": "2020-10-28 16:07:00", "title": "Amgen stock rises after earnings beat", "image": "https://cdn.snapi.dev/images/v1/p/v/biotech15.jpg", "site": "Market Watch", "text": "Amgen Inc. AMGN shares rose in the extended session Wednesday after the biotech drug maker topped Wall Street estimates for the quarter. Amgen shares advanced 1.2% after hours, following a 3.2% decline in the regular session to close at $216.38.", "url": "https://www.marketwatch.com/story/amgen-stock-rises-after-earnings-beat-11603915648"}, {"symbol": "AMGN", "publishedDate": "2020-10-28 08:59:39", "title": "7 Cutting-Edge Biotech Stocks for Tomorrow\u00a0", "image": "https://cdn.snapi.dev/images/v1/e/4/drugs41.jpg", "site": "InvestorPlace", "text": "Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.", "url": "https://investorplace.com/2020/10/7-cutting-edge-biotech-stocks-for-tomorrow/"}, {"symbol": "AMGN", "publishedDate": "2020-10-27 18:57:00", "title": "Amgen Announces Webcast Of 2020 Third Quarter Financial Results", "image": "https://cdn.snapi.dev/images/v1/l/f/conf11---upis1g7r7t.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Oct. 27, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Wednesday, October 28, 2020, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the...", "url": "https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2020-third-quarter-financial-results-301161178.html"}, {"symbol": "AMGN", "publishedDate": "2020-10-27 16:00:00", "title": "Amgen Announces Participation Of Systemic Lupus Erythematosus (SLE) Adaptive Clinical Trial In The FDA Complex Innovative Trial Designs (CID) Pilot Program", "image": "https://cdn.snapi.dev/images/v1/5/k/press11---db2expinpc.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Oct. 27, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has completed trial design discussions through two Complex Innovative Trial Designs (CID) Pilot Program meetings with the U.S. Food and Drug Administration (FDA) for its planned Phase 2...", "url": "https://www.prnewswire.com/news-releases/amgen-announces-participation-of-systemic-lupus-erythematosus-sle-adaptive-clinical-trial-in-the-fda-complex-innovative-trial-designs-cid-pilot-program-301160908.html"}, {"symbol": "AMGN", "publishedDate": "2020-10-27 10:08:00", "title": "3 Biotech Stocks I'd Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/g/u/biotech23.jpg", "site": "The Motley Fool", "text": "Marketed products -- and work in the pipeline -- should translate into future growth for these shares.", "url": "https://www.fool.com/investing/2020/10/27/3-biotech-stocks-id-buy-right-now/"}, {"symbol": "AMGN", "publishedDate": "2020-10-27 10:05:07", "title": "Amgen's Earnings Outlook", "image": "https://cdn.snapi.dev/images/v1/h/l/biotech36.jpg", "site": "Benzinga", "text": "Amgen (NASDAQ:\u00a0AMGN) releases its next round of earnings this Wednesday, October 28. Here is Benzinga's essential guide to Amgen's Q3 earnings report.", "url": "https://www.benzinga.com/news/earnings/20/10/18074573/amgens-earnings-outlook"}, {"symbol": "AMGN", "publishedDate": "2020-10-27 09:55:02", "title": "Major Biotechs Have Short Sellers Looking Both Ways", "image": "https://cdn.snapi.dev/images/v1/p/5/biotech35.jpg", "site": "24/7 Wall Street", "text": "The short interest data are out for October 15, the most recent settlement date. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.", "url": "https://247wallst.com/healthcare-business/2020/10/27/major-biotechs-have-short-sellers-looking-both-ways/"}, {"symbol": "AMGN", "publishedDate": "2020-10-27 07:53:00", "title": "Better Buy: Amgen vs. Mirati Therapeutics", "image": "https://cdn.snapi.dev/images/v1/v/4/microbiology-163521-1280-6.jpg", "site": "The Motley Fool", "text": "Which one of these biotech stocks has a better chance to provide market-beating gains?", "url": "https://www.fool.com/investing/2020/10/27/better-buy-amgen-vs-mirati-therapeutics/"}, {"symbol": "AMGN", "publishedDate": "2020-10-26 11:16:46", "title": "Tiny Mirati Therapeutics Gets Jump On Giant Amgen In Cancer Drug", "image": "https://cdn.snapi.dev/images/v1/u/y/biotech5.jpg", "site": "Investors Business Daily", "text": "Tiny Mirati Therapeutics posted positive preliminary data on a colorectal and lung cancer drug therapy in competition with drug giant Amgen, sending MRTX stock soaring to an all-time high. The post Tiny Mirati Therapeutics Gets Jump On Giant Amgen In Cancer Drug appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/mrtx-stock-hits-record-high-mirati-therapeutics-gets-jump-amgen-cancer-drug/"}, {"symbol": "AMGN", "publishedDate": "2020-10-26 00:05:23", "title": "Were Hedge Funds Right About Souring On Amgen, Inc. (AMGN)?", "image": "https://cdn.snapi.dev/images/v1/p/n/biotech6.jpg", "site": "Insider Monkey", "text": "In this article we are going to use hedge fund sentiment as a tool and determine whether Amgen, Inc. (NASDAQ:AMGN) is a good investment right now. We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of news stories covering failed hedge fund investments and it is a fact that hedge funds' picks don't beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk.", "url": "https://www.insidermonkey.com/blog/were-hedge-funds-right-about-souring-on-amgen-inc-amgn-887135/"}, {"symbol": "AMGN", "publishedDate": "2020-10-23 03:05:07", "title": "Alfa SAB de CV (ALFFF) CEO on Q3 2020 Results - Earnings Call Transcript", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "Alfa SAB de CV (OTCPK:ALFFF) Q3 2020 Earnings Conference Call October 22, 2020, 13:00 ET Company Participants Hernan Lozano - VP, IR &amp; Corporate Communications Eduardo Escalante - CFO Roberto Olivares - CFO, Sigma Alberto Sada - CFO Carlos Jim\u00e9nez Barrera - Senior VP of Legal, Audit &amp; Corporate Affairs and Secretary Conference Call Participants Vanessa Quiroga - Cr\u00e9dit Suisse Nikolaj Lippmann - Morgan Stanley Eric Neguelouart - Bank of America Merrill Lynch Alejandro Azar - GBM Alfonso Salazar - Scotiabank Gilberto Garcia - Barclays Bank Jean Bruny - BBVA Andres Cardona - Citigroup Manuela Echavarr\u00eda - Credicorp Capital Alejandro Chavelas - Cr\u00e9dit Suisse Presentation Operator Greetings, and welcome to ALFA's Third Quarter 2020 Earnings Conference Call.", "url": "https://seekingalpha.com/article/4380849-alfa-sab-de-cv-alfff-ceo-on-q3-2020-results-earnings-call-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-10-21 13:01:35", "title": "Alfa Laval : supplements the tender offer document dated 12 August 2020 regarding the recommended public cash tender offer for all shares in Neles | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/ALFA-LAVAL-AB-6494532/news/Alfa-Laval-supplements-the-tender-offer-document-dated-12-August-2020-regarding-the-recommended-pu-31582765/"}, {"symbol": "AMGN", "publishedDate": "2020-10-20 13:00:48", "title": "Banking on the Next Blockbuster Drug - NetworkNewsWire", "image": "https://cdn.networkwire.news/5f8de7a1b97030.58771515_oejlfkhmnipgq.png", "site": "https://www.networknewswire.com", "text": "NetworkNewsWire Editorial Coverage: Pharmaceutical companies invest enormous amounts of time and money on the research and development of new drugs, typically years in the making and costing millions of dollars. Only occasionally is a new drug developed that\u2019s approved and generates more than $1 billion per year in sales, a benchmark in the industry commonly \u2026 Continue reading \"Banking on the Next Blockbuster Drug\"", "url": "https://www.networknewswire.com/banking-on-the-next-blockbuster-drug/"}, {"symbol": "AMGN", "publishedDate": "2020-10-20 00:00:00", "title": "Waste Heat Recovery Market to Grow at a CAGR of Over 4% Due to Increasing Focus on Reducing Carbon Footprint | Technavio", "image": "https://mms.businesswire.com/media/20201020005860/en/831838/23/IRTNTR43512.jpg", "site": "businesswire", "text": "The Global Waste Heat Recovery Market will grow by USD 11.31 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20201020005860/en/Waste-Heat-Recovery-Market-to-Grow-at-a-CAGR-of-Over-4-Due-to-Increasing-Focus-on-Reducing-Carbon-Footprint-Technavio"}, {"symbol": "AMGN", "publishedDate": "2020-10-19 17:16:03", "title": "Neles Oyj : The Board of Directors of Neles Corporation supplements its statement regarding the recommended voluntary public cash tender offer by Alfa Laval AB (publ) | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdgris.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/NELES-OYJ-1412488/news/Neles-Oyj-The-Board-of-Directors-of-Neles-Corporation-supplements-its-statement-regarding-the-reco-31568122/"}, {"symbol": "AMGN", "publishedDate": "2020-10-19 15:37:13", "title": "Amgen Is Headed For $220, But It Could Be Worth $400 (NASDAQ:AMGN)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "Following a mediocre clinical trial reading, Amgen is trading downwards. Investors are looking for a win as top drug sales decline.", "url": "https://seekingalpha.com/article/4379750-amgen-is-headed-for-220-be-worth-400"}, {"symbol": "AMGN", "publishedDate": "2020-10-19 14:48:00", "title": "Dow down 35 points on losses in shares of Cisco, UnitedHealth", "image": "https://images.mktw.net/im-220108", "site": "marketwatch", "text": "The Dow Jones Industrial Average is declining Monday morning with shares of Cisco and UnitedHealth delivering the stiffest headwinds for the index. Shares of...", "url": "https://www.marketwatch.com/story/dow-down-35-points-on-losses-in-shares-of-cisco-unitedhealth-2020-10-19"}, {"symbol": "AMGN", "publishedDate": "2020-10-19 06:52:47", "title": "Here\u2019s what you can expect from a graduate programme in pharma", "image": "https://www.siliconrepublic.com/wp-content/uploads/2020/10/VB-1.jpg", "site": "https://www.siliconrepublic.com", "text": "Veronica Boomsma discusses her experiences of entering the Amgen graduate programme after studying industrial biochemistry.", "url": "https://www.siliconrepublic.com/people/amgen-graduate-programme-veronica-boomsma"}, {"symbol": "AMGN", "publishedDate": "2020-10-19 00:00:00", "title": "Global Industrial Food Blender And Mixer Market will Exhibit Neutral Impact During 2020-2024 | Rising Demand for Custom-Designed Mixers to Improve the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20201019005498/en/831306/23/IRTNTR40999.jpg", "site": "businesswire", "text": "The Global Industrial Food Blender and Mixer Market will grow by USD 4.45 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20201019005498/en/Global-Industrial-Food-Blender-And-Mixer-Market-will-Exhibit-Neutral-Impact-During-2020-2024-Rising-Demand-for-Custom-Designed-Mixers-to-Improve-the-Market-Growth-Technavio"}, {"symbol": "AMGN", "publishedDate": "2020-10-18 13:30:00", "title": "Better Buy: Amgen vs. Bristol Myers Squibb | The Motley Fool", "image": "https://g.foolcdn.com/editorial/images/594809/two-scientists-working-in-a-lab.jpg", "site": "https://www.fool.com", "text": "Here's how these two big drugmakers stack up against each other in several key categories.", "url": "https://www.fool.com/investing/2020/10/18/better-buy-amgen-vs-bristol-myers-squibb/"}, {"symbol": "AMGN", "publishedDate": "2020-10-16 14:46:00", "title": "Dow's 311-point rally highlighted by gains for shares of Boeing, Caterpillar", "image": "https://images.mktw.net/im-220108", "site": "marketwatch", "text": "Buoyed by positive momentum for shares of Boeing and Caterpillar, the Dow Jones Industrial Average is rallying Friday morning. The Dow is trading 311 points...", "url": "https://www.marketwatch.com/story/dows-311-point-rally-highlighted-by-gains-for-shares-of-boeing-caterpillar-2020-10-16"}, {"symbol": "AMGN", "publishedDate": "2020-10-16 14:31:34", "title": "Alfa Laval : amends its recommended offer for Neles acceptance level condition lowered to 50% and acceptance period extended | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdgris.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/ALFA-LAVAL-AB-6494532/news/Alfa-Laval-amends-its-recommended-offer-for-Neles-acceptance-level-condition-lowered-to-50-and-ac-31554442/"}, {"symbol": "AMGN", "publishedDate": "2020-10-16 00:00:00", "title": "Global Drug Substance Manufacturing Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024", "image": "https://mms.businesswire.com/media/20201016005325/en/830944/23/Drug_Substance_Manufacturing_Market.jpg", "site": "businesswire", "text": "Drug Substance Manufacturing market will register an incremental spend of about $77 billion, growing at a CAGR of 6.31% during the five-year forecast", "url": "https://www.businesswire.com/news/home/20201016005325/en/Global-Drug-Substance-Manufacturing-Market-Procurement-Intelligence-Report-with-COVID-19-Impact-Analysis-Global-Forecasts-2020-2024"}, {"symbol": "AMGN", "publishedDate": "2020-10-15 06:33:01", "title": "Alfa Laval Lowers Acceptance Level of Neles Bid, Extends Acceptance Period | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdgris.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/ALFA-LAVAL-AB-6494532/news/Alfa-Laval-Lowers-Acceptance-Level-of-Neles-Bid-Extends-Acceptance-Period-31543088/"}, {"symbol": "AMGN", "publishedDate": "2020-10-15 06:28:00", "title": "Alfa Laval lowers acceptance level of Neles bid", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "STOCKHOLM--Alfa Laval AB said Thursday that it has lowered the acceptance level of its bid for Neles Oyj and extended the acceptance period. Alfa Laval...", "url": "https://www.marketwatch.com/story/alfa-laval-lowers-acceptance-level-of-neles-bid-2020-10-15"}, {"symbol": "AMGN", "publishedDate": "2020-10-15 00:00:00", "title": "Global Food Processing Machinery Market will Showcase Neutral Impact During 2020-2024 | Anticipated Growth In Global Packaged Food Market to Boost Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20201015005690/en/830675/23/IRTNTR43232.jpg", "site": "businesswire", "text": "The Global Food Processing Machinery Market will grow by $ 16.15 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20201015005690/en/Global-Food-Processing-Machinery-Market-will-Showcase-Neutral-Impact-During-2020-2024-Anticipated-Growth-In-Global-Packaged-Food-Market-to-Boost-Market-Growth-Technavio"}, {"symbol": "AMGN", "publishedDate": "2020-10-14 16:33:14", "title": "Mahindra and Mahindra : rolls out BS6 variants of Alfa, its popular 3-wheeler brand | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/MAHINDRA-AND-MAHINDRA-LTD-9058830/news/Mahindra-and-Mahindra-rolls-out-BS6-variants-of-Alfa-its-popular-3-wheeler-brand-31539958/"}, {"symbol": "AMGN", "publishedDate": "2020-10-14 12:35:00", "title": "Got $500? 3 Big Pharma Stocks You Can Buy Now That Pay Dividends | The Motley Fool", "image": "https://g.foolcdn.com/editorial/images/594777/scientist-in-lab-getty.jpg", "site": "https://www.fool.com", "text": "For less than $500 you can get these successful drugmakers to send you a growing share of their bottom line.", "url": "https://www.fool.com/investing/2020/10/14/got-500-3-big-pharma-stocks-you-can-buy-now-that-p/"}, {"symbol": "AMGN", "publishedDate": "2020-10-14 10:45:00", "title": "2 Cheap Dividend Stocks You Can Buy Right Now | The Motley Fool", "image": "https://g.foolcdn.com/editorial/images/594887/stack-of-100-dollar-bills.jpg", "site": "https://www.fool.com", "text": "These value investments can generate above-average payouts for your portfolio. And they're trading at pretty fair prices.", "url": "https://www.fool.com/investing/2020/10/14/2-cheap-dividend-stocks-you-can-buy-right-now/"}, {"symbol": "AMGN", "publishedDate": "2020-10-14 04:30:41", "title": "Q3 2020 EPS Estimates for Amgen Inc. (NASDAQ:AMGN) Raised by Jefferies Financial Group", "image": "https://www.marketbeat.com/logos/amgen-inc-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Amgen Inc. (NASDAQ:AMGN) \u2013 Jefferies Financial Group lifted their Q3 2020 earnings per share (EPS) estimates for shares of Amgen in a note issued to investors on Monday, October 12th. Jefferies Financial Group analyst M. Yee now anticipates that the medical research company will post earnings of $3.82 per share for the quarter, up from [\u2026]", "url": "https://www.thelincolnianonline.com/2020/10/14/q3-2020-eps-estimates-for-amgen-inc-nasdaqamgn-raised-by-jefferies-financial-group.html"}, {"symbol": "AMGN", "publishedDate": "2020-10-13 14:19:50", "title": "Arrowhead Is A Buy On Takeda Deal And Massive Pipeline (NASDAQ:ARWR)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "Arrowhead Pharmaceuticals establishes deal with Takeda for the use of ARO-AAT in a deal worth up to $1.04 billion.", "url": "https://seekingalpha.com/article/4378829-arrowhead-is-buy-on-takeda-deal-and-massive-pipeline"}, {"symbol": "AMGN", "publishedDate": "2020-10-13 12:37:46", "title": "Amgen Inc. (NASDAQ:AMGN) Shares Sold by Tiaa Fsb", "image": "https://www.marketbeat.com/logos/amgen-inc-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Tiaa Fsb lessened its position in shares of Amgen Inc. (NASDAQ:AMGN) by 8.0% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 103,820 shares of the medical research company\u2019s stock after selling 9,032 shares during the quarter. Tiaa Fsb\u2019s holdings in Amgen were worth [\u2026]", "url": "https://www.thelincolnianonline.com/2020/10/13/amgen-inc-nasdaqamgn-shares-sold-by-tiaa-fsb.html"}, {"symbol": "AMGN", "publishedDate": "2020-10-13 00:00:00", "title": "Global Hepatocellular Carcinoma Drugs Market (2020 to 2024) - Featuring AbbVie, Amgen and AstraZeneca Among Others - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20201013005648/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20201013005648/en/Global-Hepatocellular-Carcinoma-Drugs-Market-2020-to-2024---Featuring-AbbVie-Amgen-and-AstraZeneca-Among-Others---ResearchAndMarkets.com"}, {"symbol": "AMGN", "publishedDate": "2020-10-09 14:36:55", "title": "Amgen's stock paces the Dow's decliners after analyst downgrade in wake of disappointing trial results", "image": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "site": "marketwatch", "text": "Shares of Amgen Inc. undefined dropped 1.8% in morning trading Friday, enough to pace the Dow Jones Industrial Average's undefined decliners, after Truist...", "url": "https://www.marketwatch.com/story/amgens-stock-paces-the-dows-decliners-after-analyst-downgrade-in-wake-of-disappointing-trial-results-2020-10-09"}, {"symbol": "AMGN", "publishedDate": "2020-10-09 14:27:19", "title": "Dow Movers: AMGN, CRM", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 09, 2020 (MarketNewsVideo.com via COMTEX) -- In early trading on Friday, shares of Salesforce.com topped the list of the day's best performing Dow Jones...", "url": "https://www.marketwatch.com/press-release/dow-movers-amgn-crm-2020-10-09"}, {"symbol": "AMGN", "publishedDate": "2020-10-09 13:30:10", "title": "Alfa Laval : opens new global Application & Innovation centre in Denmark | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdgris.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/ALFA-LAVAL-AB-6494532/news/Alfa-Laval-opens-new-global-Application-Innovation-centre-in-Denmark-31512831/"}, {"symbol": "AMGN", "publishedDate": "2020-10-09 13:16:30", "title": "Amgen : Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/Amgen-Cytokinetics-And-Servier-Announce-Topline-Results-From-GALACTIC-HF-A-Phase-3-Trial-Of-Omeca-31512649/"}, {"symbol": "AMGN", "publishedDate": "2020-10-09 09:41:15", "title": "COVID-19's impact Global Neurological Disorder Drugs Market 2020 Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2025", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 09, 2020 (The Expresswire) --\nThe global \u201cNeurological Disorder Drugs Market\u201d report can help to understand the market and strategize for business...", "url": "https://www.marketwatch.com/press-release/covid-19s-impact-global-neurological-disorder-drugs-market-2020-production-revenue-price-and-gross-margin-analysis-with-forecasts-to-2025-2020-10-09"}, {"symbol": "AMGN", "publishedDate": "2020-10-09 09:41:14", "title": "COVID-19's impact Global Monoclonal Antibodies Market 2020 Segmented by Application and Geography Trends, Growth and Forecasts to 2025", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 09, 2020 (The Expresswire) --\nGlobal \u201cMonoclonal Antibodies market\u201d competitive landscape provides particulars and data information by players. The...", "url": "https://www.marketwatch.com/press-release/covid-19s-impact-global-monoclonal-antibodies-market-2020-segmented-by-application-and-geography-trends-growth-and-forecasts-to-2025-2020-10-09"}, {"symbol": "AMGN", "publishedDate": "2020-10-09 08:34:45", "title": "Creative Financial Designs Inc. ADV Boosts Stake in Amgen Inc. (NASDAQ:AMGN)", "image": "https://www.marketbeat.com/logos/amgen-inc-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Creative Financial Designs Inc. ADV lifted its position in Amgen Inc. (NASDAQ:AMGN) by 4,042.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 290 shares of the medical research company\u2019s stock after acquiring an additional 283 shares during the period. Creative [\u2026]", "url": "https://www.thelincolnianonline.com/2020/10/09/creative-financial-designs-inc-adv-boosts-stake-in-amgen-inc-nasdaqamgn.html"}, {"symbol": "AMGN", "publishedDate": "2020-10-09 07:40:53", "title": "Amgen, Cytokinetics und Servier geben Topline-Ergebnisse von\nGALACTIC-HF bekannt, einer Phase-3-Studie mit Omecamtiv-Mecarbil bei\nPatienten mit Herzinsuffizienz", "image": "https://static.ots.at/css/images/distributed-by-apa-ots_250px.png", "site": "https://www.ots.at", "text": "THOUSAND OAKS, Kalifornien / SOUTH SAN FRANCISCO, Kalifornien / SURESNES, Frankreich (ots) - - Studie erreicht prim\u00e4ren kombinierten Endpunkt der Reduktion von kardiovaskul\u00e4ren Todesf\u00e4llen oder \u2026", "url": "https://www.ots.at/presseaussendung/OTS_20201009_OTS0036/amgen-cytokinetics-und-servier-geben-topline-ergebnisse-von-galactic-hf-bekannt-einer-phase-3-studie-mit-omecamtiv-mecarbil-bei-patienten-mit-herzinsuffizienz"}, {"symbol": "AMGN", "publishedDate": "2020-10-09 06:26:11", "title": "Generic Drugs Market Size, Share 2020 Global Growth Insight, Trends, Industry Key Players, Regional Forecast To 2024", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 09, 2020 (The Expresswire) --\nGlobal \"Generic Drugs Market\" report consists of important factors such as the latest trends, performance drivers, key...", "url": "https://www.marketwatch.com/press-release/generic-drugs-market-size-share-2020-global-growth-insight-trends-industry-key-players-regional-forecast-to-2024-2020-10-09"}, {"symbol": "AMGN", "publishedDate": "2020-10-09 00:00:00", "title": "Cervical Cancer Therapeutics Market | Rising Prevalence of Cervical Cancer to Boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20201009005348/en/829080/23/IRTNTR41609.jpg", "site": "businesswire", "text": "The Global Cervical Cancer Therapeutics Market will grow by USD 1.06 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20201009005348/en/Cervical-Cancer-Therapeutics-Market-Rising-Prevalence-of-Cervical-Cancer-to-Boost-the-Market-Growth-Technavio"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 18:20:00", "title": "Opinion | The Trump Treatment for Covid Is Coming Soon", "image": "https://images.wsj.net/im-241993/social", "site": "wsj", "text": "Antibody drugs like the one the president took may be a bridge to a vaccine.", "url": "https://www.wsj.com/articles/the-trump-treatment-for-covid-is-coming-soon-11602181229"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 17:14:51", "title": "Antibody drugs are no cure but seem promising for COVID-19", "image": "https://s.abcnews.com/images/Health/WireAP_9d7ba30cae5548f48441dfb0e2ae767a_16x9_992.jpg", "site": "abcnews", "text": "Experimental antibody drugs are among the most promising therapies being tested for treating and preventing coronavirus infections", "url": "https://abcnews.go.com/Business/wireStory/antibody-drugs-cure-promising-covid-19-73503648"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 17:14:19", "title": "Antibody drugs are no cure but seem promising for COVID-19", "image": "https://s.abcnews.com/images/Health/WireAP_9d7ba30cae5548f48441dfb0e2ae767a_16x9_992.jpg", "site": "abcnews", "text": "Experimental antibody drugs are among the most promising therapies being tested for treating and preventing coronavirus infections", "url": "https://abcnews.go.com/Health/wireStory/antibody-drugs-cure-promising-covid-19-73503647"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 14:55:58", "title": "Nasdaq 100 Movers: AMGN, PAYX", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (MarketNewsVideo.com via COMTEX) -- In early trading on Thursday, shares of Paychex topped the list of the day's best performing components of...", "url": "https://www.marketwatch.com/press-release/nasdaq-100-movers-amgn-payx-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 14:51:58", "title": "Dow Movers: AMGN, IBM", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (MarketNewsVideo.com via COMTEX) --\nIn early trading on Thursday, shares of International Business Machines topped the list of the day's best...", "url": "https://www.marketwatch.com/press-release/dow-movers-amgn-ibm-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 13:01:18", "title": "Monoclonal Antibody Therapy Market to Witness Astonishing Growth by 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (Heraldkeepers) --\nThe report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure...", "url": "https://www.marketwatch.com/press-release/monoclonal-antibody-therapy-market-to-witness-astonishing-growth-by-2026-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 12:32:16", "title": "Amgen : Cytokinetics and Servier Announce Topline Results From GALACTIC-HF, a Phase 3 Trial of Omecamtiv Mecarbil in Patients With Heart Failure | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/Amgen-Cytokinetics-and-Servier-Announce-Topline-Results-From-GALACTIC-HF-a-Phase-3-Trial-of-Omeca-31505338/"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 12:30:18", "title": "Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif. and SURESNES, France, Oct. 8, 2020 /PRNewswire via COMTEX/ --\nTHOUSAND OAKS, Calif. and\u00a0SOUTH SAN...", "url": "https://www.marketwatch.com/press-release/amgen-cytokinetics-and-servier-announce-topline-results-from-galactic-hf-a-phase-3-trial-of-omecamtiv-mecarbil-in-patients-with-heart-failure-2020-10-08-81833018"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 12:30:15", "title": "Amgen, Cytokinetics and Servier Announce Topline Results From GALACTIC-HF, a Phase 3 Trial of Omecamtiv Mecarbil in Patients With Heart Failure", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif. and SURESNES,\u00a0France, Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) --\nTrial Met Primary Composite Endpoint...", "url": "https://www.marketwatch.com/press-release/amgen-cytokinetics-and-servier-announce-topline-results-from-galactic-hf-a-phase-3-trial-of-omecamtiv-mecarbil-in-patients-with-heart-failure-2020-10-08-81843015"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 12:30:11", "title": "Amgen, Cytokinetics and Servier Announce Topline Results From GALACTIC-HF, a Phase 3 Trial of Omecamtiv Mecarbil in Patients With Heart Failure", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif. and SURESNES, France, Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) -- Trial Met Primary Composite Endpoint...", "url": "https://www.marketwatch.com/press-release/amgen-cytokinetics-and-servier-announce-topline-results-from-galactic-hf-a-phase-3-trial-of-omecamtiv-mecarbil-in-patients-with-heart-failure-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 10:28:25", "title": "Biosimilars Market Share 2020 Global Trend, Industry News, Industry Demand, Business Growth, Top Key Players Update, Business Statistics and Research Methodology by Forecast to 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (The Expresswire) --\nGlobal Biosimilars Market Report tracks the major market events including product launches, development trends, mergers and...", "url": "https://www.marketwatch.com/press-release/biosimilars-market-share-2020-global-trend-industry-news-industry-demand-business-growth-top-key-players-update-business-statistics-and-research-methodology-by-forecast-to-2026-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 09:19:13", "title": "Bone Metastasis Market Size, Share Report 2020 Shipments, Price, Revenue and Gross profit till 2025 With Impact of COVID-19", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (The Expresswire) --\n\"Final Report will add the analysis of the impact of COVID-19 on this industry.\" \u201cBone Metastasis Market\u201d research report...", "url": "https://www.marketwatch.com/press-release/bone-metastasis-market-size-share-report-2020-shipments-price-revenue-and-gross-profit-till-2025-with-impact-of-covid-19-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 09:14:46", "title": "The global regenerative medicine market is projected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "New York, Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) --\nNew York, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report...", "url": "https://www.marketwatch.com/press-release/the-global-regenerative-medicine-market-is-projected-to-reach-usd-179-billion-by-2025-from-usd-85-billion-in-2020-at-a-cagr-of-159-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 08:56:06", "title": "Biopharmaceuticals Market Size 2020 - Growth Opportunities and Trends, Industry Drivers, Business plans with Share, Competitors Analysis, and Global Revenue Forecast to 2024", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (The Expresswire) --\nThe \u201cBiopharmaceuticals Market\u201d report provides coverage of current and emerging market trends, market drivers, and...", "url": "https://www.marketwatch.com/press-release/biopharmaceuticals-market-size-2020---growth-opportunities-and-trends-industry-drivers-business-plans-with-share-competitors-analysis-and-global-revenue-forecast-to-2024-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 08:50:41", "title": "Neutropenia Treatment Market 2020 Therapeutic Survey Reviews, Analysis \u2013 Amgen, Novartis, Teva Pharmaceutical", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (Market Insight Reports) --\nThe Global Neutropenia Treatment Market is a valuable source of insightful data for business strategists. It...", "url": "https://www.marketwatch.com/press-release/neutropenia-treatment-market-2020-therapeutic-survey-reviews-analysis-amgen-novartis-teva-pharmaceutical-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 08:34:00", "title": "Red Biotechnology market Growth Factors, Restraints, Trends, Competitive Landscape 2020 to 2027", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (Profound via COMTEX) --\nThe latest study collated and published by Precedence Research analyzes the historical and present-day scenario of the...", "url": "https://www.marketwatch.com/press-release/red-biotechnology-market-growth-factors-restraints-trends-competitive-landscape-2020-to-2027-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 07:27:02", "title": "Exane Derivatives Sells 9,047 Shares of Amgen Inc. (NASDAQ:AMGN)", "image": "https://www.marketbeat.com/logos/amgen-inc-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Exane Derivatives reduced its position in Amgen Inc. (NASDAQ:AMGN) by 94.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 523 shares of the medical research company\u2019s stock after selling 9,047 shares during the quarter. Exane Derivatives\u2019 holdings in Amgen were worth $133,000 at the [\u2026]", "url": "https://www.thelincolnianonline.com/2020/10/08/exane-derivatives-sells-9047-shares-of-amgen-inc-nasdaqamgn.html"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 06:35:40", "title": "Sodium Silicate Market Product Analysis, Threat, Growth, Market Demand and  Revenue | Tokuyama Corporation, Solvay S.A.", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (WiredRelease via Comtex) --\nMarketResearch.Biz has posted a newly modern statistical statistics, titled as Sodium Silicate Market. It is a...", "url": "https://www.marketwatch.com/press-release/sodium-silicate-market-product-analysis-threat-growth-market-demand-and-revenue-tokuyama-corporation-solvay-sa-2020-10-08"}, {"symbol": "AMGN", "publishedDate": "2020-10-08 01:53:31", "title": "Angina Market 2020 Global Industry Analysis, By Key Players, Segmentation, Trends and Forecast By 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 07, 2020 (MarketersMedia) --\nWiseguyreports.Com Publish New Market Research Report On \"Angina Market 2020 Global Analysis, Size, Share, Trends,...", "url": "https://www.marketwatch.com/press-release/angina-market-2020-global-industry-analysis-by-key-players-segmentation-trends-and-forecast-by-2026-2020-10-07"}, {"symbol": "AMGN", "publishedDate": "2020-10-07 14:49:39", "title": "New Alfa Laval PureCool, developed with engine designer WinGD, enables up to 50% methane slip reduction", "image": "https://gcaptain.com/wp-content/uploads/2020/10/4f8bfc88-daad-4cfa-ac33-20211ed881cd-scaled.jpg", "site": "https://gcaptain.com", "text": "With IMO targeting a 50% reduction in greenhouse gas emissions by 2050, LNG is becoming a natural choice for shipowners in the transition to carbon-neutral fuels. Methane slip regulations are a pos\u2026", "url": "https://gcaptain.com/new-alfa-laval-purecool-developed-with-engine-designer-wingd-enables-up-to-50-methane-slip-reduction/"}, {"symbol": "AMGN", "publishedDate": "2020-10-07 14:25:03", "title": "Renal Anemia Treatment Market Analysis, Trends and CAGR Projections 2020-2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 07, 2020 (Profound via COMTEX) --\nThe report provides revenue of the global Renal Anemia Treatment market for the period 2016ndash;2026, considering 2019...", "url": "https://www.marketwatch.com/press-release/renal-anemia-treatment-market-analysis-trends-and-cagr-projections-2020-2026-2020-10-07"}, {"symbol": "AMGN", "publishedDate": "2020-10-07 11:39:04", "title": "Women\u2019s Health Care Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 07, 2020 (Market Insight Reports) --\nThe Global Women\u2019s Health Care Market is estimated to value over USD 20.8 billion by 2027 end with a CAGR of over...", "url": "https://www.marketwatch.com/press-release/womens-health-care-market-global-trends-market-share-industry-size-growth-opportunities-and-market-forecast-2020-to-2027-2020-10-07"}, {"symbol": "AMGN", "publishedDate": "2020-10-07 11:26:46", "title": "Orthopedic Oncology Treatment Market (Global Countries Data) 2020 dynamics (drivers, restraints, opportunities), plans, Competitive Outlook and Market Size & Growth by Forecast to 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 07, 2020 (Profound via COMTEX) --\nThe report provides revenue of the global Orthopedic Oncology Treatment market for the period 2016ndash;2026,...", "url": "https://www.marketwatch.com/press-release/orthopedic-oncology-treatment-market-global-countries-data-2020-dynamics-drivers-restraints-opportunities-plans-competitive-outlook-and-market-size-growth-by-forecast-to-2026-2020-10-07"}, {"symbol": "AMGN", "publishedDate": "2020-10-07 11:07:47", "title": "Orthopedic Oncology Treatment Market Services, Technologies, Future Trends, Company Profiles, Share Analysis, Global Industry Size, Growth Drivers, Regional Scope and Demand Overview 2020-2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 07, 2020 (Profound via COMTEX) --\nThe report provides revenue of the global Orthopedic Oncology Treatment market for the period 2016ndash;2026,...", "url": "https://www.marketwatch.com/press-release/orthopedic-oncology-treatment-market-services-technologies-future-trends-company-profiles-share-analysis-global-industry-size-growth-drivers-regional-scope-and-demand-overview-2020-2026-2020-10-07"}, {"symbol": "AMGN", "publishedDate": "2020-10-07 09:25:06", "title": "Global Bispecific Antibodies Therapy Blincyto Hemlibra Antibody Therapeutics Market Size To Witness 118% Growth To Reach US$ 10 Billion By 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "DELHI, India, Oct 07, 2020 (GLOBE NEWSWIRE via COMTEX) --\nDELHI, India, Oct. 07, 2020 (GLOBE NEWSWIRE) -- \"Global Bispecific Antibody Market Opportunity,...", "url": "https://www.marketwatch.com/press-release/global-bispecific-antibodies-therapy-blincyto-hemlibra-antibody-therapeutics-market-size-to-witness-118-growth-to-reach-us-10-billion-by-2026-2020-10-07"}, {"symbol": "AMGN", "publishedDate": "2020-10-07 06:29:12", "title": "Immunotherapy drugs market Report Analysis, Share, Revenue, Growth Rate With Forecast Overview", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 07, 2020 (AmericaNewsHour) --\nThis market research report includes a detailed segmentation of the global immunotherapy drugs market by drug type...", "url": "https://www.marketwatch.com/press-release/immunotherapy-drugs-market-report-analysis-share-revenue-growth-rate-with-forecast-overview-2020-10-07"}, {"symbol": "AMGN", "publishedDate": "2020-10-07 06:23:15", "title": "Red Biotechnology Market Breakdown Data by Manufacturers, Segments and Regions 2027", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 07, 2020 (Profound via COMTEX) --\nThe Red Biotechnology market research report includes specific segments by region (country), by company, by all...", "url": "https://www.marketwatch.com/press-release/red-biotechnology-market-breakdown-data-by-manufacturers-segments-and-regions-2027-2020-10-07"}, {"symbol": "AMGN", "publishedDate": "2020-10-07 03:23:03", "title": "Alexion Pharmaceuticals: More Potential Ahead Despite Upbeat Guidance (NASDAQ:ALXN)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "Alexion\u2019s just-released revision to 2020 revenue guidance suggests continuing top line momentum. Given the strong performance through the pandemic, we believe there is even more room for growth as margins hold up.", "url": "https://seekingalpha.com/article/4377917-alexion-pharmaceuticals-potential-ahead-despite-upbeat-guidance"}, {"symbol": "AMGN", "publishedDate": "2020-10-07 00:00:00", "title": "Global Immuno-Oncology Market Size & Forecast 2020-2024 with Impact Analysis of COVID-19 & Profiles of Merck and Co., Pfizer, Amgen and Roche - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20201007005416/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20201007005416/en/Global-Immuno-Oncology-Market-Size-Forecast-2020-2024-with-Impact-Analysis-of-COVID-19-Profiles-of-Merck-and-Co.-Pfizer-Amgen-and-Roche---ResearchAndMarkets.com"}, {"symbol": "AMGN", "publishedDate": "2020-10-06 16:38:00", "title": "Charting a bullish Q4 start:  S&P 500 extends rally from major support", "image": "https://s.marketwatch.com/public/resources/images/MW-IQ204_spx100_MD_20201006120943.jpg", "site": "marketwatch", "text": "The major U.S. benchmarks are off to a constructive October start, rising atop key technical levels, writes Michael Ashbaugh.", "url": "https://www.marketwatch.com/story/charting-a-bullish-q4-start-sp-500-extends-rally-from-major-support-2020-10-06-121033737"}, {"symbol": "AMGN", "publishedDate": "2020-10-06 13:48:26", "title": "Amgen : Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib in Advanced Non-Small Cell Lung Cancer | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdgris.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/Amgen-Announces-Positive-Topline-Phase-2-Results-For-Investigational-KRAS-G12C-Inhibitor-Sotorasib-31491443/"}, {"symbol": "AMGN", "publishedDate": "2020-10-06 13:48:00", "title": "Amgen Says Study Results on Its Novel Cancer Drug Were Positive", "image": "https://images.barrons.com/im-241153/social", "site": "barrons", "text": "Amgen\u2019s investigational drug sotorasib could be the first KRAS inhibitor to reach the market.", "url": "https://www.barrons.com/articles/amgen-study-results-novel-cancer-drug-were-positive-51601991983"}, {"symbol": "AMGN", "publishedDate": "2020-10-06 00:00:00", "title": "Stocks Continue To Move Higher", "image": "https://i-invdn-com.akamaized.net/redesign/images/seo/v2/investingcom_analysis_og.jpg", "site": "investing", "text": "Stocks Analysis by Naeem Aslam covering: S&P 500, Dow Jones Industrial Average, Nikkei 225, Hang Seng. Read Naeem Aslam's latest article on Investing.com", "url": "https://www.investing.com/analysis/stock-market-breadth-stocks-continue-to-move-higher-200540068"}, {"symbol": "AMGN", "publishedDate": "2020-10-05 20:41:00", "title": "Bristol-Myer\u2019s $13 Billion Deal for MyoKardia Spotlights Cardiac Drugs", "image": "https://images.barrons.com/im-240816/social", "site": "barrons", "text": "The $13 billion cash buyout announced Monday has sent investors scouting for the next big biotech deal.", "url": "https://www.barrons.com/articles/bristol-myers-deal-myokardia-spotlights-cardiac-drugs-pipeline-51601930399"}, {"symbol": "AMGN", "publishedDate": "2020-10-05 20:31:06", "title": "Amgen : Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdgris.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/Amgen-Announces-Positive-Topline-Phase-2-Results-For-Investigational-KRAS-G12C-Inhibitor-Sotorasib-31485973/"}, {"symbol": "AMGN", "publishedDate": "2020-10-05 19:08:00", "title": "Dow rallies 416 points on gains for Amgen Inc., Travelers shares", "image": "https://images.mktw.net/im-220108", "site": "marketwatch", "text": "Led by strong returns for shares of Amgen Inc. and Travelers, the Dow Jones Industrial Average is rallying Monday afternoon. Shares of Amgen Inc. and...", "url": "https://www.marketwatch.com/story/dow-rallies-416-points-on-gains-for-amgen-inc-travelers-shares-2020-10-05"}, {"symbol": "AMGN", "publishedDate": "2020-10-05 16:01:00", "title": "Charting a successful technical test, S&P 500 rallies from major support", "image": "https://s.marketwatch.com/public/resources/images/MW-IQ097_spx100_MD_20201005120450.jpg", "site": "marketwatch", "text": "U.S. stocks are firmly higher early Monday, rising as a constructive October start remains underway. Against this backdrop, the S&P 500 is challenging...", "url": "https://www.marketwatch.com/story/charting-a-successful-technical-test-sp-500-rallies-from-major-support-2020-10-05"}, {"symbol": "AMGN", "publishedDate": "2020-10-05 12:44:16", "title": "Red Biotechnology Market Outlook 2020 to 2027", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 05, 2020 (Profound via COMTEX) --\nThe report provides revenue of the global red biotechnology market for the period 2016ndash;2027, considering 2019 as...", "url": "https://www.marketwatch.com/press-release/red-biotechnology-market-outlook-2020-to-2027-2020-10-05"}, {"symbol": "AMGN", "publishedDate": "2020-10-05 10:49:27", "title": "Red Biotechnology Market Growth, Competitive Landscape, Segment Forecasts and Regional Outlook 2020 - 2027", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 05, 2020 (Profound via COMTEX) --\nThe study offers valuable information about the global Red Biotechnology market to illustrate how the market would grow...", "url": "https://www.marketwatch.com/press-release/red-biotechnology-market-growth-competitive-landscape-segment-forecasts-and-regional-outlook-2020---2027-2020-10-05"}, {"symbol": "AMGN", "publishedDate": "2020-10-05 05:20:59", "title": "Global Solid Tumor Therapeutics Market 2020 Top countries data  - Industry Size, Growth Factors, Top Leaders, Development Strategy, Future Trends, Historical Analysis, Competitive Landscape and Regional Forecast By 360 Market Updates", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 05, 2020 (The Expresswire) --\nGlobal \u201cSolid Tumor Therapeutics Market\u201d Size report 2020 - 2024 gives complete analysis of industry position and viewpoint...", "url": "https://www.marketwatch.com/press-release/global-solid-tumor-therapeutics-market-2020-top-countries-data---industry-size-growth-factors-top-leaders-development-strategy-future-trends-historical-analysis-competitive-landscape-and-regional-forecast-by-360-market-updates-2020-10-05"}, {"symbol": "AMGN", "publishedDate": "2020-10-05 04:30:17", "title": "Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Share 2020 Report by Sales Revenue, Future Demands, Growth Factors, Emerging Trends, Competitive Landscape and Forecast to 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 05, 2020 (The Expresswire) --\n\"Final Report will add the analysis of the impact of COVID-19 on this industry.\" Global \u201cChimeric Antigen Receptor (CAR)...", "url": "https://www.marketwatch.com/press-release/global-chimeric-antigen-receptor-car-t-cell-therapy-market-size-and-share-2020-report-by-sales-revenue-future-demands-growth-factors-emerging-trends-competitive-landscape-and-forecast-to-2026-2020-10-05"}, {"symbol": "AMGN", "publishedDate": "2020-10-04 00:00:00", "title": "Amgen Announces Collaboration With Two NHS Organisations to Help Improve Cholesterol Management for People at High Risk of a Heart Attack or Stroke", "image": "https://mms.businesswire.com/media/20201004005019/en/827093/23/AMGEN-LOGO.jpg", "site": "businesswire", "text": "Amgen today announced a new partnership with two NHS organisations, the North West Coast Innovation Agency and Imperial College Health Partners. This", "url": "https://www.businesswire.com/news/home/20201004005019/en/Amgen-Announces-Collaboration-With-Two-NHS-Organisations-to-Help-Improve-Cholesterol-Management-for-People-at-High-Risk-of-a-Heart-Attack-or-Stroke"}, {"symbol": "AMGN", "publishedDate": "2020-10-03 10:45:00", "title": "Market Crash 2.0: 3 Stocks to Save Your Portfolio | The Motley Fool", "image": "https://g.foolcdn.com/editorial/images/593145/gettyimages-1182774086.jpg", "site": "https://www.fool.com", "text": "These healthcare and retail giants have proven their resilience during a rough-and-tumble year.", "url": "https://www.fool.com/investing/2020/10/03/market-crash-20-3-stocks-to-save-your-portfolio/"}, {"symbol": "AMGN", "publishedDate": "2020-10-03 08:05:10", "title": "Amgen Announces Five-Year Data That Reinforce The Safety And Efficacy Profile Of Aimovig\u00ae (erenumab-aooe) In Adult Patients With Episodic Migraine", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "THOUSAND OAKS, Calif., Oct. 3, 2020 /PRNewswire via COMTEX/ --\nTHOUSAND OAKS, Calif., Oct. 3, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that...", "url": "https://www.marketwatch.com/press-release/amgen-announces-five-year-data-that-reinforce-the-safety-and-efficacy-profile-of-aimovig-erenumab-aooe-in-adult-patients-with-episodic-migraine-2020-10-03"}, {"symbol": "AMGN", "publishedDate": "2020-10-02 19:12:00", "title": "Amgen Inc., Apple Inc. share losses lead Dow's 75-point drop", "image": "https://images.mktw.net/im-220108", "site": "marketwatch", "text": "The Dow Jones Industrial Average is declining Friday afternoon with shares of Amgen Inc. and Apple Inc. facing the biggest drops for the price-weighted...", "url": "https://www.marketwatch.com/story/amgen-inc-apple-inc-share-losses-lead-dows-75-point-drop-2020-10-02"}, {"symbol": "AMGN", "publishedDate": "2020-10-02 16:15:00", "title": "Dow falls 60 points on losses for shares of Amgen Inc., Apple Inc.", "image": "https://images.mktw.net/im-220108", "site": "marketwatch", "text": "Behind losses for shares of Amgen Inc. and Apple Inc., the Dow Jones Industrial Average is trading down Friday afternoon. Shares of Amgen Inc. and Apple Inc....", "url": "https://www.marketwatch.com/story/dow-falls-60-points-on-losses-for-shares-of-amgen-inc-apple-inc-2020-10-02"}, {"symbol": "AMGN", "publishedDate": "2020-10-02 15:14:00", "title": "Dow's 150-point drop led by losses in shares of Amgen Inc., Boeing", "image": "https://images.mktw.net/im-220108", "site": "marketwatch", "text": "Shares of Amgen Inc. and Boeing are posting losses Friday morning, sending the Dow Jones Industrial Average into negative territory. The Dow was most...", "url": "https://www.marketwatch.com/story/dows-150-point-drop-led-by-losses-in-shares-of-amgen-inc-boeing-2020-10-02"}, {"symbol": "AMGN", "publishedDate": "2020-10-02 11:35:03", "title": "Cytokinetics Announces Publication of Manuscript Detailing Baseline Characteristics of GALACTIC-HF in European Journal of Heart Failure", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "SOUTH SAN FRANCISCO, Calif., Oct 02, 2020 (GLOBE NEWSWIRE via COMTEX) --\nHeart Failure Patients in Phase 3 Clinical Trial of Omecamtiv Mecarbil Are at High...", "url": "https://www.marketwatch.com/press-release/cytokinetics-announces-publication-of-manuscript-detailing-baseline-characteristics-of-galactic-hf-in-european-journal-of-heart-failure-2020-10-02"}, {"symbol": "AMGN", "publishedDate": "2020-10-02 06:10:14", "title": "Wearable Injectors Market 2020 Research and New Innovations in Medical Sector- Amgen, Becton, Dickinson and Company, Dexcom, Insulet Corporation", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 02, 2020 (Market Insight Reports) -- This Global Wearable Injectors Market Research Report Forecast 2020-2025 is a valuable source of insightful data for...", "url": "https://www.marketwatch.com/press-release/wearable-injectors-market-2020-research-and-new-innovations-in-medical-sector--amgen-becton-dickinson-and-company-dexcom-insulet-corporation-2020-10-02"}, {"symbol": "AMGN", "publishedDate": "2020-10-02 00:00:00", "title": "Global Precision Medicine Market 2020-2030: Focus on Ecosystem, Technology, Application, and Competitive Landscape - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20201002005187/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20201002005187/en/Global-Precision-Medicine-Market-2020-2030-Focus-on-Ecosystem-Technology-Application-and-Competitive-Landscape---ResearchAndMarkets.com"}, {"symbol": "AMGN", "publishedDate": "2020-10-01 17:55:00", "title": "Stocks Are Expensive. These 14 Are Cheap and Could Grow.", "image": "https://images.barrons.com/im-238891/social", "site": "barrons", "text": "Microsoft, FedEx, Amgen, and AbbVie\u2014among others\u2014came up in our screen for stocks that are inexpensive relative to their industry and are expected to see earnings growth.", "url": "https://www.barrons.com/articles/microsoft-and-13-other-cheap-stocks-with-strong-growth-prospects-51601548201"}, {"symbol": "AMGN", "publishedDate": "2020-10-01 10:40:17", "title": "Vasomotor Symptoms of Menopause Treatment Market Size and Business Analysis 2020-2026 | Industry Share Overview, Development Status, Opportunities, Key Players, Demand, Growth Factors, Trends and Business Boosting Strategies", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 01, 2020 (The Expresswire) --\n\"Final Report will add the analysis of the impact of COVID-19 on this industry.\" Global \u201cVasomotor Symptoms of Menopause...", "url": "https://www.marketwatch.com/press-release/vasomotor-symptoms-of-menopause-treatment-market-size-and-business-analysis-2020-2026-industry-share-overview-development-status-opportunities-key-players-demand-growth-factors-trends-and-business-boosting-strategies-2020-10-01"}, {"symbol": "AMGN", "publishedDate": "2020-10-01 10:30:00", "title": "Stocks Are Expensive. These 14 Are Cheap and Could Grow.", "image": "https://images.barrons.com/im-238891/social", "site": "marketwatch", "text": "Microsoft, FedEx, Amgen, and AbbVie\u2014among others\u2014came up in our screen for stocks that are inexpensive relative to their industry and are expected to see...", "url": "https://www.marketwatch.com/articles/microsoft-and-13-other-cheap-stocks-with-strong-growth-prospects-51601548201"}, {"symbol": "AMGN", "publishedDate": "2020-09-30 16:02:00", "title": "Here are the biggest winners in a solid third quarter for U.S. stocks", "image": "https://s.marketwatch.com/public/resources/images/MW-IP729_tesla__ZG_20200930113121.jpg", "site": "marketwatch", "text": "Gains were spread across tech, materials, industrials and retailers.", "url": "https://www.marketwatch.com/story/here-are-the-biggest-winners-in-a-solid-third-quarter-for-us-stocks-2020-09-30"}, {"symbol": "AMGN", "publishedDate": "2020-09-30 13:33:31", "title": "Federal Circuit Reinstates Jury Verdict Finding Claims of Biogen\u2019s MS Drug Were Anticipated", "image": "https://www.ipwatchdog.com/wp-content/uploads/2016/01/federal-circuit-cafc-4a.jpg", "site": "https://www.ipwatchdog.com", "text": "On Monday, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in Biogen MA, Inc. v. EMD Serono, Inc., reversing the U.S. District Court for the District of New Jersey\u2019s judgment as a matter of law (JMOL) for Biogen.", "url": "https://www.ipwatchdog.com/2020/09/30/federal-circuit-reinstates-jury-verdict-finding-claims-biogens-ms-drug-anticipated/id=125729/"}, {"symbol": "AMGN", "publishedDate": "2020-09-30 13:20:55", "title": "Solving One of the Largest Drivers of Disease: Inflammation", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Sep 30, 2020 (NetworkNewsWire via COMTEX) --\nNetworkNewsWire Editorial Coverage: Inflammation typically occurs in the body as a natural response to threats...", "url": "https://www.marketwatch.com/press-release/solving-one-of-the-largest-drivers-of-disease-inflammation-2020-09-30-91502055"}, {"symbol": "AMGN", "publishedDate": "2020-09-30 13:00:04", "title": "Solving One of the Largest Drivers of Disease: Inflammation - NetworkNewsWire", "image": "https://cdn.networkwire.news/5f736630146eb4.80648075_hqknlpigmjfoe.png", "site": "https://www.networknewswire.com", "text": "NetworkNewsWire Editorial Coverage: Inflammation typically occurs in the body as a natural response to threats such as infection or injury, but chronic inflammation can cause severe damage and even death. Inflammation is a well-known symptom of multiple infectious diseases. However, multidiscipline research strongly suggests that inflammation is also closely linked with a broad range of \u2026 Continue reading \"Solving One of the Largest Drivers of Disease: Inflammation\"", "url": "https://www.networknewswire.com/solving-one-of-the-largest-drivers-of-disease-inflammation/"}, {"symbol": "AMGN", "publishedDate": "2020-09-30 12:30:15", "title": "Solving One of the Largest Drivers of Disease: Inflammation", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "NEW YORK, Sept. 30, 2020 /PRNewswire via COMTEX/ --\nNEW YORK, Sept. 30, 2020 /PRNewswire/ --\u00a0Inflammation typically occurs in the body as a natural response...", "url": "https://www.marketwatch.com/press-release/solving-one-of-the-largest-drivers-of-disease-inflammation-2020-09-30"}, {"symbol": "AMGN", "publishedDate": "2020-09-30 10:34:30", "title": "Red Biotechnology Market Share, CAGR, Trends, Segmentation and Forecast 2020 to 2027", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Sep 30, 2020 (Profound via COMTEX) --\nThe global red biotechnology market size was valued at US$ 320.76 billion in 2019 and expected to reach US$ 510 billion...", "url": "https://www.marketwatch.com/press-release/red-biotechnology-market-share-cagr-trends-segmentation-and-forecast-2020-to-2027-2020-09-30"}, {"symbol": "AMGN", "publishedDate": "2020-09-30 00:00:00", "title": "Carmot Therapeutics Expands Leadership Team and Closes $47 Million Series C Financing to Advance Novel Incretin Receptor Modulators Through Phase 2 Studies", "image": "http://www.businesswire.com/images/bwlogo_square.png", "site": "businesswire", "text": "Carmot Therapeutics, Inc. (Berkeley, CA), a biotechnology company focused on bringing transformative therapies to patients with metabolic diseases, an", "url": "https://www.businesswire.com/news/home/20200930005254/en/Carmot-Therapeutics-Expands-Leadership-Team-and-Closes-47-Million-Series-C-Financing-to-Advance-Novel-Incretin-Receptor-Modulators-Through-Phase-2-Studies"}, {"symbol": "AMGN", "publishedDate": "2020-09-29 14:37:57", "title": "Dow Movers: BA, AMGN", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Sep 29, 2020 (MarketNewsVideo.com via COMTEX) -- In early trading on Tuesday, shares of Amgen topped the list of the day's best performing Dow Jones...", "url": "https://www.marketwatch.com/press-release/dow-movers-ba-amgn-2020-09-29"}, {"symbol": "AMGN", "publishedDate": "2020-09-29 10:04:00", "title": "Better Buy: Gilead Sciences vs. Amgen | The Motley Fool", "image": "https://g.foolcdn.com/editorial/images/593116/female-scientist-holding-2-test-tubes.jpg", "site": "https://markets.businessinsider.com", "text": "These big biotechs are both moving into new areas. Which is most likely to move the needle for investors?", "url": "https://markets.businessinsider.com/news/stocks/better-buy--gilead-sciences-vs--amgen-9341108"}, {"symbol": "AMGN", "publishedDate": "2020-09-29 07:36:00", "title": "European stocks, Dow futures slip on virus concerns and political uncertainty", "image": "https://images.mktw.net/im-237794/social", "site": "marketwatch", "text": "European stocks slipped Tuesday, amid political uncertainty and concerns about the economic impact of a second coronavirus wave.", "url": "https://www.marketwatch.com/story/european-stocks-dow-futures-slip-on-virus-concerns-and-political-uncertainty-11601364991"}, {"symbol": "AMGN", "publishedDate": "2020-09-29 04:31:25", "title": "Global Orphan Drugs Market Latest Analysis Report 2020 - Top Manufacturer and Vendors Covered, Market Share, Size and Industry Growth Prospect 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Sep 29, 2020 (The Expresswire) --\nGlobal \u201cOrphan Drugs Market\u201d Report discusses about the important developments impacting and increasing the growth in...", "url": "https://www.marketwatch.com/press-release/global-orphan-drugs-market-latest-analysis-report-2020---top-manufacturer-and-vendors-covered-market-share-size-and-industry-growth-prospect-2026-2020-09-29"}, {"symbol": "AMGN", "publishedDate": "2020-09-28 17:50:40", "title": "3 Reasons To Be Bullish On Biotech Giant Amgen", "image": "https://investorplace.com/wp-content/uploads/2019/11/amgn-stock-1.jpg", "site": "https://investorplace.com", "text": "Amgen stock looks poised for the long haul.", "url": "https://investorplace.com/2020/09/3-reasons-to-be-bullish-on-biotech-giant-amgen-stock/"}, {"symbol": "AMGN", "publishedDate": "2020-09-28 00:00:00", "title": "Global Industrial Valves Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024", "image": "https://mms.businesswire.com/media/20200928005389/en/825423/23/Industrial_Valves_Market.jpg", "site": "businesswire", "text": "Industrial Valves market will register an incremental spend of about $16 billion, growing at a CAGR of 4.04% during the five-year forecast period.", "url": "https://www.businesswire.com/news/home/20200928005389/en/Global-Industrial-Valves-Market-Procurement-Intelligence-Report-with-COVID-19-Impact-Analysis-Global-Forecasts-2020-2024"}, {"symbol": "AMGN", "publishedDate": "2020-09-27 00:00:00", "title": "Sanitary Pumps Market- Roadmap for Recovery from COVID-19 | Growing Consolidation of Vendors to Boost Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20200927005012/en/824795/23/IRTNTR41160.jpg", "site": "businesswire", "text": "The Global Sanitary Pumps Market will grow by USD 753.17 mn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200927005012/en/Sanitary-Pumps-Market--Roadmap-for-Recovery-from-COVID-19-Growing-Consolidation-of-Vendors-to-Boost-Market-Growth-Technavio"}, {"symbol": "AMGN", "publishedDate": "2020-09-25 00:00:00", "title": "Insights on the Neutropenia Treatment Global Market to 2026 - Featuring Amgen, Novartis & Pfizer Among Others - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20200925005330/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20200925005330/en/Insights-on-the-Neutropenia-Treatment-Global-Market-to-2026---Featuring-Amgen-Novartis-Pfizer-Among-Others---ResearchAndMarkets.com"}, {"symbol": "AMGN", "publishedDate": "2020-09-24 13:46:00", "title": "Dow's 129-point drop led by losses for Boeing, Walt Disney shares", "image": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "site": "marketwatch", "text": "Shares of Boeing and Walt Disney are posting losses Thursday morning, sending the Dow Jones Industrial Average into negative territory. Shares of Boeing and...", "url": "https://www.marketwatch.com/story/dows-129-point-drop-led-by-losses-for-boeing-walt-disney-shares-2020-09-24"}, {"symbol": "AMGN", "publishedDate": "2020-09-24 00:00:00", "title": "Pea Protein Processing Equipment Market: COVID-19 Business Continuity Plan | Evolving Opportunities with AKYUREK TECHNOLOGY and Alfa Laval AB | Technavio", "image": "https://mms.businesswire.com/media/20200923005594/en/824039/23/IRTNTR44981.jpg", "site": "businesswire", "text": "The Global Pea Protein Processing Equipment Market will grow by $ 23.04 mn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200923005594/en/Pea-Protein-Processing-Equipment-Market-COVID-19-Business-Continuity-Plan-Evolving-Opportunities-with-AKYUREK-TECHNOLOGY-and-Alfa-Laval-AB-Technavio"}, {"symbol": "AMGN", "publishedDate": "2020-09-23 15:00:18", "title": "Sanofi Reports Positive Lung Cancer Data, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:SNY)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "Sanofi reports positive data for pivotal lung cancer trial. AstraZeneca announces positive data for Lynparza in prostate cancer.", "url": "https://seekingalpha.com/article/4375928-sanofi-reports-positive-lung-cancer-data-and-news-good-bad-and-ugly-of-biopharma"}, {"symbol": "AMGN", "publishedDate": "2020-09-23 00:00:00", "title": "Anti-inflammatory Therapeutics Market- Roadmap for Recovery from COVID-19|Increase In Prevalence Of IMID to boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20200922005958/en/823668/23/IRTNTR41324.jpg", "site": "businesswire", "text": "The Global Anti-inflammatory Therapeutics Market will grow by USD 30.62 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200922005958/en/Anti-inflammatory-Therapeutics-Market--Roadmap-for-Recovery-from-COVID-19Increase-In-Prevalence-Of-IMID-to-boost-the-Market-Growth-Technavio"}, {"symbol": "AMGN", "publishedDate": "2020-09-22 19:45:00", "title": "Dow's 162-point jump led by gains for Nike, Microsoft shares", "image": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "site": "marketwatch", "text": "Shares of Nike and Microsoft are seeing positive growth Tuesday afternoon, propelling the Dow Jones Industrial Average into positive territory. Shares of...", "url": "https://www.marketwatch.com/story/dows-162-point-jump-led-by-gains-for-nike-microsoft-shares-2020-09-22"}, {"symbol": "AMGN", "publishedDate": "2020-09-22 18:41:00", "title": "Dow's nearly 100-point climb led by gains for shares of Nike, Microsoft", "image": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "site": "marketwatch", "text": "The Dow Jones Industrial Average is climbing Tuesday afternoon with shares of Nike and Microsoft leading the way for the index. The Dow was most recently...", "url": "https://www.marketwatch.com/story/dows-nearly-100-point-climb-led-by-gains-for-shares-of-nike-microsoft-2020-09-22"}, {"symbol": "AMGN", "publishedDate": "2020-09-22 11:05:49", "title": "Angina Market 2020 Global Trends, Share, Growth, Analysis, Opportunities and Forecast To 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Sep 22, 2020 (Heraldkeepers) --\nWiseguyreports.Com Publish New Market Research Report On \"Angina Market 2020 Global Analysis, Size, Share, Trends,...", "url": "https://www.marketwatch.com/press-release/angina-market-2020-global-trends-share-growth-analysis-opportunities-and-forecast-to-2026-2020-09-22"}, {"symbol": "AMGN", "publishedDate": "2020-09-22 00:00:00", "title": "Global Migraine Drugs Market (2020 to 2024) - Insights and Forecast with Potential Impact of COVID-19 - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20200922005802/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20200922005802/en/Global-Migraine-Drugs-Market-2020-to-2024---Insights-and-Forecast-with-Potential-Impact-of-COVID-19---ResearchAndMarkets.com"}, {"symbol": "AMGN", "publishedDate": "2020-09-21 14:42:00", "title": "Anticancer Drug Team-Ups Show Promise. 4 Stocks That Stand to Gain.", "image": "https://images.barrons.com/im-234426/social", "site": "marketwatch", "text": "Some of the best news at the European Society for Medical Oncology conference was for breast-cancer patients.", "url": "https://www.marketwatch.com/articles/anticancer-drug-team-ups-show-promise-lilly-j-j-amgen-and-gilead-stand-to-gain-51600699366"}, {"symbol": "AMGN", "publishedDate": "2020-09-21 09:46:47", "title": "DIA: Investors Need A Catalyst (NYSEARCA:DIA)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "Since March 23rd, 2020, the SPDR Dow Jones Industrial Average Trust has rallied by as much as 58.2%, with relatively few corrective retracements to the downside.", "url": "https://seekingalpha.com/article/4375392-dia-investors-need-catalyst"}, {"symbol": "AMGN", "publishedDate": "2020-09-20 18:18:27", "title": "The 5 Undervalued Blue Chip High Dividend Growth Stocks You Need To Buy Now", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "The core of a dividend portfolio should be made of all weather dividend stocks. Buying these stocks when they are undervalued is important if you want great performance.", "url": "https://seekingalpha.com/article/4375322-5-undervalued-blue-chip-high-dividend-growth-stocks-you-need-to-buy-now"}, {"symbol": "AMGN", "publishedDate": "2020-09-20 10:08:40", "title": "Amgen: Growing At A Reasonable Price (NASDAQ:AMGN)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "Amgen is a leading biotechnology company that has a presence in 100 countries and produces innovative medicines that reach millions around the world.", "url": "https://seekingalpha.com/article/4375302-amgen-growing-reasonable-price"}, {"symbol": "AMGN", "publishedDate": "2020-09-19 11:00:00", "title": "Where Will Amgen Be in 1 Year? | The Motley Fool", "image": "https://g.foolcdn.com/editorial/images/591566/gettyimages-1156456292.jpg", "site": "https://www.fool.com", "text": "While the biotech stares down a busy year ahead, shareholders should buckle up for an exciting ride.", "url": "https://www.fool.com/investing/2020/09/19/where-will-amgen-be-in-1-year/"}, {"symbol": "AMGN", "publishedDate": "2020-09-18 20:16:00", "title": "High Hopes for Amgen and Gilead at Europe\u2019s Biggest Cancer Research Conference", "image": "https://images.barrons.com/im-233788/social", "site": "barrons", "text": "Europe\u2019s biggest conference for cancer researchers will be a virtual affair this weekend, but it is still expected to be a big deal for companies like Amgen and for Immunomedics, which just agreed to a $21 billion acquisition by Gilead Sciences.\n\t\t\n\t\t\tundefined", "url": "https://www.barrons.com/articles/europes-biggest-cancer-research-conference-happens-this-weekend-what-to-watch-51600460193"}, {"symbol": "AMGN", "publishedDate": "2020-09-18 12:59:32", "title": "Eli Lilly and : Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/ELI-LILLY-AND-COMPANY-13401/news/Eli-Lilly-and-Lilly-and-Amgen-Announce-Manufacturing-Collaboration-for-COVID-19-Antibody-Therapies-31320621/"}, {"symbol": "AMGN", "publishedDate": "2020-09-17 14:49:00", "title": "Coronavirus update: Global cases near 30 million; Trump contradicts CDC head on vaccine timetable and again derides face masks", "image": "https://s.marketwatch.com/public/resources/images/MW-IK153_redfie_ZG_20200709173716.jpg", "site": "marketwatch", "text": "The number of confirmed cases of the coronavirus that causes COVID-19 worldwide continued to head toward 30 million on Thursday, and the U.S. case tally...", "url": "https://www.marketwatch.com/story/coronavirus-update-global-cases-near-30-million-trump-contradicts-cdc-head-on-vaccine-timetable-and-again-derides-face-masks-2020-09-17"}, {"symbol": "AMGN", "publishedDate": "2020-09-17 13:17:14", "title": "AbbVie: The Best Dividend Growth Challenger In The Margin Of Safety (NYSE:ABBV)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "Dividend Radar is a great resource to uncover opportunities among dividend-paying companies. Using Dividend Radar, we evaluate the best dividend challengers at or below fair value, with a 3-year total trailing return CAGR of at least 15%.", "url": "https://seekingalpha.com/article/4374883-abbvie-best-dividend-growth-challenger-in-margin-of-safety"}, {"symbol": "AMGN", "publishedDate": "2020-09-17 10:41:26", "title": "Eli Lilly and Amgen to collaborate on COVID-19 antibody therapies", "image": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "site": "marketwatch", "text": "Eli Lilly and Co. undefined and Amgen Inc. undefined said Thursday they will collaborate on COVID-19 antibody treatments as a way to significantly boost...", "url": "https://www.marketwatch.com/story/eli-lilly-and-amgen-to-collaborate-on-covid-19-antibody-therapies-2020-09-17-6914126"}, {"symbol": "AMGN", "publishedDate": "2020-09-17 00:00:00", "title": "Oil And Gas Separators Market- Roadmap for Recovery from COVID-19|Rising Global Energy Demand to boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20200916005738/en/821909/23/IRTNTR44022.jpg", "site": "businesswire", "text": "The Global Oil and Gas Separators Market will grow by $ 298.61 mn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200916005738/en/Oil-And-Gas-Separators-Market--Roadmap-for-Recovery-from-COVID-19Rising-Global-Energy-Demand-to-boost-the-Market-Growth-Technavio"}, {"symbol": "AMGN", "publishedDate": "2020-09-14 00:00:00", "title": "Industrial Valves Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024", "image": "https://mms.businesswire.com/media/20200914005530/en/820873/23/Industrial_Valves.jpg", "site": "businesswire", "text": "Industrial Valves market will register an incremental spend of about $16 billion, growing at a CAGR of 4.04% during the five-year forecast period.", "url": "https://www.businesswire.com/news/home/20200914005530/en/Industrial-Valves-Market-Procurement-Intelligence-Report-with-COVID-19-Impact-Analysis-Global-Forecasts-2020-2024"}, {"symbol": "AMGN", "publishedDate": "2020-09-13 12:31:13", "title": "Dividends And Reasonable Price Appreciation: Introducing The 'DARPA' Portfolio", "image": "https://static.seekingalpha.com/uploads/2020/9/10/7008211-15997551555157187_origin.jpg", "site": "seekingalpha.com", "text": "Focusing exclusively on dividend income can lead to substantial erosion of a portfolio over time if the dividends are high because the companies are stagnant.", "url": "https://seekingalpha.com/article/4373960-dividends-and-reasonable-price-appreciation-introducing-darpa-portfolio"}, {"symbol": "AMGN", "publishedDate": "2020-09-12 09:00:00", "title": "Retire Rich: Buy Low And Sell High Consistently", "image": "https://static.seekingalpha.com/uploads/2020/9/9/434815-1599687149176113_origin.png", "site": "seekingalpha.com", "text": "What if we could buy low and sell high on a consistent basis? Sounds too good to be true? We discuss a systematic and rather conservative strategy to buy low and sell high using DGI stocks with minimal trading.", "url": "https://seekingalpha.com/article/4373781-retire-rich-buy-low-and-sell-high-consistently"}, {"symbol": "AMGN", "publishedDate": "2020-09-11 20:01:04", "title": "Amgen : To Present At The 18th Annual Morgan Stanley Global Healthcare Conference | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/Amgen-To-Present-At-The-18th-Annual-Morgan-Stanley-Global-Healthcare-Conference-31280523/"}, {"symbol": "AMGN", "publishedDate": "2020-09-11 15:49:39", "title": "Amgen (AMGN) Investor Presentation - Slideshow", "image": "https://static3.seekingalpha.com/uploads/sa_presentations/365/60365/slides/1.jpg?1599853457", "site": "seekingalpha.com", "text": "The following slide deck was published by Amgen Inc. in conjunction with this event..", "url": "https://seekingalpha.com/article/4373810-amgen-amgn-investor-presentation-slideshow"}, {"symbol": "AMGN", "publishedDate": "2020-09-11 08:58:44", "title": "Why Stocks Could Be Ready To Rally", "image": "https://static1.seekingalpha.com/uploads/2020/9/10/486106-15997506743329172.png", "site": "seekingalpha.com", "text": "The market indexes pulled back significantly in the past week, with the NASDAQ 100 ETF losing 11% from its September high to its low this week.", "url": "https://seekingalpha.com/article/4373703-why-stocks-be-ready-to-rally"}, {"symbol": "AMGN", "publishedDate": "2020-09-10 19:26:04", "title": "Amgen Inc. (AMGN) Presents at Citi 15th Annual Biopharma Conference (Transcript)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Amgen Inc. (NASDAQ:AMGN) Citi 15th Annual Biopharma Conference Call September 10, 2020 02:25 PM ET Company Participants Murdo Gordon - EVP, Global Commercial Operations Peter Griffith - CFO Arvind Sood - Head, IR Conference Call Participants Mohit Bansal - Citi Presentation Mohit Bansal Great.", "url": "https://seekingalpha.com/article/4373613-amgen-inc-amgn-presents-citi-15th-annual-biopharma-conference-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-09-10 19:18:00", "title": "Dow drops nearly 425 points on losses for Apple Inc., Microsoft stocks", "image": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "site": "marketwatch", "text": "Behind declines for shares of Apple Inc. and Microsoft, the Dow Jones Industrial Average is seeing a selloff Thursday afternoon. Shares of Apple Inc. and...", "url": "https://www.marketwatch.com/story/dow-drops-nearly-425-points-on-losses-for-apple-inc-microsoft-stocks-2020-09-10"}, {"symbol": "AMGN", "publishedDate": "2020-09-10 14:45:12", "title": "And Tomorrow the Entire World review \u2013 German antifa drama skewers left and right", "image": "https://i.guim.co.uk/img/media/67dbb7296a3b1b36d61abd998633cab898a278df/0_248_7360_4415/master/7360.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctcmV2aWV3LTQucG5n&enable=upscale&s=5d3076ee89a3f69d9fa5df5e2eac6d2a", "site": "theguardian", "text": "Julia von Heinz\u2019s film brings current conflicts to Venice, as a law student in an anti-fascist group finds everyone is compromised", "url": "https://www.theguardian.com/film/2020/sep/10/and-tomorrow-the-entire-world-review-german-antifa-drama-skewers-left-and-right"}, {"symbol": "AMGN", "publishedDate": "2020-09-09 14:12:43", "title": "Amgen: Massive Pharmaceutical Strength", "image": "https://static1.seekingalpha.com/uploads/2020/9/9/saupload_saupload_amgen3_thumb1_thumb1.jpg", "site": "seekingalpha.com", "text": "Amgen has an impressive portfolio of assets. It has seen revenue increase through COVID-19 increasing 6% YoY.", "url": "https://seekingalpha.com/article/4373314-amgen-massive-pharmaceutical-strength"}, {"symbol": "AMGN", "publishedDate": "2020-09-09 09:55:58", "title": "There Is No Alternative", "image": "https://static.seekingalpha.com/uploads/2020/9/8/414172-15995848105091221_origin.png", "site": "seekingalpha.com", "text": "We hear numerous market strategists talk about stocks which are going up because \u201cthere is no alternative\u201d to owning them.", "url": "https://seekingalpha.com/article/4373243-is-no-alternative"}, {"symbol": "AMGN", "publishedDate": "2020-09-07 06:59:02", "title": "Nicholas Ward's Dividend Growth Portfolio: August 2020 Review", "image": "https://static2.seekingalpha.com/uploads/2020/9/2/5939041-15991034977826867.png", "site": "seekingalpha.com", "text": "My passive income increased 15.9% year over year. My portfolio posted gains of 8.6% during August.", "url": "https://seekingalpha.com/article/4372875-nicholas-wards-dividend-growth-portfolio-august-2020-review"}, {"symbol": "AMGN", "publishedDate": "2020-09-05 09:00:38", "title": "Amgen Still A Buy After Joining The Dow", "image": "https://static1.seekingalpha.com/uploads/2020/9/4/saupload_eb62d175237faf2ad074c6b885a038f3.png", "site": "seekingalpha.com", "text": "Amgen still a buy after joining the Dow. Amgen was added to the Dow Jones Industrial Average on August 31, 2020.", "url": "https://seekingalpha.com/article/4372743-amgen-still-buy-after-joining-dow"}, {"symbol": "AMGN", "publishedDate": "2020-09-04 20:01:04", "title": "Amgen : To Present At The 15th Annual Citi BioPharma Conference | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdgris.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/Amgen-To-Present-At-The-15th-Annual-Citi-BioPharma-Conference-31233546/"}, {"symbol": "AMGN", "publishedDate": "2020-09-04 10:11:00", "title": "Here are the biggest stock-market losers on Thursday as the tech sector tanks", "image": "https://s.marketwatch.com/public/resources/images/MW-IN481_Zoom_ZG_20200828153804.jpg", "site": "marketwatch", "text": "Thursday\u2019s decline was broad, with all sectors of the S&P 500 ending lower.", "url": "https://www.marketwatch.com/story/here-are-the-biggest-stock-market-losers-on-thursday-as-the-tech-sector-tanks-2020-09-03"}, {"symbol": "AMGN", "publishedDate": "2020-09-03 18:47:12", "title": "The Sell-Off Accelerates, What To Do Now", "image": "https://static.seekingalpha.com/uploads/2020/9/3/486106-15991532517022426.png", "site": "seekingalpha.com", "text": "The S&P 500's sell-off accelerates. The best sectors and stocks to consider when it bottoms.", "url": "https://seekingalpha.com/article/4372506-sell-off-accelerates-what-to-now"}, {"symbol": "AMGN", "publishedDate": "2020-09-03 07:13:34", "title": "Amarin's Vascepa Data, And Other News: The Good, Bad And Ugly Of Biopharma", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Amarin reports positive data for Vascepa. Amgen reports positive Phase 3B data for Repatha.", "url": "https://seekingalpha.com/article/4372295-amarins-vascepa-data-and-news-good-bad-and-ugly-of-biopharma"}, {"symbol": "AMGN", "publishedDate": "2020-09-02 22:31:11", "title": "Illusion, Perception And Reality: Stock Splits And Index Inclusions", "image": "https://static.seekingalpha.com/uploads/2020/9/2/saupload_EventPicture.jpg", "site": "seekingalpha.com", "text": "I have long argued that value and price, while used interchangeably by many, are different concepts, driven by different forces, and lead to different numbers.", "url": "https://seekingalpha.com/article/4372255-illusion-perception-and-reality-stock-splits-and-index-inclusions"}, {"symbol": "AMGN", "publishedDate": "2020-09-01 17:34:56", "title": "V&M Breakouts: Top Growth And Dividend Mega-Cap Stocks For September 2020", "image": "https://static.seekingalpha.com/uploads/2020/8/30/43516266-1598791025502474_origin.png", "site": "seekingalpha.com", "text": "Releasing two top mega-cap stocks from the MDA Growth and Dividend Breakout portfolio for long-term gain potential into 2020.", "url": "https://seekingalpha.com/article/4372002-v-and-m-breakouts-top-growth-and-dividend-mega-cap-stocks-for-september-2020"}, {"symbol": "AMGN", "publishedDate": "2020-09-01 12:14:54", "title": "Back To School: 8 Hot All Weather Dividend Buys, And 3 We Might Sell", "image": "https://static.seekingalpha.com/uploads/2020/9/1/29440305-15989487751290586.jpg", "site": "seekingalpha.com", "text": "The stock market is heating up faster than we had imagined. Some of our positions are approaching Sell territory.", "url": "https://seekingalpha.com/article/4371941-back-to-school-8-hot-all-weather-dividend-buys-and-3-might-sell"}, {"symbol": "AMGN", "publishedDate": "2020-08-31 11:48:03", "title": "Whether Dumped By The Dow Or Added To It, Companies Should Be Judged On Their Own Merits", "image": "https://static1.seekingalpha.com/uploads/2020/8/30/1115549-15988033713472419.jpg", "site": "seekingalpha.com", "text": "Amgen, Honeywell and Salesforce.com are now Dow Jones Industrial Average components, replacing Exxon Mobil, Pfizer, and Raytheon Technologies.", "url": "https://seekingalpha.com/article/4371707-whether-dumped-dow-added-to-companies-should-be-judged-on-own-merits"}, {"symbol": "AMGN", "publishedDate": "2020-08-31 07:00:36", "title": "Wall Street Breakfast: High Profile Stock Splits", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.", "url": "https://seekingalpha.com/article/4371627-wall-street-breakfast-high-profile-stock-splits"}, {"symbol": "AMGN", "publishedDate": "2020-08-30 07:40:21", "title": "Wall Street Breakfast: The Week Ahead", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.", "url": "https://seekingalpha.com/article/4371542-wall-street-breakfast-week-ahead"}, {"symbol": "AMGN", "publishedDate": "2020-08-29 14:01:25", "title": "Wall Street Breakfast: What Moved Markets", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.", "url": "https://seekingalpha.com/article/4371522-wall-street-breakfast-what-moved-markets"}, {"symbol": "AMGN", "publishedDate": "2020-08-29 10:56:23", "title": "Dividend Champion And Contender Highlights: Week Of August 30", "image": "", "site": "seekingalpha.com", "text": "", "url": "https://seekingalpha.com/article/4371517-dividend-champion-and-contender-highlights-week-of-august-30"}, {"symbol": "AMGN", "publishedDate": "2020-08-29 09:44:00", "title": "Retirement: 10 Recession-Proof DGI Stocks (Almost)", "image": "https://static3.seekingalpha.com/uploads/2020/8/26/saupload_45fcdb3ed60df60eb03ecbb1342411bb.png", "site": "seekingalpha.com", "text": "The S&P 500 has recently made new all-time highs. We are interested to know which stocks had the best chance of upside during the recovery following the big correction early.", "url": "https://seekingalpha.com/article/4371137-retirement-10-recession-proof-dgi-stocks-almost"}, {"symbol": "AMGN", "publishedDate": "2020-08-29 08:00:00", "title": "Stocks To Watch: Nvidia, Intel And Zoom Look To Dazzle", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.", "url": "https://seekingalpha.com/article/4371250-stocks-to-watch-nvidia-intel-and-zoom-look-to-dazzle"}, {"symbol": "AMGN", "publishedDate": "2020-08-29 03:06:14", "title": "Investing At 60 Vs. Investing At 20: Why It Should Be Different", "image": "https://static.seekingalpha.com/uploads/2020/8/26/29440305-1598416147338434.jpg", "site": "seekingalpha.com", "text": "One of our fellow contributors recently published a thought-provoking piece on dividend investing strategy.", "url": "https://seekingalpha.com/article/4371492-investing-60-vs-investing-20-why-should-be-different"}, {"symbol": "AMGN", "publishedDate": "2020-08-28 20:50:00", "title": "3 things to know about Apple\u2019s stock split", "image": "https://s.marketwatch.com/public/resources/images/MW-HO439_applel_ZG_20190730164539.jpg", "site": "marketwatch", "text": "Apple Inc.\u2019s stock price will appear quite a bit lower Monday morning, but investors shouldn\u2019t fret.", "url": "https://www.marketwatch.com/story/3-things-to-know-about-apples-stock-split-2020-08-28"}, {"symbol": "AMGN", "publishedDate": "2020-08-28 13:49:25", "title": "Exxon Mobil Exit Reveals S&P 500 Index Structural Flaws", "image": "https://static1.seekingalpha.com/uploads/2015/5/13631982_14329327704589_1_thumb.jpg", "site": "seekingalpha.com", "text": "Exxon joined the Dow Jones Industrial Average in 1928, entering the vaunted index before the violent market downturn that occurred alongside the Great Depression.", "url": "https://seekingalpha.com/article/4371418-exxon-mobil-exit-reveals-s-and-p-500-index-structural-flaws"}, {"symbol": "AMGN", "publishedDate": "2020-08-27 12:21:15", "title": "Dow Jones Shake-Up: 2 Buys, 1 Hold, And 1 Sell", "image": "https://static1.seekingalpha.com/uploads/2020/8/27/29440305-15985202791865711.jpg", "site": "seekingalpha.com", "text": "Following Apple's 4 to 1 stock split, the Dow Jones booted 3 companies and added 3 others. While the Dow's changes are trend following in nature, they are not enough to inform buy or sell decisions.", "url": "https://seekingalpha.com/article/4371130-dow-jones-shake-up-2-buys-1-hold-and-1-sell"}, {"symbol": "AMGN", "publishedDate": "2020-08-26 15:56:27", "title": "Amgen could be the biggest winner of the Dow shake-up, says the options market", "image": "https://image.cnbcfm.com/api/v1/image/101879382-RTX14J0R.jpg?v=1598389870", "site": "cnbc", "text": "Of the three newest names joining the Dow, the options market is betting Amgen might be the biggest winner.", "url": "https://www.cnbc.com/2020/08/26/amgen-could-be-biggest-winner-of-dow-shake-up-says-the-options-market.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-26 11:21:24", "title": "The Dow should consider swapping Walgreens out for Amazon or Alphabet, trader says after shake-up", "image": "https://image.cnbcfm.com/api/v1/image/102291839-1598387351738-wall.jpg?v=1598387384", "site": "cnbc", "text": "Amazon or Alphabet would be more \"reflective of the modern economy\" than something like Walgreens, said Todd Gordon of Ascent Wealth Partners.", "url": "https://www.cnbc.com/2020/08/26/dow-should-swap-walgreens-out-for-amazon-alphabet-trader.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-26 10:11:00", "title": "Salesforce, Amgen, and Honeywell Are Being Added to the Dow Jones Index: Are They Buys? | The Motley Fool", "image": "https://g.foolcdn.com/editorial/images/589263/data-analytics.jpg", "site": "https://www.fool.com", "text": "The iconic index is getting an adjustment to better reflect the U.S. economy.", "url": "https://www.fool.com/investing/2020/08/26/salesforce-amgen-and-honeywell-are-being-added-to/"}, {"symbol": "AMGN", "publishedDate": "2020-08-26 00:05:11", "title": "Cramer reacts to Dow Jones additions of Salesforce, Amgen and Honeywell: 'The job's almost done'", "image": "https://image.cnbcfm.com/api/v1/image/101879382-RTX14J0R.jpg?v=1598389870", "site": "cnbc", "text": "\"This rebalancing came about because of a need for more technology in this index,\" the \"Mad Money\" host said.", "url": "https://www.cnbc.com/2020/08/25/cramer-reacts-to-new-additions-to-dow-jones.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-26 00:00:00", "title": "Honeywell, Salesforce.com, Amgen: Worth Buying After The Dow Index Shake-Up?", "image": "https://i-invdn-com.akamaized.net/redesign/images/seo/v2/investingcom_analysis_og.jpg", "site": "investing", "text": "Stocks Analysis by Investing.com (Haris Anwar/Investing.com) covering: Dow Jones Industrial Average, Apple Inc, Amgen Inc, Exxon Mobil Corp. Read Investing.com (Haris Anwar/Investing.com)'s latest article on Investing.com", "url": "https://www.investing.com/analysis/honeywell-salesforcecom-amgen-worth-buying-after-dow-shakeup-200535212"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 22:01:33", "title": "TikTok reveals staggering user growth in new lawsuit against the U.S. government: CNBC After Hours", "image": "https://image.cnbcfm.com/api/v1/image/106678018-1598392769154-AH_YT_Thumb_2.jpg?v=1598392790", "site": "cnbc", "text": "CNBC.com's MacKenzie Sigalos brings you the day's top business news headlines. On today's show, CNBC.com's Alex Sherman breaks down TikTok's impressive user growth in the wake of its lawsuit against the U.S. government.", "url": "https://www.cnbc.com/2020/08/25/tiktok-reveals-staggering-user-growth-in-new-lawsuit-against-the-us-government.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 20:13:07", "title": "Here's what happened to the stock market on Tuesday", "image": "https://image.cnbcfm.com/api/v1/image/106208275-1572295521762gettyimages-1161832016.jpeg?v=1598382184", "site": "cnbc", "text": "The Dow fell amid a rare decline in Apple and a big shake-up for the average.", "url": "https://www.cnbc.com/2020/08/25/what-happened-to-the-stock-market-on-tuesday-dow-falls-as-apple-snaps-winning-streak.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 19:45:00", "title": "Why Amgen Stock Vaulted Higher Today | The Motley Fool", "image": "https://g.foolcdn.com/editorial/images/589276/dow-in-a-green-circle.jpg", "site": "https://www.fool.com", "text": "The company is set to become the first biotech included in the Dow Jones Industrial Average.", "url": "https://www.fool.com/investing/2020/08/25/why-amgen-stock-vaulted-higher-today/"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 18:25:00", "title": "Why Dow\u2019s shake-up is bad for stocks added to it\u2014and less bad for those booted", "image": "https://images.mktw.net/im-224811/social", "site": "marketwatch", "text": "Inclusion in the 124-year old, blue-chip equity benchmark is usually coveted by major companies but recent history suggests that the near-term performance of...", "url": "https://www.marketwatch.com/story/why-dows-shake-up-is-bad-for-stocks-added-to-itand-less-bad-for-those-booted-11598379932"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 16:56:00", "title": "Stock Markets Close Mixed, But the Dow's New Stocks Look Good", "image": "https://cdn.snapi.dev/images/v1/t/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5892982ffireworks-gettyimages-868481630jpgw700opresize.jpg", "site": "The Motley Fool", "text": "An after-hours earnings beat lifted one of the soon-to-be Dow components even further.", "url": "https://www.fool.com/investing/2020/08/25/stock-markets-close-mixed-but-the-dows-new-stocks/"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 16:31:14", "title": "XLV: The Healthcare Sector Is Underestimated", "image": "https://static2.seekingalpha.com/uploads/2020/8/24/saupload_e365826a993cd034699f8a7dd8754427.png", "site": "seekingalpha.com", "text": "XLV is a diversified healthcare ETF including some of the larger caps in the S&P 500. Despite knowing some upside, it has been underperforming when comparing with peers.", "url": "https://seekingalpha.com/article/4370720-xlv-healthcare-sector-is-underestimated"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 16:22:25", "title": "Stocks making the biggest moves midday: Gap, Medtronic, Apple, Starbucks, Chipotle and more", "image": "https://image.cnbcfm.com/api/v1/image/106644901-1598291582234-gap2.jpg?v=1598291608", "site": "cnbc", "text": "These are the stocks posting the largest moves in midday trading.", "url": "https://www.cnbc.com/2020/08/25/stocks-making-the-biggest-moves-midday-gap-medtronic-apple-starbucks-chipotle.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 16:00:00", "title": "New Amgen Data To Be Presented At ESC Congress 2020 Highlighting Repatha\u00ae (evolocumab) Efficacy In High-Risk Patient Populations", "image": "https://cdn.snapi.dev/images/v1/d/7/press19-3.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Aug. 25, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of 12 cardiovascular scientific research abstracts, including clinical trial and real-world evidence studies of Repatha\u00ae (evolocumab), that add to the growing body of evidence.", "url": "https://www.prnewswire.com/news-releases/new-amgen-data-to-be-presented-at-esc-congress-2020-highlighting-repatha-evolocumab-efficacy-in-high-risk-patient-populations-301118228.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 15:45:00", "title": "Why Amgen Stock Vaulted Higher Today", "image": "https://cdn.snapi.dev/images/v1/t/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5394062fbiotech2jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company is set to become the first biotech included in the Dow Jones Industrial Average.", "url": "https://www.fool.com/investing/2020/08/25/why-amgen-stock-vaulted-higher-today/"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 15:06:00", "title": "Pfizer Got Kicked Off the Dow Just as Things Were Looking Up", "image": "https://images.barrons.com/im-224672/social", "site": "barrons", "text": "The pharmaceutical company is being replaced by Amgen. Excitement over Pfizer\u2019s Covid-19 vaccine candidate has boosted the stock.", "url": "https://www.barrons.com/articles/pfizer-amgen-dow-jones-industrial-average-apple-51598367813"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 10:15:43", "title": "There's a cohort of buyers whose enthusiasm can't be quelled by the facts, something unseen since the 80's", "image": "https://cdn.snapi.dev/images/v1/m/q/theres-a-cohort-of-buyers-whose-enthusiasm-cant-be-quelled-by-the-facts-something-unseen-since-the-80s.jpg", "site": "CNBC Television", "text": "CNBC's Jim Cramer joins 'Squawk Box' to discuss the Dow's removal of Pfizer, Raytheon and Exxon, and its addition of Salesforce.com, Amgen and Honeywell.", "url": "https://www.youtube.com/watch?v=nevEDmgHvTc"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 09:22:00", "title": "3 ETFs For The New Look Dow Jones Industrial Average", "image": "https://cdn.snapi.dev/images/v1/m/n/chart-594212-1920-14.jpg", "site": "Benzinga", "text": "The venerable Dow Jones Industrial Average is being reshaped in significant fashion.", "url": "https://www.benzinga.com/trading-ideas/long-ideas/20/08/17222390/3-etfs-for-the-new-look-dow-jones-industrial-average"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 07:47:34", "title": "Salesforce, Amgen and Honeywell higher premarket on Dow-joining news; Exxon, Pfizer and Raytheon move lower", "image": "https://cdn.snapi.dev/images/v1/n/7/1blis-1.jpg", "site": "Market Watch", "text": "Shares of the three new additions to the Dow Jones Industrial Average DJIA, +1.35% were higher in premarket trade Tuesday, while the three departing members moved lower, a day after S&P Dow Jones Indices announced a shake-up for the 30-member index.", "url": "https://www.marketwatch.com/story/salesforce-amgen-and-honeywell-higher-premarket-on-news-to-join-dow-exxon-pfizer-and-raytheon-move-lower-2020-08-25"}, {"symbol": "AMGN", "publishedDate": "2020-08-25 00:17:38", "title": "Apple Stock Split Causes Dow Jones Industrial Average Shuffle; Salesforce, Amgen, Honeywell To Make Entry", "image": "https://cdn.snapi.dev/images/v1/6/a/austin-distel-empz7yrzogw-unsplash-1.jpg", "site": "Benzinga", "text": "The S&P Dow Jones Indices,\u00a0a division of S&P Global (NYSE: SPGI), on Monday\u00a0announced certain changes to the Dow Jones Industrial Average (DJIA) composition, effective Aug.", "url": "https://www.benzinga.com/news/20/08/17223039/apple-stock-split-causes-dow-jones-industrial-average-shuffle-salesforce-amgen-honeywell-to-make-ent"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 22:52:00", "title": "Salesforce to Join Dow Jones Industrial Average", "image": "https://cdn.snapi.dev/images/v1/q/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5378132fsalesforce-earnings-crmjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Amgen and Honeywell International are also graduating to the hallowed ranks of the Dow.", "url": "https://www.fool.com/investing/2020/08/24/salesforce-to-join-dow-jones-industrial-average/"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 18:45:37", "title": "Major shakeup for the Dow Jones Industrial Average index: 3 new stocks join", "image": "https://cdn.snapi.dev/images/v1/z/j/ij9223f-1.jpg", "site": "CNN Business", "text": "The Dow Jones Industrial Average is getting a massive shakeup to balance out the disruption from Apple's stock split.", "url": "https://www.cnn.com/2020/08/24/investing/dow-jones-salesforce-amgen-honeywell/index.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 18:33:34", "title": "Salesforce, Amgen and Honeywell to join Dow Jones", "image": "https://cdn.snapi.dev/images/v1/f/z/salesforce-amgen-and-honeywell-to-join-dow-jones.jpg", "site": "CNBC Television", "text": "Howard Silverblatt, S&P Dow Jones Indices senior index analyst, discusses what it means that Exxon, Pfizer and Raytheon are being replaced in the Dow Jones Industrial Average.", "url": "https://www.youtube.com/watch?v=Fzd0IMfAov0"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 18:23:00", "title": "Salesforce.com, Amgen and Honeywell International Set to Join Dow Jones Industrial Average", "image": "https://cdn.snapi.dev/images/v1/m/y/press10-3.jpg", "site": "PRNewsWire", "text": "NEW YORK, Aug. 24, 2020 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the Dow Jones Industrial Average (DJIA) effective prior to the opening of trading on Monday, August 31: Salesforce.com (NYSE:CRM) will replace Exxon Mobil Corp.", "url": "https://www.prnewswire.com/news-releases/salesforcecom-amgen-and-honeywell-international-set-to-join-dow-jones-industrial-average-301117395.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 18:15:28", "title": "Amgen, Salesforce.com, Honeywell Added To Dow Jones Industrial Average", "image": "https://cdn.snapi.dev/images/v1/p/l/plde23.jpg", "site": "Investors Business Daily", "text": "Amgen, Salesforce.com and Honeywell will join the Dow Jones Industrial Average in a shuffling of the index that will give it more of a technology flavor.\r\nThe post Amgen, Salesforce.com, Honeywell Added To Dow Jones Industrial Average appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/dow-jones-industrials-add-amgen-salesforce-com-honeywell-exxon-raytheon-pfizer-out/"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 18:13:00", "title": "Salesforce, Amgen, Honeywell to join Dow Jones Industrial", "image": "https://cdn.snapi.dev/images/v1/q/8/stocks151-65.jpg", "site": "Reuters", "text": "Shares of Salesforce.com , Amgen and Honeywell International each surged over 3% in extended trade on Monday after it was announced they would join the Dow Jones Industrial Average as of Aug. 31.", "url": "https://www.reuters.com/article/us-usa-stocks-dow/salesforce-amgen-honeywell-to-join-dow-jones-industrial-idUSKBN25K2J9"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 17:54:00", "title": "The Dow Announces Its Biggest Shakeup Since 2013", "image": "https://cdn.snapi.dev/images/v1/f/u/dow-jones-industrial-average-shakeup.jpg", "site": "Kiplinger", "text": "The Dow Jones Industrial Average will lose its longest-standing component as part of\u00a0the blue-chip index's biggest shakeup in years.", "url": "https://www.kiplinger.com/investing/stocks/blue-chip-stocks/601288/dow-jones-industrial-average-crm-amgn-hon-xom-pfe-rtx"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 17:46:28", "title": "Salesforce, Amgen, Honeywell to become new Dow Average components", "image": "https://cdn.snapi.dev/images/v1/d/w/dw33f2-5.jpg", "site": "Market Watch", "text": "Salesforce.com Inc., Amgen Inc., and Honeywell International Inc. will become new members of the Dow Jones Industrial Average by the end of the month", "url": "https://www.marketwatch.com/story/salesforce-amgen-honeywell-to-become-new-dow-average-components-2020-08-24"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 17:38:00", "title": "Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average", "image": "https://cdn.snapi.dev/images/v1/o/u/106352054-1579805381707dsc03758r.jpg", "site": "CNBC", "text": "Major changes are coming to the Dow Jones Industrial Average.", "url": "https://www.cnbc.com/2020/08/24/salesforce-amgen-and-honeywell-added-to-dow-in-major-shakeup-to-the-average.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 14:45:05", "title": "Other market sectors will rally if we get a vaccine: Jefferies' Michael Yee", "image": "https://cdn.snapi.dev/images/v1/d/e/other-market-sectors-will-rally-if-we-get-a-vaccine-jefferies-michael-yee.jpg", "site": "CNBC Television", "text": "Michael Yee, Jefferies managing director, joins 'Power Lunch' to discuss the pullback in biotech stocks and his outlook for the sector over the next few months.", "url": "https://www.youtube.com/watch?v=fFm6izMD-0A"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 09:25:12", "title": "A Quality Exec Comp Plan Lowers The Risk Of Investing In Amgen Inc.", "image": "https://cdn.snapi.dev/images/v1/t/r/a-quality-exec-comp-plan-lowers-the-risk-of-investing-in-amgen-inc.jpg", "site": "Forbes", "text": "AMGN's executive compensation plan lowers the risk of investing in the company\u2019s stock because executives\u2019 interests are tied to shareholders\u2019 interests.", "url": "https://www.forbes.com/sites/greatspeculations/2020/08/24/a-quality-exec-comp-plan-lowers-the-risk-of-investing-in-amgen-inc/"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 08:30:00", "title": "Ligand Announces Amgen\u2019s KYPROLIS\u00ae Approved by FDA as Combination Regimen with DARZALEX\u00ae and Dexamethasone in Once- and Twice-Weekly Dosing Regimens for Patients with Relapsed/Refractory Multiple Myeloma", "image": "https://cdn.snapi.dev/images/v1/k/q/press7-4.jpg", "site": "Business Wire", "text": "SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that a major Captisol customer Amgen (NASDAQ: AMGN) has received U.S. Food and Drug Administration (FDA) approval for the expansion of the KYPROLIS\u00ae (carfilzomib) U.S.", "url": "https://www.businesswire.com/news/home/20200824005098/en/Ligand-Announces-Amgen%E2%80%99s-KYPROLIS%C2%AE-Approved-FDA-Combination/"}, {"symbol": "AMGN", "publishedDate": "2020-08-24 06:45:00", "title": "Analysis on the Impact of COVID-19- Generic Drugs Market 2020-2024 | Evolving Opportunities With Amgen Inc. and Dr. Reddys Laboratories Ltd.", "image": "https://cdn.snapi.dev/images/v1/a/t/press15-4.jpg", "site": "Business Wire", "text": "LONDON--(BUSINESS WIRE)-- #GenericDrugsMarket--The Global Generic Drugs Market will grow by $ 123.50 mn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200824005024/en/Analysis-Impact-COVID-19--Generic-Drugs-Market-2020-2024/"}, {"symbol": "AMGN", "publishedDate": "2020-08-21 10:47:00", "title": "Amgen's New Kyprolis Combo Gets FDA Nod for Multiple Myeloma", "image": "https://cdn.snapi.dev/images/v1/2/v/biotech9.jpg", "site": "Zacks Investment Research", "text": "Amgen's (AMGN) Kyprolis gets FDA approval for label expansion as second to fourth-line treatment for relapsed/refractory multiple myeloma in combination with J&J's Darzalex and dexamethasone.", "url": "https://www.zacks.com/stock/news/1045491/amgens-new-kyprolis-combo-gets-fda-nod-for-multiple-myeloma"}, {"symbol": "AMGN", "publishedDate": "2020-08-21 09:00:53", "title": "Is Amgen Stock A Buy As It Takes A Dual Approach To Targeting Coronavirus?", "image": "https://cdn.snapi.dev/images/v1/0/w/biotech2.jpg", "site": "Investors Business Daily", "text": "Amgen stock broke out amid a two-pronged approach to coronavirus treatment, partnering with Adaptive Biotechnologies and testing Otezla in Covid-19. So, is Amgen stock a buy now?", "url": "https://www.investors.com/news/technology/amgen-stock-buy-now/"}, {"symbol": "AMGN", "publishedDate": "2020-08-20 17:33:00", "title": "FDA Approves New KYPROLIS\u00ae (carfilzomib) Combination Regimen With DARZALEX\u00ae (daratumumab) And Dexamethasone In Both Once- And Twice-Weekly Dosing Regimens", "image": "https://cdn.snapi.dev/images/v1/k/y/press8.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Aug. 20, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the U.S.", "url": "https://www.prnewswire.com/news-releases/fda-approves-new-kyprolis-carfilzomib-combination-regimen-with-darzalex-daratumumab-and-dexamethasone-in-both-once--and-twice-weekly-dosing-regimens-301116047.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-17 15:23:58", "title": "How Amgen Makes Billions On Just A Few Drugs", "image": "https://cdn.snapi.dev/images/v1/g/u/biotech32.jpg", "site": "Investopedia", "text": "Amgen produces relatively few drugs, but that doesn't mean it's any less essential or profitable.", "url": "https://www.investopedia.com/articles/markets/110514/how-amgen-makes-billions-just-few-drugs.asp"}, {"symbol": "AMGN", "publishedDate": "2020-08-17 07:30:00", "title": "Amgen Stock Up 50% But Revenues Grew Just 3%", "image": "https://cdn.snapi.dev/images/v1/g/e/amgen-stock-up-50-but-revenues-grew-just-3.jpg", "site": "Forbes", "text": "The stock price of pharmaceutical giant Amgen has seen a growth of roughly 50% since the end of 2017, while its revenue grew a mere 3%. Large stock movements without any top line evidence are common in the pharmaceutical industry when promising drugs pass critical clinical trials or get approved.", "url": "https://www.forbes.com/sites/greatspeculations/2020/08/17/amgen-stock-up-50-but-revenues-grew-just-3/"}, {"symbol": "AMGN", "publishedDate": "2020-08-15 09:05:00", "title": "3 Great Stocks for Your IRA", "image": "https://cdn.snapi.dev/images/v1/y/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5686502fgettyimage-stockchartjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investors should consider what a qualified retirement account does and doesn't do well before diving into a position.", "url": "https://www.fool.com/investing/2020/08/15/3-great-stocks-for-your-ira/"}, {"symbol": "AMGN", "publishedDate": "2020-08-13 21:52:00", "title": "Amgen Announces Pricing Terms For Senior Notes Exchange Offers, Increases The Maximum Notes Exchange Cap And Accepts Tendered Notes", "image": "https://cdn.snapi.dev/images/v1/w/e/press11-3.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., Aug. 13, 2020 /PRNewswire/ -- Amgen Inc.", "url": "https://www.prnewswire.com/news-releases/amgen-announces-pricing-terms-for-senior-notes-exchange-offers-increases-the-maximum-notes-exchange-cap-and-accepts-tendered-notes-301112329.html"}, {"symbol": "AMGN", "publishedDate": "2020-08-13 07:24:00", "title": "US Continues to Secure Coronavirus Vaccines: 4 Stocks to Watch", "image": "https://cdn.snapi.dev/images/v1/n/c/biotech12.jpg", "site": "Zacks Investment Research", "text": "The deal with Moderna yet again renewed hopes among millions about a possible vaccine by the end of this year.", "url": "https://www.zacks.com/stock/news/1041006/us-continues-to-secure-coronavirus-vaccines-4-stocks-to-watch"}, {"symbol": "AMGN", "publishedDate": "2020-08-10 08:38:00", "title": "5 Stocks in the Spotlight on Trump's Coronavirus Vaccine Optimism", "image": "https://cdn.snapi.dev/images/v1/l/c/biotech21-2.jpg", "site": "Zacks Investment Research", "text": "Millions are pinning their hopes on a handful of drugmakers, which are into the final phases of their vaccine trial.", "url": "https://www.zacks.com/stock/news/1038610/5-stocks-in-the-spotlight-on-trumps-coronavirus-vaccine-optimism"}, {"symbol": "AMGN", "publishedDate": "2020-08-08 12:26:00", "title": "3 Top Healthcare Stocks to Buy in August", "image": "https://cdn.snapi.dev/images/v1/4/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5509672f2-scientists-side-by-side-in-a-labjpgw700opresize.jpg", "site": "The Motley Fool", "text": "New products mean solid revenue may be ahead for these companies.", "url": "https://www.fool.com/investing/2020/08/08/3-top-healthcare-stocks-to-buy-in-august.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-08-07 16:31:14", "title": "Pfizer, Amgen Leading Pharma Into 'Golden Age' of Biosimilars", "image": "https://cdn.snapi.dev/images/v1/o/e/biotech19-2.jpg", "site": "GuruFocus", "text": "Two members of Big Pharma are ushering in the \"golden age\" of biologics in the United States, according to Bernstein analyst Ronny Gal.", "url": "https://www.gurufocus.com/news/1206093/pfizer-amgen-leading-pharma-into-golden-age-of-biosimilars"}, {"symbol": "AMGN", "publishedDate": "2020-08-04 08:29:00", "title": "Pharma Stocks in Focus on Late-Stage Coronavirus Vaccine Trials", "image": "https://cdn.snapi.dev/images/v1/8/o/biotech15.jpg", "site": "Zacks Investment Research", "text": "Hopes of a vaccine have once again started rising with a number of companies now entering the final phase of their trials.", "url": "https://www.zacks.com/stock/news/1035071/pharma-stocks-in-focus-on-late-stage-coronavirus-vaccine-trials"}, {"symbol": "AMGN", "publishedDate": "2020-08-03 07:56:29", "title": "AbbVie, Amgen and Takeda start testing drugs as COVID-19 treatments", "image": "https://cdn.snapi.dev/images/v1/1/6/drugs18.jpg", "site": "Market Watch", "text": "AbbVie Inc. ABBV, -1.17% , Amgen Inc. AMGN, -0.59% , and Takeda Pharmaceutical Co.", "url": "https://www.marketwatch.com/story/abbvie-amgen-and-takeda-start-testing-drugs-as-covid-19-treatments-2020-08-03"}, {"symbol": "AMGN", "publishedDate": "2020-07-29 11:03:00", "title": "Amgen (AMGN) Stock Moves Lower Despite Q2 Earnings Beat", "image": "https://cdn.snapi.dev/images/v1/v/g/biotech17.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) beats Q2 estimates for both earnings and sales. It maintains its previously-issued sales guidance while raising the earnings range.", "url": "https://www.zacks.com/stock/news/1022894/amgen-amgn-stock-moves-lower-despite-q2-earnings-beat"}, {"symbol": "AMGN", "publishedDate": "2020-07-29 10:14:00", "title": "Amgen Blows Past EPS Estimates for the Second Quarter", "image": "https://cdn.snapi.dev/images/v1/s/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5843652fdoctor-making-a-consultationjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The biotech delivered growth on both the top and bottom lines despite the COVID-19 pandemic.", "url": "https://www.fool.com/investing/2020/07/29/amgen-blows-past-eps-estimates-for-the-second-quar.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-07-28 23:19:09", "title": "Amgen Inc. (AMGN) CEO Bob Bradway on Q2 2020 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/e/s/transcript48.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) CEO Bob Bradway on Q2 2020 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4361637-amgen-inc-amgn-ceo-bob-bradway-on-q2-2020-results-earnings-call-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-07-28 17:25:11", "title": "Amgen (AMGN) Tops Q2 Earnings and Revenue Estimates", "image": "https://cdn.snapi.dev/images/v1/6/n/biotech11.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) delivered earnings and revenue surprises of 11.55% and 0.39%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/1022146/amgen-amgn-tops-q2-earnings-and-revenue-estimates"}, {"symbol": "AMGN", "publishedDate": "2020-07-28 17:18:54", "title": "Amgen Stock Falls Late After Sales Outlook Remains Unchanged", "image": "https://cdn.snapi.dev/images/v1/u/c/amg.jpg", "site": "Investors Business Daily", "text": "Late Tuesday, Amgen reported second-quarter sales that merely met Wall Street expectations. The giant drugmaker also maintained its revenue guidance for 2020, and Amgen stock fell late.", "url": "https://www.investors.com/news/technology/amgen-stock-fall-maintains-sales-outlook/"}, {"symbol": "AMGN", "publishedDate": "2020-07-28 16:25:42", "title": "Recap: Amgen Q2 Earnings", "image": "https://cdn.snapi.dev/images/v1/4/6/biotech9.jpg", "site": "Benzinga", "text": "Shares of Amgen (NASDAQ:AMGN) were flat in after-market trading after the company reported Q2 results.", "url": "https://www.benzinga.com/news/earnings/20/07/16816179/recap-amgen-q2-earnings"}, {"symbol": "AMGN", "publishedDate": "2020-07-28 16:17:45", "title": "Amgen stock heads lower after company Q2's profit below expectations", "image": "https://cdn.snapi.dev/images/v1/n/k/biotech8-2.jpg", "site": "Market Watch", "text": "Shares of Amgen Inc. AMGN, +0.63% fell more than 2% in the late session Tuesday after the pharma company reported second-quarter earnings below Wall Street expectations.", "url": "https://www.marketwatch.com/story/amgen-stock-heads-lower-after-company-q2s-profit-below-expectations-2020-07-28"}, {"symbol": "AMGN", "publishedDate": "2020-07-28 16:11:00", "title": "Amgen second-quarter revenue rises 6%, adjusted profit tops Street view", "image": "https://cdn.snapi.dev/images/v1/c/6/m02d20200728t2i1527451031w940fhfwllplsqrlynxnpeg6r1kr.jpg", "site": "Reuters", "text": "Amgen Inc on Tuesday reported second-quarter revenue rose 6% as higher sales of newer drugs, including recently-added psoriasis treatment Otezla, offset declining sales of older medicines.", "url": "https://www.reuters.com/article/us-amgen-results/amgen-second-quarter-revenue-rises-6-adjusted-profit-tops-street-view-idUSKCN24T2RC"}, {"symbol": "AMGN", "publishedDate": "2020-07-28 08:19:00", "title": "Coronavirus Vaccine Development Puts These Stocks in Focus", "image": "https://cdn.snapi.dev/images/v1/h/t/biotech6.jpg", "site": "Zacks Investment Research", "text": "Moderna and Pfizer launches two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year.", "url": "https://www.zacks.com/stock/news/1017236/coronavirus-vaccine-development-puts-these-stocks-in-focus"}, {"symbol": "AMGN", "publishedDate": "2020-07-26 11:13:37", "title": "10 Dividend Growth Stocks For July 2020", "image": "https://cdn.snapi.dev/images/v1/x/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5292912fa-person-using-a-calulator-with-financial-charts-on-the-deskjpgw700opresize.jpg", "site": "Seeking Alpha", "text": "In my monthly series of 10 Dividend Growth Stocks, I rank a selection of dividend growth stocks in Dividend Radar and present the 10 top-ranked stocks for consideration.", "url": "https://seekingalpha.com/article/4360834-10-dividend-growth-stocks-for-july-2020?utm_source=feed_articles_dividends_dividend_quick_picks&utm_medium=referral"}, {"symbol": "AMGN", "publishedDate": "2020-07-24 11:13:00", "title": "Amgen (AMGN) to Report Q2 Earnings: What's in the Cards?", "image": "https://cdn.snapi.dev/images/v1/d/z/biotech13.jpg", "site": "Zacks Investment Research", "text": "Investor focus is likely to be on the extent of the impact of the coronavirus outbreak on Amgen's (AMGN) performance when it reports second-quarter results.", "url": "https://www.zacks.com/stock/news/1015515/amgen-amgn-to-report-q2-earnings-whats-in-the-cards"}, {"symbol": "AMGN", "publishedDate": "2020-07-24 10:51:30", "title": "Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks", "image": "https://cdn.snapi.dev/images/v1/s/c/106298733-1576513139338gettyimages-880891422.jpeg", "site": "24/7 Wall Street", "text": "The health care sector has been a big winner in 2020, far outpacing the Dow Jones industrial average and S&P 500.", "url": "https://247wallst.com/healthcare-business/2020/07/24/goldman-sachs-sees-big-gains-from-7-biotech-pharma-conviction-buy-stocks/"}, {"symbol": "AMGN", "publishedDate": "2020-07-23 17:00:00", "title": "Amgen Announces Webcast Of 2020 Second Quarter Financial Results", "image": "https://cdn.snapi.dev/images/v1/k/q/conf7.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., July 23, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 28, 2020, after the close of the U.S.", "url": "https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2020-second-quarter-financial-results-301099104.html"}, {"symbol": "AMGN", "publishedDate": "2020-07-23 16:15:00", "title": "Amgen Announces 2020 Third Quarter Dividend", "image": "https://cdn.snapi.dev/images/v1/7/h/press18-2.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., July 23, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the third quarter of 2020.", "url": "https://www.prnewswire.com/news-releases/amgen-announces-2020-third-quarter-dividend-301099038.html"}, {"symbol": "AMGN", "publishedDate": "2020-07-22 07:28:53", "title": "4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020", "image": "https://cdn.snapi.dev/images/v1/u/j/1blis-1.jpg", "site": "24/7 Wall Street", "text": "Increasingly, the Wall Street firms we cover agree that while the future is still bright for the U.S.", "url": "https://247wallst.com/investing/2020/07/22/4-first-half-growth-stock-winners-are-top-picks-for-the-rest-of-2020/"}, {"symbol": "AMGN", "publishedDate": "2020-07-21 12:31:36", "title": "Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for", "image": "https://cdn.snapi.dev/images/v1/h/h/biotech31.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/1010865/analysts-estimate-amgen-amgn-to-report-a-decline-in-earnings-what-to-look-out-for"}, {"symbol": "AMGN", "publishedDate": "2020-07-21 07:01:00", "title": "Better Buy: Amgen vs. Gilead Sciences", "image": "https://cdn.snapi.dev/images/v1/y/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5828572f2-scientists-side-by-side-in-a-labjpgw700opresize.jpg", "site": "The Motley Fool", "text": "They're alike in some ways. But key differences make one of these big biotech stocks the better pick.", "url": "https://www.fool.com/investing/2020/07/21/better-buy-amgen-vs-gilead-sciences.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-07-13 15:34:31", "title": "3 Top Stock Trades for the Week Ahead", "image": "https://cdn.snapi.dev/images/v1/w/2/stock-market-ticker-lights-768x432.jpg", "site": "InvestorPlace", "text": "It's a bull market, dude. Don't overthink it.", "url": "https://investorplace.com/top-stock-trades-for-this-week/"}, {"symbol": "AMGN", "publishedDate": "2020-07-13 10:11:00", "title": "Amgen (AMGN) Invests Further in China-Based Oncology Partner", "image": "https://cdn.snapi.dev/images/v1/y/i/biotech11.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) announces additional investment of approximately $421 million in BeiGene. The companies have a collaboration for oncology products signed in 2019.", "url": "https://www.zacks.com/stock/news/1002893/amgen-amgn-invests-further-in-china-based-oncology-partner"}, {"symbol": "AMGN", "publishedDate": "2020-07-12 22:01:00", "title": "Amgen Announces Additional Investment In BeiGene", "image": "https://cdn.snapi.dev/images/v1/j/l/press15-2.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., July 12, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares, which maintains Amgen's current pro rata ownership of BeiGene at approximately 20.3%....", "url": "https://www.prnewswire.com/news-releases/amgen-announces-additional-investment-in-beigene-301091975.html"}, {"symbol": "AMGN", "publishedDate": "2020-07-07 08:00:53", "title": "Amgen Stock: Is The Biotech Behemoth A Buy Amid A Breakout?", "image": "https://cdn.snapi.dev/images/v1/w/e/biotech3.jpg", "site": "Investors Business Daily", "text": "Amgen stock broke out amid a two-pronged approach to coronavirus treatment, partnering with Adaptive Biotechnologies and testing Otezla in Covid-19. So, is Amgen stock a buy now?", "url": "https://www.investors.com/news/technology/amgen-stock-buy-now/"}, {"symbol": "AMGN", "publishedDate": "2020-07-06 16:07:38", "title": "4 California Stocks to Keep On Hold Until Post-Coronavirus", "image": "https://cdn.snapi.dev/images/v1/l/d/californiastocks1600-768x432.jpg", "site": "InvestorPlace", "text": "These four strong California stocks deserve your attention and further due diligence to be included in long-term portfolios.", "url": "https://investorplace.com/2020/07/4-california-stocks-to-keep-on-hold-until-post-coronavirus/"}, {"symbol": "AMGN", "publishedDate": "2020-07-02 18:00:00", "title": "Stocks To Watch: Amgen Sees Relative Strength Rating Jump To 83", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech24-8.jpg", "site": "Investors Business Daily", "text": "Amgen sees its Relative Strength Rating enter the 80-plus level.", "url": "https://www.investors.com/news/technology/stocks-to-watch-amgen-sees-relative-strength-rating-jump-to-83/"}, {"symbol": "AMGN", "publishedDate": "2020-07-02 11:00:00", "title": "Amgen Gets Favorable Appeals Court Ruling for Enbrel Patent", "image": "https://cdn.snapi.dev/images/v1/t/a/biotech13.jpg", "site": "Zacks Investment Research", "text": "An appeals court ruled in Amgen's (AMGN) favor in a case challenging the validity of two patents on its top-selling medicine, Enbrel.", "url": "https://www.zacks.com/stock/news/997114/amgen-gets-favorable-appeals-court-ruling-for-enbrel-patent"}, {"symbol": "AMGN", "publishedDate": "2020-07-02 08:55:00", "title": "Amgen (AMGN) Looks Good: Stock Adds 8.2% in Session", "image": "https://cdn.snapi.dev/images/v1/w/z/biotech2.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.", "url": "https://www.zacks.com/stock/news/996808/amgen-amgn-looks-good-stock-adds-82-in-session"}, {"symbol": "AMGN", "publishedDate": "2020-07-02 06:00:00", "title": "Is There More Upside For Amgen At $235?", "image": "https://cdn.snapi.dev/images/v1/g/f/is-there-more-upside-for-amgen-at-235.jpg", "site": "Forbes", "text": "Despite a 27% rise since the March 23 lows of this year, at the current price of around $235 per share we believe Amgen Inc. stock has more room for growth.", "url": "https://www.forbes.com/sites/greatspeculations/2020/07/02/is-there-more-upside-for-amgen-at-235/"}, {"symbol": "AMGN", "publishedDate": "2020-07-01 15:47:00", "title": "Amgen's Win, Netflix's Hire Send Nasdaq Higher", "image": "https://cdn.snapi.dev/images/v1/o/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5807672fcourtroom-gettyimages-78494709jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The Nasdaq scored some more gains Wednesday.", "url": "https://www.fool.com/investing/2020/07/01/amgens-win-netflixs-hire-send-nasdaq-higher.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-07-01 15:31:56", "title": "Why Amgen's Stock Is Trading Higher Today", "image": "https://cdn.snapi.dev/images/v1/i/f/biotech28.jpg", "site": "Benzinga", "text": "Amgen\u00a0(NASDAQ: AMGN) shares are trading higher on Wednesday after an appeals court confirmed the validity of its Enbrel patents.", "url": "https://www.benzinga.com/general/biotech/20/07/16475966/why-amgens-stock-is-trading-higher-today"}, {"symbol": "AMGN", "publishedDate": "2020-07-01 15:30:42", "title": "Why Amgen Shares Jumped Today", "image": "https://cdn.snapi.dev/images/v1/u/w/healthcare1600a-768x432-2.jpg", "site": "The Motley Fool", "text": "Investors reacted positively to a big patent litigation win for the biotech.", "url": "https://www.fool.com/investing/2020/07/01/why-amgen-shares-jumped-today.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-07-01 14:35:00", "title": "Amgen's Enbrel Patents to Be Upheld Through 2029", "image": "https://cdn.snapi.dev/images/v1/c/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5807432fcash-prescription-drugs-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "An appeals court ruling means biosimilar competition won't affect U.S. Enbrel sales for a long time.", "url": "https://www.fool.com/investing/2020/07/01/amgens-enbrel-patents-to-be-upheld-through-2029.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-07-01 13:16:53", "title": "Amgen Breaks Out After Beating Novartis In Blockbuster Patent Battle", "image": "https://cdn.snapi.dev/images/v1/h/k/biotech26.jpg", "site": "Investors Business Daily", "text": "Amgen stock popped Wednesday after an appeals court blocked Novartis from knocking off the biotech giant's blockbuster drug, Enbrel. Sandoz was seeking to launch a copycat called Erelzi.", "url": "https://www.investors.com/news/technology/amgen-stock-pops-after-winning-enbrel-patent-battle-novartis/"}, {"symbol": "AMGN", "publishedDate": "2020-07-01 12:07:56", "title": "10 Stocks to Invest in the Health Care Revolution", "image": "https://cdn.snapi.dev/images/v1/l/i/dm-medical-petri.jpg", "site": "Kiplinger", "text": "The pandemic has put the health care industry under a global spotlight.", "url": "https://www.kiplinger.com/investing/stocks/healthcare-stocks/600975/10-stocks-to-invest-in-the-health-care-revolution"}, {"symbol": "AMGN", "publishedDate": "2020-06-30 07:03:00", "title": "Is Amgen a Great Dividend Stock?", "image": "https://cdn.snapi.dev/images/v1/1/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5801902fsuitcase-full-of-cashjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Its payouts have doubled in just five years.", "url": "https://www.fool.com/investing/2020/06/30/is-amgen-a-great-dividend-stock.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-06-29 19:13:00", "title": "Canada federal court dismisses drugmakers' plea challenging drug price rules", "image": "https://cdn.snapi.dev/images/v1/d/r/drugs12.jpg", "site": "Reuters", "text": "The federal court of Canada on Monday dismissed a plea by drugmakers challenging the Canadian government's new regulations aimed at lowering prices of patented drugs that could potentially lead them to lose billions over a decade.", "url": "https://www.reuters.com/article/us-canada-drug-price/canada-federal-court-dismisses-drugmakers-plea-challenging-drug-price-rules-idUSKBN24034L"}, {"symbol": "AMGN", "publishedDate": "2020-06-25 07:00:00", "title": "Can Amgen See Higher Levels?", "image": "https://cdn.snapi.dev/images/v1/q/p/can-amgen-see-higher-levels.jpg", "site": "Forbes", "text": "Amgen Inc. stock has rallied 26% over recent weeks (vs. about a 40% gain in the S&P 500) to its current level of $236 after falling to a low of $186 in late March as a rapid increase in the number of Covid-19 cases outside China resulted in heightened fears of an imminent global economic downturn.", "url": "https://www.forbes.com/sites/greatspeculations/2020/06/25/can-amgen-see-higher-levels/"}, {"symbol": "AMGN", "publishedDate": "2020-06-23 19:21:06", "title": "Amgen Inc. (AMGN) Presents at BMO 2020 Prescriptions for Success Healthcare Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/1/7/transcript43.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) Presents at BMO 2020 Prescriptions for Success Healthcare Conference (Transcript)", "url": "https://seekingalpha.com/article/4355275-amgen-inc-amgn-presents-bmo-2020-prescriptions-for-success-healthcare-conference-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-06-22 16:00:00", "title": "Amgen Is Supporting Advancement Of AMG 634 For Global Health Diseases In Developing Countries", "image": "https://cdn.snapi.dev/images/v1/h/0/press4-2.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., June 22, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced it is supporting the further study of AMG 634, a phosphodiesterase type 4 (PDE4) inhibitor, for the treatment of tuberculosis (TB) and erythema nodosum leprosum (ENL), an inflammatory cutaneous and...", "url": "https://www.prnewswire.com/news-releases/amgen-is-supporting-advancement-of-amg-634-for-global-health-diseases-in-developing-countries-301081303.html"}, {"symbol": "AMGN", "publishedDate": "2020-06-18 16:00:00", "title": "Amgen To Present At The BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference", "image": "https://cdn.snapi.dev/images/v1/c/m/press9-2.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., June 18, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference at 4:00 p.m. ET on Tuesday, June 23, 2020. Elliott Levy, senior vice president of R&D Strategy and Operations at Amgen,...", "url": "https://www.prnewswire.com/news-releases/amgen-to-present-at-the-bmo-capital-markets-2020-prescriptions-for-success-healthcare-conference-301079806.html"}, {"symbol": "AMGN", "publishedDate": "2020-06-18 09:31:00", "title": "Is Amgen Stock a Buy?", "image": "https://cdn.snapi.dev/images/v1/p/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5788092fdna-chain-and-scientist-working-on-ipadjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Should you scoop up this large-cap stock?", "url": "https://www.fool.com/investing/2020/06/18/is-amgen-stock-a-buy.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-06-10 17:57:08", "title": "Amgen, Inc. (AMGN) Presents at Goldman Sachs Healthcare Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/e/e/transcript1-2.jpg", "site": "Seeking Alpha", "text": "Amgen, Inc. (AMGN) Presents at Goldman Sachs Healthcare Conference (Transcript)", "url": "https://seekingalpha.com/article/4353186-amgen-inc-amgn-presents-goldman-sachs-healthcare-conference-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-06-09 08:00:53", "title": "Is Amgen Stock A Buy As It Takes A Two-Pronged Approach To Coronavirus?", "image": "https://cdn.snapi.dev/images/v1/r/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5513862fblack-and-white-of-two-test-tubesjpgw700opresize.jpg", "site": "Investors Business Daily", "text": "Amgen stock is consolidating as it takes a two-pronged approach to coronavirus treatment, partnering with Adaptive Biotechnologies and testing Otezla in Covid-19. Is Amgen stock a buy?", "url": "https://www.investors.com/news/technology/amgen-stock-buy-now/"}, {"symbol": "AMGN", "publishedDate": "2020-06-08 07:55:00", "title": "Drugmakers Target Coronavirus Vaccine in 2020: 4 Stocks in Focus", "image": "https://cdn.snapi.dev/images/v1/e/o/biotech17.jpg", "site": "Zacks Investment Research", "text": "Several drugmakers have started ramping up production, anticipating huge demand if the candidates prove successful.", "url": "https://www.zacks.com/stock/news/971051/drugmakers-target-coronavirus-vaccine-in-2020-4-stocks-in-focus"}, {"symbol": "AMGN", "publishedDate": "2020-06-05 16:00:00", "title": "Amgen To Present At The Goldman Sachs 41st Annual Global Healthcare Conference", "image": "https://cdn.snapi.dev/images/v1/q/z/press18-2.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., June 5, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 41st Annual Virtual Global Healthcare Conference on Wednesday, June 10, 2020 at 1:20 p.m. ET. Peter H. Griffith, executive vice president and chief financial officer, and David M....", "url": "https://www.prnewswire.com/news-releases/amgen-to-present-at-the-goldman-sachs-41st-annual-global-healthcare-conference-301071495.html"}, {"symbol": "AMGN", "publishedDate": "2020-06-03 11:38:00", "title": "3 Top Large-Cap Stocks to Buy in June", "image": "https://cdn.snapi.dev/images/v1/c/t/etf13-59.jpg", "site": "The Motley Fool", "text": "With the coronavirus outbreak still weighing on companies, it's time to favor those with long-term drivers of revenue growth.", "url": "https://www.fool.com/investing/2020/06/03/3-top-large-cap-stocks-to-buy-in-june.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-06-02 21:42:05", "title": "Amgen Inc. (AMGN) Management Presents at Jefferies 2020 Virtual Healthcare Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/2/1/transcript38.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) Management Presents at Jefferies 2020 Virtual Healthcare Conference (Transcript)", "url": "https://seekingalpha.com/article/4351626-amgen-inc-amgn-management-presents-jefferies-2020-virtual-healthcare-conference-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-06-01 07:47:00", "title": "Drugmakers Focus on Coronavirus Vaccine by 2020: 4 Winners", "image": "https://cdn.snapi.dev/images/v1/t/6/biotech2.jpg", "site": "Zacks Investment Research", "text": "Clinical trials of non-COVID-19 drugs have taken a backseat as most drugmakers and biotechnology companies are speeding up development of a vaccine for the novel coronavirus.", "url": "https://www.zacks.com/stock/news/956716/drugmakers-focus-on-coronavirus-vaccine-by-2020-4-winners"}, {"symbol": "AMGN", "publishedDate": "2020-05-30 11:31:42", "title": "Why Is Amgen (AMGN) Down 4% Since Last Earnings Report?", "image": "https://cdn.snapi.dev/images/v1/j/y/biotech26-2.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/954148/why-is-amgen-amgn-down-4-since-last-earnings-report"}, {"symbol": "AMGN", "publishedDate": "2020-05-28 17:00:00", "title": "Amgen To Present At The Jefferies 2020 Virtual Healthcare Conference", "image": "https://cdn.snapi.dev/images/v1/l/1/press20-3.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., May 28, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Jefferies 2020 Virtual Healthcare Conference at 4:00 p.m. ET on Tuesday, June 2, 2020. David M. Reese, M.D., executive vice president of Research and Development at Amgen, will be leading the...", "url": "https://www.prnewswire.com/news-releases/amgen-to-present-at-the-jefferies-2020-virtual-healthcare-conference-301067373.html"}, {"symbol": "AMGN", "publishedDate": "2020-05-28 14:26:51", "title": "Alexion Jumps After Reportedly Settling Amgen Patent Battle", "image": "https://cdn.snapi.dev/images/v1/2/w/2wede22.jpg", "site": "Investors Business Daily", "text": "Biotech companies Amgen and Alexion Pharmaceuticals reportedly reached an agreement in a patent battle over blockbuster rare-disease drug Soliris. ALXN stock popped Thursday.", "url": "https://www.investors.com/news/technology/alxn-stock-pop-potential-soliris-patent-deal-amgn/"}, {"symbol": "AMGN", "publishedDate": "2020-05-26 07:52:00", "title": "Coronavirus Vaccine Development Gathers Steam: 4 Winners", "image": "https://cdn.snapi.dev/images/v1/y/v/biotech27.jpg", "site": "Zacks Investment Research", "text": "Many biotech companies are coming up with impressive reports on their development of drugs, vaccines and therapies for COVID-19.", "url": "https://www.zacks.com/stock/news/944654/coronavirus-vaccine-development-gathers-steam-4-winners"}, {"symbol": "AMGN", "publishedDate": "2020-05-21 07:24:35", "title": "Tread carefully if you're buying biotech stocks, traders say as group nears all-time highs", "image": "https://cdn.snapi.dev/images/v1/g/k/106298733-1576513139338gettyimages-880891422.jpeg", "site": "CNBC", "text": "As biotechnology stocks surge, traders advice investors to be selective.", "url": "https://www.cnbc.com/2020/05/21/coronavirus-stock-market-careful-buying-biotech-stocks-traders-say.html"}, {"symbol": "AMGN", "publishedDate": "2020-05-20 19:00:00", "title": "Amgen Announces Voting Results Of Annual Meeting Of Stockholders", "image": "https://cdn.snapi.dev/images/v1/2/m/press1.jpg", "site": "PRNewsWire", "text": "THOUSAND OAKS, Calif., May 20, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced voting results from the Company's Annual Meeting of Stockholders on May 20, 2020, held virtually this year due to the COVID-19 pandemic. More than 88 percent of outstanding shares were represented at...", "url": "https://www.prnewswire.com/news-releases/amgen-announces-voting-results-of-annual-meeting-of-stockholders-301063209.html"}, {"symbol": "AMGN", "publishedDate": "2020-05-19 08:03:00", "title": "5 Biotech Stocks in Focus as Race for Coronavirus Vaccine Heats Up", "image": "https://cdn.snapi.dev/images/v1/b/w/biotech17.jpg", "site": "Zacks Investment Research", "text": "Drugmakers and biotech companies are initiating development of drugs, vaccines and therapies for COVID-19 and substantial progress has been made over the past month.", "url": "https://www.zacks.com/stock/news/932827/5-biotech-stocks-in-focus-as-race-for-coronavirus-vaccine-heats-up"}, {"symbol": "AMGN", "publishedDate": "2020-05-19 00:01:45", "title": "Our Chief Picks In Pharma", "image": "https://cdn.snapi.dev/images/v1/g/z/biotech13.jpg", "site": "Seeking Alpha", "text": "Our Chief Picks In Pharma", "url": "https://seekingalpha.com/article/4348608-chief-picks-in-pharma"}, {"symbol": "AMGN", "publishedDate": "2020-05-18 12:00:05", "title": "Amgen (AMGN) Upgraded to Buy: What Does It Mean for the Stock?", "image": "https://cdn.snapi.dev/images/v1/w/i/biotech1-2.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "url": "https://www.zacks.com/stock/news/931464/amgen-amgn-upgraded-to-buy-what-does-it-mean-for-the-stock"}, {"symbol": "AMGN", "publishedDate": "2020-05-14 15:17:56", "title": "5 ASCO Abstracts Moving Biopharma Stocks", "image": "https://cdn.snapi.dev/images/v1/o/o/cells-1872666-1920-2-8.jpg", "site": "Benzinga", "text": "The American Society of Clinical Oncology annual conference brings together oncology professionals, patient advocates, industry representatives, and major media outlets from across the globe.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/05/16034766/5-asco-abstracts-moving-biopharma-stocks"}, {"symbol": "AMGN", "publishedDate": "2020-05-13 06:32:00", "title": "Is Now Still a Good Time To Buy Amgen?", "image": "https://cdn.snapi.dev/images/v1/x/i/amge2.jpg", "site": "The Motley Fool", "text": "The biotech giant is back on track after a strong first quarter.", "url": "https://www.fool.com/investing/2020/05/13/amgens-pipeline-will-lift-it-to-new-heights.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-05-12 09:00:53", "title": "Biotech Amgen Is Tackling Coronavirus From Two Sides \u2014 But Is It A Buy?", "image": "https://cdn.snapi.dev/images/v1/c/g/biotech6-2.jpg", "site": "Investors Business Daily", "text": "Amgen stock is forming a cup base as it takes a two-pronged approach to coronavirus treatment, partnering with Adaptive Biotechnologies and testing Otezla in Covid-19. Is Amgen stock a buy?", "url": "https://www.investors.com/news/technology/amgen-stock-buy-now/"}, {"symbol": "AMGN", "publishedDate": "2020-05-11 12:15:19", "title": "Biotech Stock Rally Is Crushing Short Sellers", "image": "https://cdn.snapi.dev/images/v1/1/x/hospital-3089884-1920-30.jpg", "site": "Benzinga", "text": "Biotech stocks are often high-risk, high-reward investments that have binary outcomes based on one or a handful of drug or device candidates in development.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/05/16001179/biotech-stock-rally-is-crushing-short-sellers"}, {"symbol": "AMGN", "publishedDate": "2020-05-11 09:07:00", "title": "Why Amgen Soared in April", "image": "https://cdn.snapi.dev/images/v1/d/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5736212fcovid19jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Amgen's stock ripped higher in April. Here's why.", "url": "https://www.fool.com/investing/2020/05/11/why-amgen-soared-in-april.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-05-08 11:23:17", "title": "5 Biopharmas Where BofA Would Put Its Money To Work", "image": "https://cdn.snapi.dev/images/v1/m/i/microbiology-163521-1280-6.jpg", "site": "Benzinga", "text": "Biopharma shares have outperformed the broader market\u00a0year-to-date, giving rise to apprehension over\u00a0whether a pullback is in the offing.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/05/15989612/5-biopharmas-where-bofa-would-put-its-money-to-work"}, {"symbol": "AMGN", "publishedDate": "2020-05-01 10:54:00", "title": "Amgen (AMGN) Q1 Earnings Top, to Study Otezla for Coronavirus", "image": "https://cdn.snapi.dev/images/v1/2/e/biotech32.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) beats estimates for both earnings and sales. It maintains its previously-issued financial guidance for 2020.", "url": "https://www.zacks.com/stock/news/910436/amgen-amgn-q1-earnings-top-to-study-otezla-for-coronavirus"}, {"symbol": "AMGN", "publishedDate": "2020-05-01 09:21:14", "title": "Amgen says it will test Otezla for COVID-19 as it posts an upbeat Q1 earnings report", "image": "https://cdn.snapi.dev/images/v1/9/x/139685693-s-740x416.jpg", "site": "Invezz", "text": "Amgen Inc. (NASDAQ: AMGN) reported stronger than expected financial results on Thursday that initially pushed share prices up roughly 2% in after-hours trading but the stock settled around 0.5% lower than the price at which it closed the regular session. Amgen also announced on Thursday that it plans on testing Otezla (psoriasis drug) as a potential treatment for the novel respiratory disease that Coronavirus causes.", "url": "https://invezz.com/news/2020/05/01/amgen-says-it-will-test-otezla-for-covid-19-as-it-posts-an-upbeat-q1-earnings-report/"}, {"symbol": "AMGN", "publishedDate": "2020-05-01 07:29:20", "title": "Amgen is studying Otezla for coronavirus; its first-quarter results beat Street estimates", "image": "https://cdn.snapi.dev/images/v1/w/p/103973226-1548793652023gettyimages-563574597.jpg", "site": "CNBC", "text": "Amgen reported better-than-expected first-quarter results and said it plans to study psoriasis drug Otezla as a potential treatment for Covid-19, the respiratory disease caused by the new coronavirus.", "url": "https://www.cnbc.com/2020/05/01/amgen-amgn-earnings-q1-2020.html"}, {"symbol": "AMGN", "publishedDate": "2020-05-01 00:18:07", "title": "Amgen Inc. (AMGN) CEO Bob Bradway on Q1 2020 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/p/u/transcript46.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) CEO Bob Bradway on Q1 2020 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4341844-amgen-inc-amgn-ceo-bob-bradway-on-q1-2020-results-earnings-call-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-04-30 18:52:49", "title": "Amgen studying Otezla for coronavirus, looking into other treatments", "image": "https://cdn.snapi.dev/images/v1/q/p/biotech27-2.jpg", "site": "Reuters", "text": "Amgen Inc  on Thursday reported better-than-expected first-quarter results and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus.", "url": "https://www.reuters.com/article/us-amgen-results/amgen-studying-otezla-for-coronavirus-looking-into-other-treatments-idUSKBN22C3NC"}, {"symbol": "AMGN", "publishedDate": "2020-04-30 17:25:04", "title": "Amgen (AMGN) Q1 Earnings and Revenues Surpass Estimates", "image": "https://cdn.snapi.dev/images/v1/o/p/biotech8.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) delivered earnings and revenue surprises of 12.70% and 2.53%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/909782/amgen-amgn-q1-earnings-and-revenues-surpass-estimates"}, {"symbol": "AMGN", "publishedDate": "2020-04-30 16:12:36", "title": "Amgen stock ticks higher after earnings beat", "image": "https://cdn.snapi.dev/images/v1/v/d/biotech5.jpg", "site": "Market Watch", "text": "Amgen Inc. AMGN, +1.37% shares advanced in the extended session Thursday after the biotech drug maker topped Wall Street estimates for the quarter.", "url": "https://www.marketwatch.com/story/amgen-stock-ticks-higher-after-earnings-beat-2020-04-30"}, {"symbol": "AMGN", "publishedDate": "2020-04-30 16:12:21", "title": "Amgen Pops As Biotech Behemoth Tops Earnings Views And Keeps Outlook", "image": "https://cdn.snapi.dev/images/v1/b/l/biotech4.jpg", "site": "Investors Business Daily", "text": "Amgen stock rose late Thursday after the biotech reported adjusted income of $4.17 per share on $6.16 billion in first-quarter sales.\nThe post Amgen Pops As Biotech Behemoth Tops Earnings Views And Keeps Outlook appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/amgen-stock-amgen-earnings-q1-2020/"}, {"symbol": "AMGN", "publishedDate": "2020-04-30 16:06:48", "title": "Amgen studying Otezla for coronavirus, first-quarter results beat Street estimates", "image": "https://cdn.snapi.dev/images/v1/l/d/m02d20200430t2i1517080244rlynxmpeg3t2b4w640.jpg", "site": "Reuters", "text": "Amgen Inc  on Thursday reported better-than-expected first-quarter results on Thursday and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus.", "url": "https://www.reuters.com/article/us-amgen-results/amgen-studying-otezla-for-coronavirus-first-quarter-results-beat-street-estimates-idUSKBN22C3NC"}, {"symbol": "AMGN", "publishedDate": "2020-04-29 13:31:49", "title": "CFRA Analysts Highlight 6 Health Sector Buys For Your Portfolio", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks151-65.jpg", "site": "Forbes", "text": "In spite of Covid-19 and global recession concerns, we have a positive outlook on the biotechnology sub-industry; we expect to see a ramp-up in new drug sales; the continued development of many new, innovative therapies; and a decline in the prevalence of patent expirations in 2020 and 2021.", "url": "https://www.forbes.com/sites/moneyshow/2020/04/29/cfra-analysts-highlight-6-health-sector-buys-for-your-portfolio/"}, {"symbol": "AMGN", "publishedDate": "2020-04-28 11:18:00", "title": "Amgen (AMGN) to Report Q1 Earnings: What's in the Cards?", "image": "https://cdn.snapi.dev/images/v1/q/p/biotech25.jpg", "site": "Zacks Investment Research", "text": "Investor focus is likely to be on the impact of the coronavirus outbreak on Amgen's (AMGN) performance when it reports first-quarter results.", "url": "https://www.zacks.com/stock/news/894243/amgen-amgn-to-report-q1-earnings-whats-in-the-cards"}, {"symbol": "AMGN", "publishedDate": "2020-04-27 10:33:00", "title": "Focus on Coronavirus Treatments to Boost Biotech Stocks", "image": "https://cdn.snapi.dev/images/v1/s/1/biotech6.jpg", "site": "Zacks Investment Research", "text": "Focus on Coronavirus Treatments to Boost Biotech Stocks", "url": "https://www.zacks.com/commentary/891342/focus-on-coronavirus-treatments-to-boost-biotech-stocks"}, {"symbol": "AMGN", "publishedDate": "2020-04-27 10:12:45", "title": "Amgen Is Attractively Valued", "image": "https://cdn.snapi.dev/images/v1/3/j/sc33.jpg", "site": "Seeking Alpha", "text": "Amgen Is Attractively Valued", "url": "https://seekingalpha.com/article/4340195-amgen-is-attractively-valued"}, {"symbol": "AMGN", "publishedDate": "2020-04-26 09:55:00", "title": "3 Coronavirus Stocks to Buy Now", "image": "https://cdn.snapi.dev/images/v1/o/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5695782fgettyimages-1210053287jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies are trying for coronavirus success -- but their commercialized products offer revenue no matter what.", "url": "https://www.fool.com/investing/2020/04/26/3-coronavirus-stocks-to-buy-now.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-04-23 12:32:29", "title": "Amgen (AMGN) Earnings Expected to Grow: Should You Buy?", "image": "https://cdn.snapi.dev/images/v1/v/a/biotech13.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/885844/amgen-amgn-earnings-expected-to-grow-should-you-buy"}, {"symbol": "AMGN", "publishedDate": "2020-04-23 08:06:00", "title": "3 Dividend Stocks Weathering the Coronavirus Storm", "image": "https://cdn.snapi.dev/images/v1/t/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5686502fgettyimage-stockchartjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These three stocks aren't just surviving the coronavirus storm -- they're thriving in it.", "url": "https://www.fool.com/investing/2020/04/23/3-dividend-stocks-weathering-the-coronavirus-storm.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-04-23 07:01:00", "title": "Better Buy: Amgen vs. Johnson & Johnson", "image": "https://cdn.snapi.dev/images/v1/y/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5686172fgloved-hands-holding-2-test-tubesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which stock wins in a battle between these two healthcare giants?", "url": "https://www.fool.com/investing/2020/04/23/better-buy-amgen-vs-johnson-johnson.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-04-23 06:21:14", "title": "Amgen A Buy On Otezla Revenue", "image": "https://cdn.snapi.dev/images/v1/d/o/biotech35.jpg", "site": "Seeking Alpha", "text": "Amgen A Buy On Otezla Revenue", "url": "https://seekingalpha.com/article/4339346-amgen-buy-on-otezla-revenue"}, {"symbol": "AMGN", "publishedDate": "2020-04-20 05:44:06", "title": "If You Had Invested Right After Amgen's IPO (AMGN)", "image": "https://cdn.snapi.dev/images/v1/j/x/biotech5-2.jpg", "site": "Investopedia", "text": "Discover how much money investors made from Amgen during its initial public offering (IPO).", "url": "https://www.investopedia.com/articles/markets/113015/if-you-had-invested-right-after-amgens-ipo.asp"}, {"symbol": "AMGN", "publishedDate": "2020-04-17 12:40:22", "title": "4 Healthcare Stocks to Buy For Coronavirus Innovation", "image": "https://cdn.snapi.dev/images/v1/d/f/healthcare1600a-768x432.jpg", "site": "InvestorPlace", "text": "As the world and the markets continue to grapple with the effects of the novel coronavirus outbreak, these innovative healthcare stocks to buy look poised for success.", "url": "https://investorplace.com/2020/04/4-healthcare-stocks-to-buy-for-coronavirus-innovation/"}, {"symbol": "AMGN", "publishedDate": "2020-04-15 10:07:00", "title": "4 GARP Stocks to Scoop Up for  Maximum Returns", "image": "https://cdn.snapi.dev/images/v1/0/6/etf25-27.jpg", "site": "Zacks Investment Research", "text": "If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.", "url": "https://www.zacks.com/stock/news/872211/4-garp-stocks-to-scoop-up-for-maximum-returns"}, {"symbol": "AMGN", "publishedDate": "2020-04-15 08:52:00", "title": "6 Recession-Proof Picks Amid Coronavirus-Led \"The Great Lockdown\"", "image": "https://cdn.snapi.dev/images/v1/d/2/1blis-1.jpg", "site": "Zacks Investment Research", "text": "Coronavirus outbreak-induced global lockdowns are making recession inevitable. Here are six recession-resistant stocks including Netflix (NFLX) to beat COVID-19 induced recession woes.", "url": "https://www.zacks.com/stock/news/872034/6-recession-proof-picks-amid-coronavirus-led-the-great-lockdown"}, {"symbol": "AMGN", "publishedDate": "2020-04-10 10:45:00", "title": "1 Stock That Crushed the Market During the Last Recession", "image": "https://cdn.snapi.dev/images/v1/3/b/human-skeleton-163715-1280-2-0.jpg", "site": "The Motley Fool", "text": "Amgen outperformed the market in 2008; can the company do the same in today's recessionary conditions?", "url": "https://www.fool.com/investing/2020/04/10/1-stock-that-crushed-the-market-during-the-last-re.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-04-08 09:41:44", "title": "Biotech Stocks To Watch And Pharma Industry News", "image": "https://cdn.snapi.dev/images/v1/n/i/etf38.jpg", "site": "Investors Business Daily", "text": "Track the latest trends and leading stocks in the biotech and pharmaceutical industries.", "url": "https://www.investors.com/news/technology/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead/"}, {"symbol": "AMGN", "publishedDate": "2020-04-07 15:51:56", "title": "Technical Trouble Could Stop Drug Stock In Its Tracks", "image": "https://cdn.snapi.dev/images/v1/q/w/technical-trouble-could-stop-drug-stock-in-its-tracks.jpg", "site": "Forbes", "text": "Amgen (AMGN) is running into resistance at its historically bearish 160-day moving average", "url": "https://www.forbes.com/sites/greatspeculations/2020/04/07/technical-trouble-could-stop-drug-stock-in-its-tracks/"}, {"symbol": "AMGN", "publishedDate": "2020-04-07 08:00:53", "title": "Biotech Giant Amgen Entered The Coronavirus Arena \u2014 But Is It A Buy?", "image": "https://cdn.snapi.dev/images/v1/n/l/biotech1.jpg", "site": "Investors Business Daily", "text": "Amgen stock is facing concerns that biosimilars could chip away at some of its biggest moneymakers. Is it time to buy shares of the biotech company?", "url": "https://www.investors.com/news/technology/amgen-stock-buy-now/"}, {"symbol": "AMGN", "publishedDate": "2020-04-06 16:26:06", "title": "Trump spoke with pharmaceutical executives regarding the response to COVID-19", "image": "https://cdn.snapi.dev/images/v1/m/q/trump-spoke-with-pharmaceutical-executives-regarding-the-response-to-covid-19.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports that President Trump spoke with pharmaceutical executives regarding the response to COVID-19.", "url": "https://www.youtube.com/watch?v=ARcdj5lq2dQ"}, {"symbol": "AMGN", "publishedDate": "2020-04-03 17:58:11", "title": "Video: 4 Large-Cap Stocks With Strong Buffett-Munger Characteristics", "image": "https://cdn.snapi.dev/images/v1/o/q/etf31.jpg", "site": "GuruFocus", "text": "With market valuations tumbling near three-year lows as the Covid-19 virus outbreak rattles markets around the globe, GuruFocus Editorial Assistant James Li discusses how investors can seek good opportunities based on Berkshire Hathaway Inc.", "url": "https://www.gurufocus.com/news/1095630/video-4-largecap-stocks-with-strong-buffettmunger-characteristics"}, {"symbol": "AMGN", "publishedDate": "2020-04-03 13:51:03", "title": "Adaptive Biotech\u2019s deal with Amgen influenced by belief that COVID-19 may return seasonally, like flu", "image": "https://cdn.snapi.dev/images/v1/m/n/adaptive-labphotography-labbench-1-768x431.jpg", "site": "GeekWire", "text": "Despite a potential vaccine, the novel coronavirus could return on a seasonal basis, much like the flu, according to Seattle-based company Adaptive Biotechnologies.", "url": "https://www.geekwire.com/2020/adaptive-biotechs-deal-amgen-influenced-belief-covid-19-may-return-seasonally-like-flu/"}, {"symbol": "AMGN", "publishedDate": "2020-04-03 10:51:00", "title": "Pharma Coronavirus Efforts Continue, Amgen & Incyte Join In", "image": "https://cdn.snapi.dev/images/v1/e/p/biotech11.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) signs a deal with Adaptive Biotechnologies to discover antibodies to prevent/treat COVID-19. Incyte/Novartis (NVS) plan to initiate study on Jakafi for COVID-19- associated cytokine storm.", "url": "https://www.zacks.com/stock/news/852988/pharma-coronavirus-efforts-continue-amgen-incyte-join-in"}, {"symbol": "AMGN", "publishedDate": "2020-04-02 22:24:48", "title": "V&M Breakouts: Top Growth And Dividend Stocks For April 2020", "image": "https://cdn.snapi.dev/images/v1/a/v/biotech12.jpg", "site": "Seeking Alpha", "text": "V&M Breakouts: Top Growth And Dividend Stocks For April 2020", "url": "https://seekingalpha.com/article/4335760-v-and-m-breakouts-top-growth-and-dividend-stocks-for-april-2020"}, {"symbol": "AMGN", "publishedDate": "2020-04-02 16:44:24", "title": "Investors should look toward tech, health care and financials: RNC Genter Capital CEO", "image": "https://cdn.snapi.dev/images/v1/g/q/investors-should-look-toward-tech-health-care-and-financials-rnc-genter-capital-ceo.jpg", "site": "CNBC Television", "text": "CNBC's Kelly Evans breaks down the best stock picks with Dan Genter, CEO of RNC Genter Capital Management.", "url": "https://www.youtube.com/watch?v=NoE4l-4ls7A"}, {"symbol": "AMGN", "publishedDate": "2020-04-02 15:21:57", "title": "Why Amgen's Stock Is Trading Higher  Today", "image": "https://cdn.snapi.dev/images/v1/i/l/biotech7.jpg", "site": "Benzinga", "text": "Amgen, Inc. (NASDAQ: AMGN) shares are trading higher on Thursday, after the company and Adaptive announced they will partner to develop a coronavirus therapeutic.", "url": "https://www.benzinga.com/news/20/04/15731235/why-amgens-stock-is-trading-higher-today"}, {"symbol": "AMGN", "publishedDate": "2020-04-02 11:00:00", "title": "Why Amgen Stock Sailed Through March Without a Scratch", "image": "https://cdn.snapi.dev/images/v1/l/t/biotech38.jpg", "site": "The Motley Fool", "text": "Amgen was one of the few blue chip stocks to post a gain during the month of March. Here's why.", "url": "https://www.fool.com/investing/2020/04/02/why-amgen-stock-sailed-through-march-without-a-scr.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-04-02 10:43:24", "title": "Amgen Teams Up With Adaptive Biotechnologies to Develop COVID-19 Therapy", "image": "https://cdn.snapi.dev/images/v1/g/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5663602fhand-holding-vial-with-bloodjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The two biotechs aren't wasting any time getting their new joint COVID-19 effort up and running.", "url": "https://www.fool.com/investing/2020/04/02/amgen-teams-up-with-adaptive-biotechnologies-to-de.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-04-02 10:20:53", "title": "The search for a COVID-19 cure: Amgen and Adaptive Biotech partner in quest for new drug", "image": "https://cdn.snapi.dev/images/v1/x/t/adaptivebiot-768x546.jpg", "site": "GeekWire", "text": "Pharmaceutical giant Amgen is aiming to develop a new drug to treat and prevent COVID-19, using insights from Seattle-based Adaptive Biotechnologies\u2019 system for sequencing the human immune system, under an expanded partnership announced by the companies Thursday morning.", "url": "https://www.geekwire.com/2020/search-covid-19-cure-amgen-adaptive-biotech-partner-quest-new-drug/"}, {"symbol": "AMGN", "publishedDate": "2020-04-02 09:34:11", "title": "Amgen, Adaptive Biotechnologies ink COVID-19 antibody development collaboration", "image": "https://cdn.snapi.dev/images/v1/t/c/biotech10.jpg", "site": "Market Watch", "text": "Shares of Amgen Inc. AMGN, -0.17% gained 1.2% in trading on Thursday after the drugmaker announced that it is collaborating with Adaptive Biotechnologies Corp.", "url": "https://www.marketwatch.com/story/guid/5d086803-4065-4021-8302-7e2a71abdf9c"}, {"symbol": "AMGN", "publishedDate": "2020-03-31 13:53:00", "title": "Amgen Pauses Some Clinical Trials to Reduce Coronavirus Transmission Risk", "image": "https://cdn.snapi.dev/images/v1/t/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5513862fblack-and-white-of-two-test-tubesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The COVID-19 pandemic has led the big biotech to join many of its peers in making timeline-altering drug study adjustments.", "url": "https://www.fool.com/investing/2020/03/31/amgen-pauses-some-clinical-trials-to-reduce-corona.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-03-30 13:06:07", "title": "Amgen Stock Looks to Break Out After Analyst Upgrade", "image": "https://cdn.snapi.dev/images/v1/b/y/biotech32.jpg", "site": "Investopedia", "text": "Amgen shares moved higher during Monday's session after Raymond James upgraded the stock to Outperform with a $255 price target.", "url": "https://www.investopedia.com/amgen-looks-to-breakout-after-analyst-upgrade-4801284"}, {"symbol": "AMGN", "publishedDate": "2020-03-30 11:14:07", "title": "Why Amgen's Stock (AMGN) Is Trading Higher Today", "image": "https://cdn.snapi.dev/images/v1/y/a/analysis-2030265-1920-8.jpg", "site": "Benzinga", "text": "Amgen, Inc. (NASDAQ: AMGN) shares are trading higher on Monday after receiving an upgrade.", "url": "https://www.benzinga.com/news/20/03/15695464/why-amgens-stock-is-trading-higher-today"}, {"symbol": "AMGN", "publishedDate": "2020-03-30 10:16:00", "title": "4 Reasons Drug Stocks Are a Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/g/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5656092fgettyimages-1165195324jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.", "url": "https://www.fool.com/investing/2020/03/30/4-reasons-drug-stocks-are-a-buy-right-now.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-03-27 08:50:00", "title": "Pharma, Biotech Players Step Up Efforts Against Coronavirus", "image": "https://cdn.snapi.dev/images/v1/j/2/biotech20.jpg", "site": "Zacks Investment Research", "text": "Several pharma & biotech companies announce their plan to fight coronavirus pandemic and state anticipated unfavorable impact of the outbreak on their business.", "url": "https://www.zacks.com/stock/news/838238/pharma-biotech-players-step-up-efforts-against-coronavirus"}, {"symbol": "AMGN", "publishedDate": "2020-03-26 07:36:00", "title": "Top Drug Stocks Under $5", "image": "https://cdn.snapi.dev/images/v1/w/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5649132fgettyimages-1146913659jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Healthcare bargain hunters can find good values in quality low-priced stocks.", "url": "https://www.fool.com/investing/2020/03/26/top-drug-stocks-under-5.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-03-25 16:48:46", "title": "Amgen: A Healthy And Defensive Pick In COVID-19 Times", "image": "https://cdn.snapi.dev/images/v1/3/6/biotech33.jpg", "site": "Seeking Alpha", "text": "Amgen: A Healthy And Defensive Pick In COVID-19 Times", "url": "https://seekingalpha.com/article/4334226-amgen-healthy-and-defensive-pick-in-covidminus-19-times"}, {"symbol": "AMGN", "publishedDate": "2020-03-25 06:14:00", "title": "4 Reasons Biotech Stocks Are a Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/q/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5646752fgettyimages-1212296671-1jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Biotech companies have outperformed the general market -- and there are plenty of reasons to remain optimistic.", "url": "https://www.fool.com/investing/2020/03/25/4-reasons-biotech-stocks-are-a-buy-right-now.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-03-16 10:31:48", "title": "7 Biotech Stocks to Buy and Hold in 2020", "image": "https://cdn.snapi.dev/images/v1/p/i/pills-768x432-3.jpg", "site": "InvestorPlace", "text": "Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.", "url": "https://investorplace.com/2020/03/7-biotech-stocks-to-buy-and-hold-in-2020/"}, {"symbol": "AMGN", "publishedDate": "2020-03-15 08:22:00", "title": "Better Buy: Biogen vs. Amgen", "image": "https://cdn.snapi.dev/images/v1/y/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5628582fgettyimages-1172482193jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Both companies offer solid products and pipelines, but only one presents a buy-right-now case.", "url": "https://www.fool.com/investing/2020/03/15/better-buy-biogen-vs-amgen.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-03-11 12:16:29", "title": "Lawmakers pressure Big Pharma on drug supply chains amid coronavirus outbreak", "image": "https://cdn.snapi.dev/images/v1/1/0/104603795-gettyimages-456015186.jpg", "site": "CNBC", "text": "Lawmakers have for years been concerned the U.S. is too reliant on foreign manufacturing of medicine.", "url": "https://www.cnbc.com/2020/03/11/lawmakers-press-big-pharma-on-drug-supply-chains-amid-coronavirus-outbreak.html"}, {"symbol": "AMGN", "publishedDate": "2020-03-09 10:19:00", "title": "Is Amgen (AMGN) Truly One of the Best Biotech Stocks to Own?", "image": "https://cdn.snapi.dev/images/v1/l/4/biotech31.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) boasts a strong biosimilars portfolio, which can drive long-term growth. Amgen is also progressing with its pipeline while regularly pursuing business development deals.", "url": "https://www.zacks.com/stock/news/804320/is-amgen-amgn-truly-one-of-the-best-biotech-stocks-to-own"}, {"symbol": "AMGN", "publishedDate": "2020-03-05 12:14:05", "title": "Daily Dividend Report: General Dynamics, Hess, Verizon Communications, Amgen, Philip Morris", "image": "https://cdn.snapi.dev/images/v1/p/z/daily-dividend-report-general-dynamics-hess-verizon-communications-amgen-philip-morris.jpg", "site": "Forbes", "text": "Daily Dividend Report: General Dynamics, Hess, Verizon Communications, Amgen, Philip Morris", "url": "https://www.forbes.com/sites/dividendchannel/2020/03/05/daily-dividend-report-general-dynamics-hess-verizon-communications-amgen-philip-morris/"}, {"symbol": "AMGN", "publishedDate": "2020-03-03 12:21:00", "title": "Amgen Stock Strength Climbs Amid 'New Product Driven' Growth", "image": "https://cdn.snapi.dev/images/v1/l/2/biotech1.jpg", "site": "Investors Business Daily", "text": "Amgen shows improving price performance, earning an upgrade to its IBD Relative Strength Rating\nThe post Amgen Stock Strength Climbs Amid 'New Product Driven' Growth appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/ibd-rating-upgrades-amgen-shows-improved-price-strength-2/"}, {"symbol": "AMGN", "publishedDate": "2020-02-29 11:31:04", "title": "Why Is Amgen (AMGN) Down 11.7% Since Last Earnings Report?", "image": "https://cdn.snapi.dev/images/v1/q/z/biotech11.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/790112/why-is-amgen-amgn-down-117-since-last-earnings-report"}, {"symbol": "AMGN", "publishedDate": "2020-02-28 11:45:00", "title": "3 Top Healthcare  Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/9/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5598522fresearch-scientists-drugs-pharma-biotechjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Coronavirus has many investors looking for a health stock bump, but these names are great for the long haul.", "url": "https://www.fool.com/investing/2020/02/28/3-top-healthcare-stocks-to-buy-right-now.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-02-27 12:33:00", "title": "IBD Rating Upgrades: Amgen Shows Improved Technical Strength", "image": "https://cdn.snapi.dev/images/v1/6/p/biotech40.jpg", "site": "Investors Business Daily", "text": "A Relative Strength Rating upgrade for Amgen shows improving technical performance. Will it continue?", "url": "https://www.investors.com/news/technology/ibd-rating-upgrades-amgen-shows-improved-technical-strength/"}, {"symbol": "AMGN", "publishedDate": "2020-02-26 08:30:00", "title": "Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis", "image": "https://cdn.snapi.dev/images/v1/r/n/press9.jpg", "site": "GlobeNewsWire", "text": "Data Monitoring Committee Recommends Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Heart Failure Continue without Changes", "url": "https://www.globenewswire.com/news-release/2020/02/26/1990968/0/en/Amgen-Cytokinetics-and-Servier-Announce-Continuation-of-GALACTIC-HF-Following-Planned-Interim-Analysis.html"}, {"symbol": "AMGN", "publishedDate": "2020-02-19 10:35:21", "title": "Revolution Medicines Joins Amgen and Mirati in Quest for New Type of Cancer Drugs", "image": "https://cdn.snapi.dev/images/v1/c/b/biotech10.jpg", "site": "GuruFocus", "text": "The share price of a clinical-stage oncology company that went public just last week has climbed more than 70% on hopes that it can develop drugs to transform the way cancer is treated.", "url": "https://www.gurufocus.com/news/1043043/revolution-medicines-joins-amgen-and-mirati-in-quest-for-new-type-of-cancer-drugs"}, {"symbol": "AMGN", "publishedDate": "2020-02-13 09:49:00", "title": "3 Biotech Stocks That Made Early Shareholders Millionaires", "image": "https://cdn.snapi.dev/images/v1/c/c/1blis-1.jpg", "site": "The Motley Fool", "text": "Amgen, Biogen, and Gilead Sciences have each transformed their early investors.", "url": "https://www.fool.com/investing/2020/02/13/3-biotech-stocks-that-made-early-shareholders-mill.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-02-08 07:00:00", "title": "Is Amgen a Stock to Buy?", "image": "https://cdn.snapi.dev/images/v1/5/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5564822fgettyimages-843765220jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Amgen\u2019s pipeline and an oncology collaboration in China are reasons to believe the recent revenue slowdown may be transient.", "url": "https://www.fool.com/investing/2020/02/08/is-amgen-a-stock-to-buy.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-02-06 11:59:00", "title": "Amgen Stock Relative Strength Climbs Ahead Of Key Drug Data", "image": "https://cdn.snapi.dev/images/v1/g/k/biotech9.jpg", "site": "Investors Business Daily", "text": "Amgen sees its Relative Strength Rating hit the 80-plus level ahead of key drug data results.\nThe post Amgen Stock Relative Strength Climbs Ahead Of Key Drug Data appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/amgen-earns-relative-strength-rating-upgrade-hits-key-threshold/"}, {"symbol": "AMGN", "publishedDate": "2020-02-05 18:16:00", "title": "Why Amgen Stock Dropped 10.4% in January", "image": "https://cdn.snapi.dev/images/v1/d/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5565012fgettyimages-92223391jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investors worried about a slowdown in revenue as biosimilars are rivals to older drugs.", "url": "https://www.fool.com/investing/2020/02/05/why-amgen-stock-dropped-104-in-january.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-02-03 10:00:53", "title": "The Biggest Biotech Is Facing Profitability Worries \u2014 Is It Time To Buy Amgen Stock?", "image": "https://cdn.snapi.dev/images/v1/n/n/biotech32.jpg", "site": "Investors Business Daily", "text": "Amgen stock is facing concerns that its adjusted earnings will slide in 2020. Is it time to buy shares of the biotech company?", "url": "https://www.investors.com/news/technology/amgen-stock-buy-now/"}, {"symbol": "AMGN", "publishedDate": "2020-02-02 07:30:00", "title": "Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?", "image": "https://cdn.snapi.dev/images/v1/q/s/drugs50.jpg", "site": "The Motley Fool", "text": "At least one of these bets is already looking like a smart move.", "url": "https://www.fool.com/investing/2020/02/02/amgen-is-making-3-big-bets-will-they-pay-off-for-i.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-01-31 11:39:45", "title": "Amgen Analysts Sidelined After Q4 Report, Say Valuation Reflects Growth Potential", "image": "https://cdn.snapi.dev/images/v1/n/b/cells-1872666-1920-17.jpg", "site": "Benzinga", "text": "Amgen, Inc.'s (NASDAQ: AMGN) disappointing 2020 EPS guidance issued Thursday spooked investors, leading to a pullback in the stock.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/01/15227358/amgen-analysts-sidelined-after-q4-report-say-valuation-reflects-growth-potential"}, {"symbol": "AMGN", "publishedDate": "2020-01-31 10:46:00", "title": "Amgen's Shares Slip on Soft Guidance. Time to Buy?", "image": "https://cdn.snapi.dev/images/v1/z/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5556472fmicroscope-3jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Amgen's fourth-quarter earnings contained mostly good news, but shareholders clearly wanted more out of the blue-chip drugmaker.", "url": "https://www.fool.com/investing/2020/01/31/amgen.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-01-31 08:13:00", "title": "Amgen (AMGN) Stock Down Despite Q4 Earnings & Revenue Beat", "image": "https://cdn.snapi.dev/images/v1/x/h/biotech7.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) stock declines despite better-than-expected fourth-quarter 2019 results. Its 2020 earnings guidance falls short of expectations.", "url": "https://www.zacks.com/stock/news/742396/amgen-amgn-stock-down-despite-q4-earnings-revenue-beat"}, {"symbol": "AMGN", "publishedDate": "2020-01-30 22:43:03", "title": "Amgen Inc. (AMGN) CEO Bob Bradway on Q4 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/m/1/transcript8.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) CEO Bob Bradway on Q4 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4320434-amgen-inc-amgn-ceo-bob-bradway-on-q4-2019-results-earnings-call-transcript"}, {"symbol": "AMGN", "publishedDate": "2020-01-30 19:34:00", "title": "Amgen Revenue Slipped 1% in the Fourth Quarter", "image": "https://cdn.snapi.dev/images/v1/o/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5555562fdoctor-patientjpgw700opresize.jpg", "site": "The Motley Fool", "text": "2020 sales are expected to accelerate year over year, but so are expenses.", "url": "https://www.fool.com/investing/2020/01/30/amgen.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-01-30 19:10:05", "title": "Amgen 2020 outlook falls short of Street estimates; shares slump", "image": "https://cdn.snapi.dev/images/v1/a/9/m02d20200130t2i1483651177rlynxmpeg0t29ow640.jpg", "site": "Reuters", "text": "Amgen Inc  on Thursday forecast 2020 earnings well  short of Wall Street estimates, sending shares of the largest U.S. biotechnology company down 2.5%.", "url": "https://www.reuters.com/article/us-amgen-results/amgen-2020-outlook-falls-short-of-street-estimates-shares-slump-idUSKBN1ZT34R"}, {"symbol": "AMGN", "publishedDate": "2020-01-30 17:29:08", "title": "Amgen 2020 outlook falls short of Street estimates, shares down 3%", "image": "https://cdn.snapi.dev/images/v1/l/e/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5275312fbiotechjpgw700opresize.jpg", "site": "Reuters", "text": "Amgen Inc  on Thursday forecast 2020 earnings well  short of current Wall Street estimates, sending shares of the largest U.S. biotechnology company down 3%.", "url": "https://www.reuters.com/article/us-amgen-results/amgen-2020-outlook-falls-short-of-street-estimates-shares-down-3-idUSKBN1ZT34R"}, {"symbol": "AMGN", "publishedDate": "2020-01-30 17:25:07", "title": "Amgen (AMGN) Q4 Earnings and Revenues Surpass Estimates", "image": "https://cdn.snapi.dev/images/v1/2/d/biotech37.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) delivered earnings and revenue surprises of 5.81% and 3.18%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/741444/amgen-amgn-q4-earnings-and-revenues-surpass-estimates"}, {"symbol": "AMGN", "publishedDate": "2020-01-30 16:12:21", "title": "Biotech Giant Amgen Tumbles On Lackluster 2020 Earnings Outlook", "image": "https://cdn.snapi.dev/images/v1/m/2/m02d20190826t2i1422931549rlynxnpef7p0nmw640.jpg", "site": "Investors Business Daily", "text": "Amgen stock toppled late Thursday after the biotech company reported adjusted earnings of $3.64 per\u00a0share on $6.2 billion in revenue for its fourth quarter ended Dec. 31.\r\nThe post Biotech Giant Amgen Tumbles On Lackluster 2020 Earnings Outlook appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/amgen-stock-amgen-earnings-q4-2019/"}, {"symbol": "AMGN", "publishedDate": "2020-01-30 16:10:54", "title": "Amgen stock slips as quarter beats Street view but outlook doesn't", "image": "https://cdn.snapi.dev/images/v1/d/k/biotech33.jpg", "site": "Market Watch", "text": "Amgen Inc. AMGN, -0.42% shares ticked lower in the extended session Thursday after the biotech drug maker's quarterly results topped Wall Street estimates but its outlook came up short.", "url": "https://www.marketwatch.com/story/amgen-stock-slips-as-quarter-beats-street-view-but-outlook-doesnt-2020-01-30"}, {"symbol": "AMGN", "publishedDate": "2020-01-29 19:21:40", "title": "Amgen: At All-Time Highs, I'm Cautiously Optimistic", "image": "https://cdn.snapi.dev/images/v1/k/w/biotech2.jpg", "site": "Seeking Alpha", "text": "Amgen: At All-Time Highs, I'm Cautiously Optimistic", "url": "https://seekingalpha.com/article/4319988-amgen-all-time-highs-cautiously-optimistic"}, {"symbol": "AMGN", "publishedDate": "2020-01-29 08:56:00", "title": "Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More", "image": "https://cdn.snapi.dev/images/v1/t/8/biotech31.jpg", "site": "Zacks Investment Research", "text": "Let us take a look at five big drug/biotech companies due to release their quarterly results on Jan 30.", "url": "https://www.zacks.com/stock/news/738675/big-drug-biotech-stock-earnings-on-jan-30-biib-alxn-more"}, {"symbol": "AMGN", "publishedDate": "2020-01-27 10:11:27", "title": "3 Healthcare Stocks Under Pressure from Bernie", "image": "https://cdn.snapi.dev/images/v1/h/e/healthcare1600a-768x432-3.jpg", "site": "InvestorPlace", "text": "These healthcare stocks are worth selling now as Sanders rises in the polls and given his stance that prices should be cut in half.\r\nThe post 3 Healthcare Stocks Under Pressure from Bernie appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/01/3-healthcare-stocks-under-pressure-from-bernie/"}, {"symbol": "AMGN", "publishedDate": "2020-01-27 09:26:00", "title": "Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?", "image": "https://cdn.snapi.dev/images/v1/n/g/biotech26.jpg", "site": "Zacks Investment Research", "text": "While Amgen's (AMGN) drugs like Prolia & Xgeva are expected to have done well, slowdown in sales of mature products are likely to have weighed on fourth-quarter sales.", "url": "https://www.zacks.com/stock/news/734721/amgen-amgn-to-report-q4-earnings-whats-in-the-cards"}, {"symbol": "AMGN", "publishedDate": "2020-01-26 07:30:00", "title": "Which Big Biotech Has the Safer Dividend -- Amgen or Gilead Sciences?", "image": "https://cdn.snapi.dev/images/v1/w/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5543232ffemale-scientist-holding-2-test-tubesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Both biotechs claim attractive dividends. But one dividend appears to be at least a little safer than the other.", "url": "https://www.fool.com/investing/2020/01/26/which-big-biotech-has-the-safer-dividend-amgen-or.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-01-24 07:00:00", "title": "Better Buy:  Amgen vs.  Gilead Sciences", "image": "https://cdn.snapi.dev/images/v1/j/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5540552fgettyimages-871536340jpgw700opresize.jpg", "site": "The Motley Fool", "text": "One of these pharma stocks is outperforming the other, but will that trend continue?", "url": "https://www.fool.com/investing/2020/01/24/better-buy-amgen-vs-gilead-sciences.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-01-22 09:20:00", "title": "5 Big Drug/Biotech Stocks Set to Trump Q4 Earnings Estimates", "image": "https://cdn.snapi.dev/images/v1/u/p/drugs30.jpg", "site": "Zacks Investment Research", "text": "Let us take a look at some drug/biotech stocks that are poised to beat on earnings in the fourth quarter.", "url": "https://www.zacks.com/stock/news/729100/5-big-drug-biotech-stocks-set-to-trump-q4-earnings-estimates"}, {"symbol": "AMGN", "publishedDate": "2020-01-19 09:01:00", "title": "3 Attractive Dividend Stocks - Whose Dividends Could Double", "image": "https://cdn.snapi.dev/images/v1/f/4/stock-market-ticker-charts-573x300.jpg", "site": "The Motley Fool", "text": "And it could happen in five years or less.", "url": "https://www.fool.com/investing/2020/01/19/3-attractive-dividend-stocks-whose-dividends-could.aspx"}, {"symbol": "AMGN", "publishedDate": "2020-01-16 09:55:00", "title": "Should Value Investors Consider Amgen (AMGN) Stock Now?", "image": "https://cdn.snapi.dev/images/v1/u/h/biotech38.jpg", "site": "Zacks Investment Research", "text": "Let's see if Amgen (AMGN) stock is a good choice for value-oriented investors right now from multiple angles.", "url": "https://www.zacks.com/stock/news/720758/should-value-investors-consider-amgen-amgn-stock-now"}, {"symbol": "AMGN", "publishedDate": "2020-01-13 09:36:00", "title": "Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - January 13, 2020", "image": "https://cdn.snapi.dev/images/v1/q/n/biotech16.jpg", "site": "Zacks Investment Research", "text": "Like many investors, you're likely aiming to build a comfortable nest egg to ensure a comfortable retirement. Make sure you know all about what financial planners dub the accumulation and distribution phases of retirement planning.", "url": "https://www.zacks.com/stock/news/715571/know-these-3-facts-to-avoid-paying-half-your-retirement-income-to-the-irs-january-13-2020"}, {"symbol": "AMGN", "publishedDate": "2020-01-10 10:00:00", "title": "Bet on Favorite Sector ETFs & Stocks This Earnings Season", "image": "https://cdn.snapi.dev/images/v1/g/q/1blis-1.jpg", "site": "Zacks Investment Research", "text": "Like the first three quarters of 2019, the earnings picture looks weak for Q4 thanks to tough comparisons and moderating economic growth.", "url": "https://www.zacks.com/stock/news/711513/bet-on-favorite-sector-etfs-stocks-this-earnings-season"}, {"symbol": "AMGN", "publishedDate": "2020-01-06 12:10:10", "title": "Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again", "image": "https://cdn.snapi.dev/images/v1/i/k/biotech31.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.", "url": "https://www.zacks.com/stock/news/705042/why-amgen-amgn-is-poised-to-beat-earnings-estimates-again"}, {"symbol": "AMGN", "publishedDate": "2020-01-06 08:23:00", "title": "Amgen Stock Up in a Year on Pipeline & Biosimilar Progress", "image": "https://cdn.snapi.dev/images/v1/w/w/biotech17.jpg", "site": "Zacks Investment Research", "text": "Pipeline development and rapid progress in biosimilars program drive Amgen's (AMGN) stock 24% higher in the past year.", "url": "https://www.zacks.com/stock/news/704543/amgen-stock-up-in-a-year-on-pipeline-biosimilar-progress"}, {"symbol": "AMGN", "publishedDate": "2020-01-03 09:20:00", "title": "7 Hot Drug Stocks To Buy In 2020", "image": "https://cdn.snapi.dev/images/v1/7/-/7-hot-drug-stocks-to-buy-in-2020.jpg", "site": "Forbes", "text": "Each year, MoneyShow asks the nation\u2019s leading financial newsletter advisors for their favorite stocks for the coming year. Here are seven favorites from the pharmaceutical and biotechnology space.", "url": "https://www.forbes.com/sites/moneyshow/2020/01/03/7-hot-drug-stocks-to-buy-in-2020/"}, {"symbol": "AMGN", "publishedDate": "2020-01-02 11:22:38", "title": "3 of the Best Healthcare Stocks to Buy in 2020", "image": "https://cdn.snapi.dev/images/v1/h/e/healthcare1600a-768x432-2.jpg", "site": "InvestorPlace", "text": "Here are three of the best healthcare stocks to buy, as the sector is flashing a 'buy-the-dip' setup to kick off the New Year.", "url": "https://investorplace.com/2020/01/3-healthcare-stocks-to-buy-2020/"}, {"symbol": "AMGN", "publishedDate": "2020-01-02 10:47:23", "title": "Here's what to watch in biotech in 2020", "image": "https://cdn.snapi.dev/images/v1/m/q/heres-what-to-watch-in-biotech-in-2020.jpg", "site": "CNBC Television", "text": "Ronny Gal of Bernstein discusses biotechnology stocks with CNBC's \"Power Lunch\" team.", "url": "https://www.youtube.com/watch?v=tvFNljIXiAw"}, {"symbol": "AMGN", "publishedDate": "2020-01-01 12:00:05", "title": "Amgen (AMGN) Upgraded to Buy: Here's What You Should Know", "image": "https://cdn.snapi.dev/images/v1/v/4/biotech8.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).", "url": "https://www.zacks.com/stock/news/697695/amgen-amgn-upgraded-to-buy-heres-what-you-should-know"}, {"symbol": "AMGN", "publishedDate": "2019-12-31 11:19:56", "title": "Sobi + Dova: A Threat For Amgen And GlaxoSmithKline", "image": "https://cdn.snapi.dev/images/v1/f/i/biotech26.jpg", "site": "Seeking Alpha", "text": "Dova combined with Sobi spells threat for a part of the business for Amgen and GlaxoSmithKline.", "url": "https://seekingalpha.com/article/4314690-sobi-dova-threat-for-amgen-and-glaxosmithkline"}, {"symbol": "AMGN", "publishedDate": "2019-12-30 16:18:53", "title": "Jefferies: Less urgency to get legislation passed in 2020", "image": "https://cdn.snapi.dev/images/v1/m/q/jefferies-less-urgency-to-get-legislation-passed-in-2020.jpg", "site": "CNBC Television", "text": "Michael Yee, Jefferies analyst, discusses his outlook on biotech companies on CNBC's \"Closing Bell.\"", "url": "https://www.youtube.com/watch?v=c8TXPRvZzac"}, {"symbol": "AMGN", "publishedDate": "2019-12-30 13:27:43", "title": "Financials, biopharma, energy & more in #AskHalftime", "image": "https://cdn.snapi.dev/images/v1/f/k/fkfkdwq1-1.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions in #AskHalftime", "url": "https://www.youtube.com/watch?v=l-vVXDYjDV0"}, {"symbol": "AMGN", "publishedDate": "2019-12-26 08:40:11", "title": "Major Biotechs See Rising Short Interest", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech1600molecule-768x432-2.jpg", "site": "24/7 Wall Street", "text": "The short interest data are out for the most recent settlement date, December 13. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.", "url": "https://247wallst.com/healthcare-business/2019/12/26/major-biotechs-see-rising-short-interest/"}, {"symbol": "AMGN", "publishedDate": "2019-12-22 10:01:00", "title": "Better Buy: Amgen (AMGN) vs. Johnson & Johnson (JNJ)", "image": "https://cdn.snapi.dev/images/v1/y/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5513862fblack-and-white-of-two-test-tubesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which stock wins in a match-up between these two healthcare giants?", "url": "https://www.fool.com/investing/2019/12/22/better-buy-amgen-vs-johnson-johnson.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-12-20 09:30:00", "title": "3 Investing Facts About Required Minimum Distributions You Need to Know - December 20, 2019", "image": "https://cdn.snapi.dev/images/v1/7/g/biotech1.jpg", "site": "Zacks Investment Research", "text": "Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.", "url": "https://www.zacks.com/stock/news/679942/3-investing-facts-about-required-minimum-distributions-you-need-to-know-december-20-2019"}, {"symbol": "AMGN", "publishedDate": "2019-12-19 07:45:00", "title": "3 Dividend Stocks That Hiked Their Payouts by More Than 100% in 5 Years", "image": "https://cdn.snapi.dev/images/v1/n/p/sto23-4.jpg", "site": "The Motley Fool", "text": "These stocks could be great sources of dividend income for many years to come.", "url": "https://www.fool.com/investing/2019/12/19/3-dividend-stocks-that-hiked-their-payouts-by-more.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-12-17 18:27:37", "title": "8 Biotech Stocks Morgan Stanley Recommends For 2020", "image": "https://cdn.snapi.dev/images/v1/l/a/lab-217041-1280-2-6.jpg", "site": "Benzinga", "text": "Biotech investing is risk-fraught, but for\u00a0investors who make the right bets, the returns can be staggering.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/19/12/15004313/8-biotech-stocks-morgan-stanley-recommends-for-2020"}, {"symbol": "AMGN", "publishedDate": "2019-12-16 14:26:13", "title": "Goldman Sachs Adds Amgen, UnitedHealth, Dentsply Sirona To Conviction List", "image": "https://cdn.snapi.dev/images/v1/o/w/human-skeleton-163715-1280-2-0.jpg", "site": "Benzinga", "text": "After a year of sector underperformance, several factors are coalescing to make 2020 a better year for the health care sector, Goldman Sachs said Monday as it added three stocks to its conviction list.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/19/12/14996192/goldman-sachs-adds-amgen-unitedhealth-dentsply-sirona-to-conviction-list"}, {"symbol": "AMGN", "publishedDate": "2019-12-16 10:55:19", "title": "Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020", "image": "https://cdn.snapi.dev/images/v1/h/e/heloo2kjedf-1.jpg", "site": "24/7 Wall Street", "text": "Health care remains a political hot button. Despite the Affordable Care Act, there remains a push and pull in the industry over which companies can survive and which ones can thrive in the decade ahead.", "url": "https://247wallst.com/healthcare-business/2019/12/16/goldman-sachs-has-3-top-health-care-stocks-to-outperform-in-2020/"}, {"symbol": "AMGN", "publishedDate": "2019-12-13 08:15:00", "title": "3 Reasons This Biotech is a Buy for Risk-Averse Investors", "image": "https://cdn.snapi.dev/images/v1/e/l/biotech38.jpg", "site": "The Motley Fool", "text": "Biotech can be a risky sector for those interested in healthcare stocks, but Amgen has found a way to manage the risk and reap the rewards.", "url": "https://www.fool.com/investing/2019/12/13/reasons-biotech-a-buy-for-risk-averse-amgen.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-12-12 10:38:00", "title": "Here's Why You Should Own Amgen Stock in 2020", "image": "https://cdn.snapi.dev/images/v1/a/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5507852fbiotech3jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The biotech titan is poised for another strong year in 2020.", "url": "https://www.fool.com/investing/2019/12/12/heres-why-you-should-own-amgen-stock-in-2020.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-12-12 09:36:00", "title": "Amgen's Osteoporosis Drug Evenity Gets Approval in Europe", "image": "https://cdn.snapi.dev/images/v1/2/p/biotech3.jpg", "site": "Zacks Investment Research", "text": "The EC grants marketing authorization to Amgen (AMGN) and partner UCB's Evenity for the treatment of severe osteoporosis in postmenopausal women at high risk of fracture.", "url": "https://www.zacks.com/stock/news/667061/amgens-osteoporosis-drug-evenity-gets-approval-in-europe"}, {"symbol": "AMGN", "publishedDate": "2019-12-11 17:45:18", "title": "Amgen (AMGN) Gains But Lags Market: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/5/7/biotech12.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) closed at $234.01 in the latest trading session, marking a +0.07% move from the prior day.", "url": "https://www.zacks.com/stock/news/666031/amgen-amgn-gains-but-lags-market-what-you-should-know"}, {"symbol": "AMGN", "publishedDate": "2019-12-11 16:18:44", "title": "Amgen board hikes dividend by 10%", "image": "https://cdn.snapi.dev/images/v1/i/b/biotech10.jpg", "site": "Market Watch", "text": "Amgen Inc. AMGN, +0.07% said late Wednesday its board hiked the quarterly dividend by 10%.", "url": "https://www.marketwatch.com/story/amgen-board-hikes-dividend-by-10-2019-12-11"}, {"symbol": "AMGN", "publishedDate": "2019-12-10 09:02:00", "title": "Healthpeak Amends & Extends Lease With Amgen in San Francisco", "image": "https://cdn.snapi.dev/images/v1/f/d/biotech17.jpg", "site": "Zacks Investment Research", "text": "Healthpeak's (PEAK) lease amendment and extension with Amgen at the Britannia Oyster Point of the former offers flexibility in addressing lease-expiration issue at this property.", "url": "https://www.zacks.com/stock/news/663733/healthpeak-amends-extends-lease-with-amgen-in-san-francisco"}, {"symbol": "AMGN", "publishedDate": "2019-12-09 19:14:05", "title": "Big biotech deals: 5 trades", "image": "https://cdn.snapi.dev/images/v1/v/f/vfeok3jn2-1.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders talk biotech after some big deals in the sector.", "url": "https://www.youtube.com/watch?v=FF8EovZqz3o"}, {"symbol": "AMGN", "publishedDate": "2019-12-09 11:12:45", "title": "3 Healthcare Stocks to Buy Before the End of 2019", "image": "https://cdn.snapi.dev/images/v1/h/e/healthcare1600c-768x432.jpg", "site": "InvestorPlace", "text": "The year-end success of the healthcare sector has led to several strong stocks to buy. Here are three of the best healthcare stocks to buy.", "url": "https://investorplace.com/2019/12/3-healthcare-stocks-to-buy-before-the-end-of-2019/"}, {"symbol": "AMGN", "publishedDate": "2019-12-09 09:02:00", "title": "Amgen Gets FDA Approval for J&J/Merck's Remicade Biosimilar", "image": "https://cdn.snapi.dev/images/v1/g/z/biotech33.jpg", "site": "Zacks Investment Research", "text": "FDA gives nod to Amgen's (AMGN) Avsola (ABP 710), a biosimilar of J&J's blockbuster rheumatoid arthritis drug, Remicade.", "url": "https://www.zacks.com/stock/news/661958/amgen-gets-fda-approval-for-jj-mercks-remicade-biosimilar"}, {"symbol": "AMGN", "publishedDate": "2019-12-08 14:00:00", "title": "Better Buy:  Biogen vs.  Amgen", "image": "https://cdn.snapi.dev/images/v1/b/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5501292ffemale-scientist-holding-2-test-tubesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which stock wins in a battle between these two big biotechs?", "url": "https://www.fool.com/investing/2019/12/08/better-buy-biogen-vs-amgen.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-12-07 13:00:00", "title": "4 FDA Dates Biotech Investors Should Circle in December", "image": "https://cdn.snapi.dev/images/v1/q/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5500192fgettyimages-106457993jpgw700opresize.jpg", "site": "The Motley Fool", "text": "FDA announcements can make or break a stock. These four events are the most important ones this month.", "url": "https://www.fool.com/investing/2019/12/07/4-fda-dates-biotech-investors-should-circle-in-dec.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-12-05 08:00:53", "title": "The Biggest Biotech Just Touched A Record High \u2014 Is Amgen Stock A Buy?", "image": "https://cdn.snapi.dev/images/v1/q/s/biotech17.jpg", "site": "Investors Business Daily", "text": "Shares of Amgen are on an upswing after the company won a patent battle over its drug Enbrel against Novartis subsidiary Sandoz. Is it time to buy shares of the massive biotech company?", "url": "https://www.investors.com/news/technology/amgen-stock-buy-now/"}, {"symbol": "AMGN", "publishedDate": "2019-12-04 11:00:00", "title": "Better Buy: Amgen vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/k/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5497152fprescription-drugsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which of these pharma giants is the better buy?", "url": "https://www.fool.com/investing/2019/12/04/better-buy-amgen-vs-pfizer.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-12-02 15:32:04", "title": "Why Novartis's $9.7 Billion Purchase of The Medicines Company Is Bad News for Amgen", "image": "https://cdn.snapi.dev/images/v1/t/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5493922fscientist-research-laboratoryjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Novartis's purchase comes with investigational cardiovascular drug inclisiran, a competitor with potential to dethrone Amgen's already embattled Repatha.", "url": "https://www.fool.com/investing/2019/12/02/why-novartis-97-billion-purchase-of-the-medicines.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-11-28 09:31:19", "title": "Amgen (AMGN) Up 11.2% Since Last Earnings Report: Can It Continue?", "image": "https://cdn.snapi.dev/images/v1/3/h/biotech37.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/645032/amgen-amgn-up-112-since-last-earnings-report-can-it-continue"}, {"symbol": "AMGN", "publishedDate": "2019-11-26 15:32:58", "title": "Healthy New Drug Sales And A Refreshed Pipeline Helping Lundbeck Set A Bottom", "image": "https://cdn.snapi.dev/images/v1/o/l/biotech3.jpg", "site": "Seeking Alpha", "text": "Healthy New Drug Sales And A Refreshed Pipeline Helping Lundbeck Set A Bottom", "url": "https://seekingalpha.com/article/4309290-healthy-new-drug-sales-refreshed-pipeline-helping-lundbeck-set-bottom"}, {"symbol": "AMGN", "publishedDate": "2019-11-25 19:17:02", "title": "Biotech M&A boom: 6 trades", "image": "https://cdn.snapi.dev/images/v1/f/e/fe222222.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders discuss the biotech sector and give you 6 trades after a $9.7B Novartis deal is announced.", "url": "https://www.youtube.com/watch?v=g__uILqohqE"}, {"symbol": "AMGN", "publishedDate": "2019-11-25 16:40:54", "title": "Amgen Inc: Taking Patent Dynamics Into Account", "image": "https://cdn.snapi.dev/images/v1/y/h/biotech17.jpg", "site": "Seeking Alpha", "text": "Amgen Inc: Taking Patent Dynamics Into Account", "url": "https://seekingalpha.com/article/4309067-amgen-inc-taking-patent-dynamics-account"}, {"symbol": "AMGN", "publishedDate": "2019-11-25 10:06:01", "title": "Biotech Stocks Awaken From Long Slumber", "image": "https://cdn.snapi.dev/images/v1/e/t/etf33.jpg", "site": "Investopedia", "text": "Biotech stocks have joined the fourth quarter rally and could post strong gains in the coming months.", "url": "https://www.investopedia.com/biotech-stocks-awaken-from-long-slumber-4777209"}, {"symbol": "AMGN", "publishedDate": "2019-11-25 03:32:15", "title": "Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker", "image": "https://cdn.snapi.dev/images/v1/t/9/m02d20191124t2i1456297103rlynxmpefan0q6w640.jpg", "site": "Reuters", "text": "Swiss drugmaker Novartis  is betting on heart drug prospect inclisiran in a $9.7 billion takeover of The Medicines Co  as it challenges cardiovascular medicines from Amgen Inc , Sanofi  and Regeneron Pharmaceuticals.", "url": "https://www.reuters.com/article/us-medicines-m-a-novartis/novartis-takes-on-sanofi-amgen-with-9-7-billion-takeover-of-heart-drug-maker-idUSKBN1XY0NL"}, {"symbol": "AMGN", "publishedDate": "2019-11-22 18:50:41", "title": "Biotech's big run: 4 trades", "image": "https://cdn.snapi.dev/images/v1/d/o/dow12edf-1.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders give you 4 trades in the Biotech Sector after those stocks enjoy a strong month.", "url": "https://www.youtube.com/watch?v=ZjQX_-dO6s8"}, {"symbol": "AMGN", "publishedDate": "2019-11-22 11:31:00", "title": "2 Stocks to Buy If You're Worried About a Recession", "image": "https://cdn.snapi.dev/images/v1/h/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5488442frecession-signjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These two dividend-paying pharma stocks are basically immune to the whims of the broader economy.", "url": "https://www.fool.com/investing/2019/11/22/3-stocks-to-buy-if-youre-worried-about-a-recession.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-11-22 09:43:00", "title": "Amgen (AMGN) Completes Otezla Buyout, Raises 2019 Guidance", "image": "https://cdn.snapi.dev/images/v1/z/z/biotech23.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) concludes the pending buyout of Celgene's psoriasis drug Otezla to acquire its worldwide rights. The company also hikes its overall 2019 view.", "url": "https://www.zacks.com/stock/news/632823/amgen-amgn-completes-otezla-buyout-raises-2019-guidance"}, {"symbol": "AMGN", "publishedDate": "2019-11-21 11:02:35", "title": "Amgen Wraps Otezla Takeover \u2014 And Other Fallout From BMY's Celgene Buy", "image": "https://cdn.snapi.dev/images/v1/r/g/biotech4.jpg", "site": "Investors Business Daily", "text": "Amgen raised its full-year outlook Thursday after the biotech company wrapped its acquisition of psoriasis treatment Otezla in the wake of Bristol-Myers Squibb's takeover of Celgene.\nThe post Amgen Wraps Otezla Takeover \u2014 And Other Fallout From BMY's Celgene Buy appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/biotech-company-amgen-wraps-otezla-buy-other-fallout-bmy-takeover-celgene/"}, {"symbol": "AMGN", "publishedDate": "2019-11-21 06:42:22", "title": "Amgen raises full-year guidance after closing $13.4 billion Otezla acquisition", "image": "https://cdn.snapi.dev/images/v1/2/r/biotech31.jpg", "site": "Market Watch", "text": "Amgen Inc. AMGN, +0.45% raised Thursday its 2019 profit and revenue guidance ranges, after the closing of the acquisition of the worldwide rights to the psoriasis treatment Otezla from Celgene Corp.", "url": "https://www.marketwatch.com/story/amgen-raises-full-year-guidance-after-closing-134-billion-otezla-acquisition-2019-11-21"}, {"symbol": "AMGN", "publishedDate": "2019-11-12 08:02:00", "title": "China seen as the next big growth area for biotechs Biogen and Amgen", "image": "https://cdn.snapi.dev/images/v1/i/u/105997678-1562007404232gettyimages-502671754.jpeg", "site": "CNBC", "text": "SunTrust initiated coverage on Biogen and Amgen on Tuesday, saying solid drug pipelines and growth opportunities in China will drive outperformance.", "url": "https://www.cnbc.com/2019/11/12/china-seen-as-the-next-big-growth-area-for-biotechs-biogen-and-amgen.html"}, {"symbol": "AMGN", "publishedDate": "2019-11-11 09:31:00", "title": "Why Amgen's Stock Soared in October", "image": "https://cdn.snapi.dev/images/v1/q/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5473322fhealthcare-blocksjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Amgen's shares posted stellar gains last month. Can this blue chip biotech stock keep churning higher?", "url": "https://www.fool.com/investing/2019/11/11/why-amgens-stock-soared-in-october.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-11-08 16:31:09", "title": "This $2.7 Billion Deal Is a Shot Across the Bow for Big Pharma", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5378762fnew-biotechjpgw700opresize.jpg", "site": "InvestorPlace", "text": "Folks who haven\u2019t been paying attention to the absolutely huge potential happening in biotech stocks right now -- both in the U.S. and other parts of the world -- have been put on notice.", "url": "https://investorplace.com/2019/11/biotech-stocks-big-pharma-deal/"}, {"symbol": "AMGN", "publishedDate": "2019-11-05 12:58:51", "title": "2020 Election Could Hurt Amgen Stock\u2019s Healthy Dividend", "image": "https://cdn.snapi.dev/images/v1/3/8/biotech8.jpg", "site": "InvestorPlace", "text": "The biggest risk to Amgen stock comes from health reform that might limit the number of drugs insurers pay for, creating price competition.", "url": "https://investorplace.com/2019/11/2020-election-could-hurt-amgen-stocks-healthy-dividend/"}, {"symbol": "AMGN", "publishedDate": "2019-11-04 16:23:36", "title": "Galera Therapeutics And Amgen In Severe Oral Mucositis", "image": "https://cdn.snapi.dev/images/v1/g/q/biotech1.jpg", "site": "Seeking Alpha", "text": "Galera Therapeutics And Amgen In Severe Oral Mucositis", "url": "https://seekingalpha.com/article/4302333-galera-therapeutics-amgen-severe-oral-mucositis"}, {"symbol": "AMGN", "publishedDate": "2019-11-02 08:27:00", "title": "Better Buy: Mirati Therapeutics vs. Amgen", "image": "https://cdn.snapi.dev/images/v1/0/4/biotech12.jpg", "site": "The Motley Fool", "text": "Both biotechs are developing revolutionary new cancer drugs, but which stock is better for your portfolio right now?", "url": "https://www.fool.com/investing/2019/11/02/mirati-mrtx849-vs-amgen-amg-510.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-10-31 17:28:52", "title": "Amgen Is Taking A $2.7 Billion Stake In A Chinese Biotech \u2014 Here's Why", "image": "https://cdn.snapi.dev/images/v1/n/8/biotech11.jpg", "site": "Investors Business Daily", "text": "BeiGene stock rocketed late Thursday after the biotech company announced a collaboration deal that will have Amgen take a $2.7 billion stake in it. That represents 20.5% of BeiGene.", "url": "https://www.investors.com/news/technology/beigene-stock-rockets-collaboration-deal-biotech-company-amgen/"}, {"symbol": "AMGN", "publishedDate": "2019-10-31 16:38:57", "title": "Amgen partners with China's BeiGene on cancer drug research", "image": "https://cdn.snapi.dev/images/v1/v/i/amgen-partners-with-chinas-beigene-on-cancer-drug-research.jpg", "site": "CNBC Television", "text": "Amgen strikes cancer drug partnership with China's BeiGene. CNBC's Seema Mody reports.", "url": "https://www.youtube.com/watch?v=R1JBnprdCmg"}, {"symbol": "AMGN", "publishedDate": "2019-10-31 16:00:00", "title": "Amgen takes 20% stake in Chinese biotech BeiGene for $2.7 billion", "image": "https://cdn.snapi.dev/images/v1/r/i/106216432-1572543423956gettyimages-978980148.jpeg", "site": "CNBC", "text": "Under the all-cash deal, Amgen will pay BeiGene shareholders $174.85 per share, a 25% premium to BeiGene's closing price on the Nasdaq on Wednesday.", "url": "https://www.cnbc.com/2019/10/31/amgen-takes-20percent-stake-in-chinese-biotech-beigene-for-2point7-billion.html"}, {"symbol": "AMGN", "publishedDate": "2019-10-31 15:19:15", "title": "Amgen acquires one-fifth of Chinese biotech BeiGene", "image": "https://cdn.snapi.dev/images/v1/n/s/biotech9.jpg", "site": "Market Watch", "text": "Amgen Inc. AMGN, +1.12% said late Thursday it was buying a sizable stake in a Chinese cancer biotech treatment company to increase its sales presence in the country.", "url": "https://www.marketwatch.com/story/amgen-acquires-one-fifth-of-chinese-biotech-beigene-2019-10-31"}, {"symbol": "AMGN", "publishedDate": "2019-10-30 11:12:00", "title": "Amgen (AMGN) Beats on Q3 Earnings, Ends Neuroscience R&D", "image": "https://cdn.snapi.dev/images/v1/g/y/biotech32.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) posts encouraging third-quarter 2019 results. It raises its previously issued sales guidance slightly while increasing the earnings range significantly.", "url": "https://www.zacks.com/stock/news/593343/amgen-amgn-beats-on-q3-earnings-ends-neuroscience-rd"}, {"symbol": "AMGN", "publishedDate": "2019-10-30 09:35:53", "title": "Amgen Reports Lower 3rd-Quarter Sales", "image": "https://cdn.snapi.dev/images/v1/9/d/biotech3.jpg", "site": "GuruFocus", "text": "After the closing bell on Tuesday, Amgen Inc. (NASDAQ:AMGN) issued its third-quarter results.", "url": "https://www.gurufocus.com/news/972578/amgen-reports-lower-3rdquarter-sales-"}, {"symbol": "AMGN", "publishedDate": "2019-10-29 21:23:04", "title": "Amgen Inc. (AMGN) CEO Bob Bradway on Q3 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/g/c/transcript44.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) CEO Bob Bradway on Q3 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4300172-amgen-inc-amgn-ceo-bob-bradway-q3-2019-results-earnings-call-transcript"}, {"symbol": "AMGN", "publishedDate": "2019-10-29 18:52:02", "title": "Amgen posts higher biosimilar sales, ends neuroscience program", "image": "https://cdn.snapi.dev/images/v1/f/6/m02d20191029t2i1446330054rlynxmpef9s1saw640.jpg", "site": "Reuters", "text": "Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales were strong and the quarterly results were ahead of Wall Street estimates.", "url": "https://www.reuters.com/article/us-amgen-results/amgen-posts-higher-biosimilar-sales-ends-neuroscience-program-idUSKBN1X82GQ"}, {"symbol": "AMGN", "publishedDate": "2019-10-29 17:15:12", "title": "Amgen (AMGN) Q3 Earnings and Revenues Top Estimates", "image": "https://cdn.snapi.dev/images/v1/b/v/biotech39.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) delivered earnings and revenue surprises of 4.27% and 1.82%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/591331/amgen-amgn-q3-earnings-and-revenues-top-estimates"}, {"symbol": "AMGN", "publishedDate": "2019-10-29 16:28:56", "title": "Amgen beats on revenue, earnings per share in Q3", "image": "https://cdn.snapi.dev/images/v1/c/y/amgen-beats-on-revenue-earnings-per-share-in-q3.jpg", "site": "CNBC Television", "text": "CNBC breaks down third quarter numbers for Amgen, which beat on revenue, $5.74 billion vs.", "url": "https://www.youtube.com/watch?v=eNIMiuGI8i0"}, {"symbol": "AMGN", "publishedDate": "2019-10-29 16:20:47", "title": "Biotech Giant Amgen Beat Third-Quarter, 2019 Outlook Estimates", "image": "https://cdn.snapi.dev/images/v1/d/y/hand-3632914-1920-0.jpg", "site": "Investors Business Daily", "text": "Amgen stock was flat late Tuesday, though Amgen earnings of $3.66 per share on $5.74 billion in sales beat Wall Street's expectations. The biotech company's stock is nearing a buy point.", "url": "https://www.investors.com/news/technology/amgen-stock-amgen-earnings-q3-2019/"}, {"symbol": "AMGN", "publishedDate": "2019-10-29 16:20:34", "title": "Why Amgen Failed to Impress in Q3", "image": "https://cdn.snapi.dev/images/v1/b/v/amgen-1.jpg", "site": "24/7 Wall Street", "text": "When Amgen Inc. (NASDAQ: AMGN) released its third-quarter financial results after the markets closed on Tuesday, the firm said that it had $3.66 in earnings per share (EPS) and $5.7 billion in revenue.", "url": "https://247wallst.com/healthcare-business/2019/10/29/why-amgen-failed-to-impress-in-q3/"}, {"symbol": "AMGN", "publishedDate": "2019-10-29 15:14:27", "title": "Amgen stock rises after company's profit, revenue beat", "image": "https://cdn.snapi.dev/images/v1/l/a/biotech35.jpg", "site": "Market Watch", "text": "Shares of Amgen Inc. AMGN, +1.94% rose less than 1% in the extended session Tuesday after the pharma company beat third-quarter adjusted profit and revenue expectations even as its sales fell due to more competition.", "url": "https://www.marketwatch.com/story/amgen-stock-rises-after-companys-profit-revenue-beat-2019-10-29"}, {"symbol": "AMGN", "publishedDate": "2019-10-29 12:40:50", "title": "Can Amgen Earnings Keep Up With Biogen?", "image": "https://cdn.snapi.dev/images/v1/k/x/amge2.jpg", "site": "24/7 Wall Street", "text": "Amgen Inc. (NASDAQ: AMGN) is set to report its most recent quarterly results after the closing bell on Tuesday.", "url": "https://247wallst.com/healthcare-business/2019/10/29/can-amgen-earnings-keep-up-with-biogen/"}, {"symbol": "AMGN", "publishedDate": "2019-10-29 09:30:14", "title": "Has Amgen (AMGN) Outpaced Other Medical Stocks This Year?", "image": "https://cdn.snapi.dev/images/v1/h/c/biotech2.jpg", "site": "Zacks Investment Research", "text": "Is  (AMGN) Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/590428/has-amgen-amgn-outpaced-other-medical-stocks-this-year"}, {"symbol": "AMGN", "publishedDate": "2019-10-29 09:00:11", "title": "Amgen (AMGN) Moves to Buy: Rationale Behind the Upgrade", "image": "https://cdn.snapi.dev/images/v1/h/3/biotech11.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).", "url": "https://www.zacks.com/stock/news/590295/amgen-amgn-moves-to-buy-rationale-behind-the-upgrade"}, {"symbol": "AMGN", "publishedDate": "2019-10-28 11:59:00", "title": "Drug/Biotech Stock Q3 Earnings Due on Oct 29: MRK, PFE & More", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5335812ft-celljpgw700opresize.jpg", "site": "Zacks Investment Research", "text": "Four drug/biotech stocks are scheduled to release third-quarter results on Oct 29. Let's see how these companies are placed before their earnings call.", "url": "https://www.zacks.com/stock/news/588895/drug-biotech-stock-q3-earnings-due-on-oct-29-mrk-pfe-more"}, {"symbol": "AMGN", "publishedDate": "2019-10-28 10:21:00", "title": "Should You Buy Amgen (AMGN) Ahead of Earnings?", "image": "https://cdn.snapi.dev/images/v1/f/u/biotech37.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.", "url": "https://www.zacks.com/stock/news/588667/should-you-buy-amgen-amgn-ahead-of-earnings"}, {"symbol": "AMGN", "publishedDate": "2019-10-25 10:05:16", "title": "Major Biotechs See Rising Tide in Short Interest (Oct 25)", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech1600molecule-768x432.jpg", "site": "24/7 Wall Street", "text": "The short interest data are out for the most recent settlement date, October 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.", "url": "https://247wallst.com/healthcare-business/2019/10/25/major-biotechs-see-rising-tide-in-short-interest-4/"}, {"symbol": "AMGN", "publishedDate": "2019-10-24 12:38:17", "title": "Amgen Cuts The Price Of A Key Drug \u2014 Prodding A Rival Biotech To Slide", "image": "https://cdn.snapi.dev/images/v1/3/n/biotech34.jpg", "site": "Investors Business Daily", "text": "Shares of Regeneron Pharmaceuticals slipped Thursday after Amgen said it will discontinue a costly version of its high cholesterol treatment, Repatha. Regeneron makes a rival medicine.", "url": "https://www.investors.com/news/technology/high-cholesterol-battle-repatha-cemented-lower-list-price/"}, {"symbol": "AMGN", "publishedDate": "2019-10-23 08:48:00", "title": "5 High-Flying Corporate Giants Set to Beat on Q3 Earnings", "image": "https://cdn.snapi.dev/images/v1/d/2/etf22-32.jpg", "site": "Zacks Investment Research", "text": "Despite almost day-to-day market fluctuations, a few corporate behemoths surged in Wall Street. Some of these are set to beat earnings estimate in the ongoing reporting cycle.", "url": "https://www.zacks.com/stock/news/578628/5-high-flying-corporate-giants-set-to-beat-on-q3-earnings"}, {"symbol": "AMGN", "publishedDate": "2019-10-18 01:31:54", "title": "Dividend Growth Stocks Of Tomorrow: Amgen Inc.", "image": "https://cdn.snapi.dev/images/v1/3/7/biotech36.jpg", "site": "Seeking Alpha", "text": "Amgen is a pharmaceutical company and one of the larger players in the sector. Its products treat a variety of conditions but focus on oncology, cardiovascular, and inflammatory diseases.", "url": "https://seekingalpha.com/article/4297217-dividend-growth-stocks-tomorrow-amgen-inc"}, {"symbol": "AMGN", "publishedDate": "2019-10-10 12:10:20", "title": "Amgen's Latest Data With KRAS G12C Inhibitor Drug Is Mixed, But Can Still Shine On Prior Evidence", "image": "https://cdn.snapi.dev/images/v1/z/w/biotech34.jpg", "site": "Seeking Alpha", "text": "Amgen's latest data using AMG 510 to treat solid tumors expressing KRAS G12C mutations were preliminary, but potential exists in synergistic combinations.", "url": "https://seekingalpha.com/article/4295919-amgens-latest-data-kras-g12c-inhibitor-drug-mixed-can-still-shine-prior-evidence"}, {"symbol": "AMGN", "publishedDate": "2019-10-10 10:58:00", "title": "3 Big Drug/Biotech Stocks Set to Beat Q3 Earnings Estimates", "image": "https://cdn.snapi.dev/images/v1/4/z/biotech33.jpg", "site": "Zacks Investment Research", "text": "Here we highlight three bigshot drug/biotech companies, which are expected to deliver positive earnings surprises in Q3.", "url": "https://www.zacks.com/stock/news/557902/3-big-drug-biotech-stocks-set-to-beat-q3-earnings-estimates"}, {"symbol": "AMGN", "publishedDate": "2019-10-07 10:36:27", "title": "Pfenex Gets FDA Seal of Approval For Amgen's Forteo Biosimilar", "image": "https://cdn.snapi.dev/images/v1/z/b/knee-2253047-1920-4.jpg", "site": "Benzinga", "text": "Shares of the micro-cap biotech Pfenex Inc (NYSE: PFNX), which pulled back ahead of the PDUFA date for its Forteo biosimilar PF708, were\u00a0advancing Monday amid a positive outcome for the binary event.", "url": "https://www.benzinga.com/general/biotech/19/10/14553298/pfenex-gets-fda-seal-of-approval-for-amgens-forteo-biosimilar"}, {"symbol": "AMGN", "publishedDate": "2019-10-04 14:55:29", "title": "Amgen's AMG 510 Targeted Cancer Therapy", "image": "https://cdn.snapi.dev/images/v1/u/t/biotech22.jpg", "site": "Seeking Alpha", "text": "AMG 510 is targeted at a specific cancer-associated mutation.", "url": "https://seekingalpha.com/article/4295136-amgens-amg-510-targeted-cancer-therapy"}, {"symbol": "AMGN", "publishedDate": "2019-10-04 09:30:57", "title": "3 Drug Stocks Poised for Gains After Cancer Conference", "image": "https://cdn.snapi.dev/images/v1/1/0/103973226-1548793652023gettyimages-563574597.jpg", "site": "Investopedia", "text": "Drug stocks have moved higher after an upbeat European cancer conference. Play three leading names using these tactical trading ideas.", "url": "https://www.investopedia.com/3-drug-stocks-poised-for-gains-after-cancer-conference-4772261"}, {"symbol": "AMGN", "publishedDate": "2019-10-03 17:45:22", "title": "Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/g/y/biotech14.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Amgen (AMGN) closed at $192.62, marking a +1.8% move from the previous day.", "url": "https://www.zacks.com/stock/news/548052/amgen-amgn-outpaces-stock-market-gains-what-you-should-know"}, {"symbol": "AMGN", "publishedDate": "2019-10-03 10:00:00", "title": "2 Great Stocks You Can Buy on Sale: ABBV & AMGN", "image": "https://cdn.snapi.dev/images/v1/d/l/drugs11.jpg", "site": "The Motley Fool", "text": "AbbVie and Amgen are two great stocks that are way too cheap right now.", "url": "https://www.fool.com/investing/2019/10/03/2-great-stocks-you-can-buy-on-sale.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-10-01 09:10:19", "title": "Should Value Investors Buy Amgen (AMGN) Stock?", "image": "https://cdn.snapi.dev/images/v1/6/v/biotech15.jpg", "site": "Zacks Investment Research", "text": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.", "url": "https://www.zacks.com/stock/news/544248/should-value-investors-buy-amgen-amgn-stock"}, {"symbol": "AMGN", "publishedDate": "2019-09-28 12:11:00", "title": "Is Amgen Really as Cheap as It Looks?", "image": "https://cdn.snapi.dev/images/v1/y/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5406972fmagnifying-glass-with-stock-chartsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Appearances can be deceiving.", "url": "https://www.fool.com/investing/2019/09/28/is-amgen-really-as-cheap-as-it-looks.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-09-27 17:50:24", "title": "Amgen (AMGN) Stock Moves -0.23%: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/z/i/biotech21.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) closed the most recent trading day at $194.94, moving -0.23% from the previous trading session.", "url": "https://www.zacks.com/stock/news/539141/amgen-amgn-stock-moves-023-what-you-should-know"}, {"symbol": "AMGN", "publishedDate": "2019-09-27 13:51:44", "title": "Cancer Results to Watch at This Weekend\u2019s European Society of Medical Oncology Congress", "image": "https://cdn.snapi.dev/images/v1/a/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5408132fousa-chea-gkuc4tmhoiy-unsplashjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Doctors, researchers, and pharmaceutical experts will converge upon Barcelona to share the latest results in cancer research. Here is a run-down on three to watch.", "url": "https://www.fool.com/investing/2019/09/27/cancer-results-to-watch-for-at-this-weeks-european.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-09-27 06:00:00", "title": "Better Buy: Biogen (BIIB) vs. Amgen (AMGN)", "image": "https://cdn.snapi.dev/images/v1/j/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5407582ffemale-scientist-holding-two-test-tubesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which stock wins in a battle between these two big biotechs?", "url": "https://www.fool.com/investing/2019/09/27/better-buy-biogen-vs-amgen.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-09-20 17:50:10", "title": "Amgen (AMGN) Gains As Market Dips: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/h/c/biotech6.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Amgen (AMGN) closed at $196.94, marking a +0.66% move from the previous day.", "url": "https://www.zacks.com/stock/news/528342/amgen-amgn-gains-as-market-dips-what-you-should-know"}, {"symbol": "AMGN", "publishedDate": "2019-09-20 16:29:00", "title": "5 Safe Bets for a Rocky Market", "image": "https://cdn.snapi.dev/images/v1/a/k/biotech4.jpg", "site": "Zacks Investment Research", "text": "Here are 5 companies with proven track records.", "url": "https://www.zacks.com/stock/news/528232/5-safe-bets-for-a-rocky-market"}, {"symbol": "AMGN", "publishedDate": "2019-09-20 08:31:00", "title": "3 Big Biotech Stocks Worth Adding to Your Portfolio Now", "image": "https://cdn.snapi.dev/images/v1/k/h/biotech35.jpg", "site": "Zacks Investment Research", "text": "We highlight a few key biotech stocks that surpass the sector so far in 2019 and are likely to witness a winning run in the near term.", "url": "https://www.zacks.com/stock/news/527589/3-big-biotech-stocks-worth-adding-to-your-portfolio-now"}, {"symbol": "AMGN", "publishedDate": "2019-09-20 06:45:00", "title": "Bull of the Day: Amgen (AMGN)", "image": "https://cdn.snapi.dev/images/v1/j/v/biotech36.jpg", "site": "Zacks Investment Research", "text": "Bull of the Day: Amgen (AMGN)", "url": "https://www.zacks.com/commentary/526629/bull-of-the-day-amgen-amgn"}, {"symbol": "AMGN", "publishedDate": "2019-09-18 06:00:00", "title": "Could Amgen's Latest Bad News Boost the Chances of More Acquisitions?", "image": "https://cdn.snapi.dev/images/v1/a/t/m02d20190826t2i1422931549rlynxnpef7p0nmw640.jpg", "site": "The Motley Fool", "text": "Amgen's recent clinical setback just might prompt the big biotech to light a fire beneath its acquisition efforts.", "url": "https://www.fool.com/investing/2019/09/18/could-amgens-latest-bad-news-boost-the-chances-of.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-09-17 08:00:00", "title": "Adaptive Biotechnologies Enters Partnership for Use Of clonoSEQ\u00ae as Preferred MRD Test for Drug Development Across Amgen\u2019s Hematology Franchise", "image": "https://cdn.snapi.dev/images/v1/t/h/press12.jpg", "site": "GlobeNewsWire", "text": "Global partnership spans Amgen\u2019s entire portfolio of pipeline and marketed blood cancer therapies Global partnership spans Amgen\u2019s entire portfolio of pipeline and marketed blood cancer therapies", "url": "https://www.globenewswire.com/news-release/2019/09/17/1916608/0/en/Adaptive-Biotechnologies-Enters-Partnership-for-Use-Of-clonoSEQ-as-Preferred-MRD-Test-for-Drug-Development-Across-Amgen-s-Hematology-Franchise.html"}, {"symbol": "AMGN", "publishedDate": "2019-09-16 14:24:06", "title": "Top Stock Picks for Week of September 16, 2019", "image": "https://cdn.snapi.dev/images/v1/s/w/etf32-8.jpg", "site": "Zacks Investment Research", "text": "A Biotech Pioneer and an E-Commerce Giant.", "url": "https://www.youtube.com/watch?v=vKw-p2a2kng"}, {"symbol": "AMGN", "publishedDate": "2019-09-16 08:48:00", "title": "Amgen's Kyprolis Combo Improves PFS in Multiple Myeloma Study", "image": "https://cdn.snapi.dev/images/v1/6/t/biotech19.jpg", "site": "Zacks Investment Research", "text": "Amgen's (AMGN) phase III study on Kyprolis in combination with dexamethasone and J&J's Darzalex meets the goal of progression-free survival for treating relapsed or refractory multiple myeloma.", "url": "https://www.zacks.com/stock/news/520871/amgens-kyprolis-combo-improves-pfs-in-multiple-myeloma-study"}, {"symbol": "AMGN", "publishedDate": "2019-09-13 18:41:29", "title": "The Market's Unluckiest Stocks: 5 trades", "image": "https://cdn.snapi.dev/images/v1/e/i/eilm2un2.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders give you 5 trades in the stocks that have had a rough month.", "url": "https://www.youtube.com/watch?v=WhtRhTaKhX4"}, {"symbol": "AMGN", "publishedDate": "2019-09-13 08:00:53", "title": "Amgen Stock Is The Biggest Biotech Stock, But Should You Buy It?", "image": "https://cdn.snapi.dev/images/v1/3/g/biotech39.jpg", "site": "Investors Business Daily", "text": "Shares of Amgen are on an upswing after winning a patent battle over its drug Enbrel against Novartis subsidiary Sandoz. Is it time to buy shares of the massive biotech company?", "url": "https://www.investors.com/news/technology/amgen-stock-buy-now/"}, {"symbol": "AMGN", "publishedDate": "2019-09-11 09:36:00", "title": "Why Amgen Stock Perked Up Last Month", "image": "https://cdn.snapi.dev/images/v1/q/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5394062fbiotech2jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Amgen's best-selling medicine is safe from biosimilar competition for now.", "url": "https://www.fool.com/investing/2019/09/11/why-amgen-stock-perked-up-last-month.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-09-11 07:00:00", "title": "5 Things You'll Want to Know About Amgen's Future", "image": "https://cdn.snapi.dev/images/v1/u/i/sto23-4.jpg", "site": "The Motley Fool", "text": "The big biotech's CEO and CFO talk about what you can expect from Amgen over the next few years.", "url": "https://www.fool.com/investing/2019/09/11/5-things-youll-want-to-know-about-amgens-future.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-09-10 17:57:46", "title": "Amgen: Otezla Brings Growth At A Reasonable Price", "image": "https://cdn.snapi.dev/images/v1/s/c/amg.jpg", "site": "Seeking Alpha", "text": "Amgen is acquiring Otezla from Celgene, as the latter has to sell the drug for anti-trust reasons.", "url": "https://seekingalpha.com/article/4290837-amgen-otezla-brings-growth-reasonable-price"}, {"symbol": "AMGN", "publishedDate": "2019-09-09 15:55:33", "title": "Amgen\u2019s Lung Cancer Study Needs to Take a Breather", "image": "https://cdn.snapi.dev/images/v1/c/f/biotech14.jpg", "site": "24/7 Wall Street", "text": "Amgen Inc. (NASDAQ: AMGN) shares dropped on Monday after the firm released additional data from its early-stage lung cancer study.", "url": "https://247wallst.com/healthcare-business/2019/09/09/amgens-lung-cancer-study-needs-to-take-a-breather/"}, {"symbol": "AMGN", "publishedDate": "2019-09-09 14:10:31", "title": "Amgen: Why This Cash Flow King Is A Buy", "image": "https://cdn.snapi.dev/images/v1/q/0/biotech12.jpg", "site": "Seeking Alpha", "text": "Given that recessionary warning signals are growing, I suggest investors focus on dividend payers with healthy balance sheets.", "url": "https://seekingalpha.com/article/4290563-amgen-cash-flow-king-buy"}, {"symbol": "AMGN", "publishedDate": "2019-09-09 10:27:04", "title": "Amgen's KRAS Inhibitor Shows Lukewarm Response In Lung Cancer Study", "image": "https://cdn.snapi.dev/images/v1/c/r/cells-1872666-1920-1-3.jpg", "site": "Benzinga", "text": "Amgen, Inc. (NASDAQ: AMGN) shares were\u00a0pulling back Monday\u00a0following the presentation of new data on its investigational compound for solid tumors.", "url": "https://www.benzinga.com/general/biotech/19/09/14397347/amgens-kras-inhibitor-shows-lukewarm-response-in-lung-cancer-study"}, {"symbol": "AMGN", "publishedDate": "2019-09-09 10:10:00", "title": "Amgen's KRAS Inhibitor Shows Response in Larger NSCLC Group", "image": "https://cdn.snapi.dev/images/v1/d/6/biotech9.jpg", "site": "Zacks Investment Research", "text": "Amgen's (AMGN) novel investigational KRAS inhibitor, AMG 510, for solid tumor shows anti-tumor activity in a larger group of NSCLC patients.", "url": "https://www.zacks.com/stock/news/509396/amgens-kras-inhibitor-shows-response-in-larger-nsclc-group"}, {"symbol": "AMGN", "publishedDate": "2019-09-09 09:58:31", "title": "The Biggest Biotech Just Hit The Skids On A Lackluster Cancer Study", "image": "https://cdn.snapi.dev/images/v1/a/m/amg7.jpg", "site": "Investors Business Daily", "text": "Amgen stock toppled Monday after the biotech company's experimental cancer treatment failed to impress investors in a Phase 1 study.", "url": "https://www.investors.com/news/technology/amgen-stock-tumbles-experimental-cancer-treatment-fails-impress/"}, {"symbol": "AMGN", "publishedDate": "2019-09-08 09:00:00", "title": "Better Buy: Amgen vs. Celgene", "image": "https://cdn.snapi.dev/images/v1/t/v/biotech13-5.jpg", "site": "The Motley Fool", "text": "Which stock wins in a battle between these two big biotechs?", "url": "https://www.fool.com/investing/2019/09/08/better-buy-amgen-vs-celgene.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-09-05 21:16:00", "title": "4 Biotech Stocks With Big Catalysts in September", "image": "https://cdn.snapi.dev/images/v1/c/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5385732fcheering-crowd-of-healthcare-providers-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Two presentations at the World Conference on Lung Cancer will make a big difference for at least four different drugmakers.", "url": "https://www.fool.com/investing/2019/09/05/biotech-stocks-with-big-catalysts-in-september.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-09-04 11:01:21", "title": "5 Companies Hit 52-Week Highs (Sep 04)", "image": "https://cdn.snapi.dev/images/v1/a/s/asset-management13-8.jpg", "site": "GuruFocus", "text": "According to GuruFocus list of 52-week highs , these guru stocks have reached their 52-week highs.", "url": "https://www.gurufocus.com/news/940363/5-companies-hit-52week-highs"}, {"symbol": "AMGN", "publishedDate": "2019-08-29 09:30:11", "title": "Is Amgen (AMGN) Outperforming Other Medical Stocks This Year?", "image": "https://cdn.snapi.dev/images/v1/l/u/biotech7.jpg", "site": "Zacks Investment Research", "text": "Is  (AMGN) Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/494268/is-amgen-amgn-outperforming-other-medical-stocks-this-year"}, {"symbol": "AMGN", "publishedDate": "2019-08-28 18:55:00", "title": "What Investors Need to Know About the Celgene, Amgen & Bristol-Myers Deals", "image": "https://cdn.snapi.dev/images/v1/n/d/biotech32.jpg", "site": "Zacks Investment Research", "text": "On Monday, Celgene (CELG) announced a sale of its psoriasis drug Otezla for $13.4 billion to Amgen (AMGN). This deal will be all cash and is expected to clear before the end of the year.", "url": "https://www.zacks.com/stock/news/493266/what-investors-need-to-know-about-the-celgene-amgen-bristol-myers-deals"}, {"symbol": "AMGN", "publishedDate": "2019-08-28 16:51:52", "title": "U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight", "image": "https://cdn.snapi.dev/images/v1/s/l/m02d20190828t2i1423783964rlynxnpef7r1wiw640.jpg", "site": "Reuters", "text": "A U.S. judge on Wednesday set aside a jury verdict that found Amgen Inc  patents on its cholesterol drug Repatha were valid, handing a victory to Regeneron Pharmaceuticals Inc  and Sanofi SA , which sells a rival drug.", "url": "https://www.reuters.com/article/us-amgen-sanofi-patent/u-s-judge-rules-for-regeneron-sanofi-in-amgen-cholesterol-drug-patent-fight-idUSKCN1VI2E9"}, {"symbol": "AMGN", "publishedDate": "2019-08-28 13:31:00", "title": "Three Top Biotech Stocks, to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5378762fnew-biotechjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Patent cliffs and pipeline risks are among the reasons these biologic drug specialists are attractively priced today.", "url": "https://www.fool.com/investing/2019/08/28/3-top-biotech-stocks-to-buy-right-now.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-08-27 11:01:27", "title": "4 Biotech Stocks to Buy That Are on the Move", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech1600molecule-768x432.jpg", "site": "InvestorPlace", "text": "Biotech stocks overall are holding up fairly well amid recent market volatility. Look at which four biotech stocks to buy have staying power.", "url": "https://investorplace.com/2019/08/4-biotech-stocks-to-buy-that-are-on-the-move/"}, {"symbol": "AMGN", "publishedDate": "2019-08-27 10:55:00", "title": "Amgen to Buy Celgene's Otezla for $13.4B: Is it a Good Buy?", "image": "https://cdn.snapi.dev/images/v1/s/i/biotech19.jpg", "site": "Zacks Investment Research", "text": "Amgen's (AMGN) purchase of Celgene's blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space.", "url": "https://www.zacks.com/stock/news/491082/amgen-to-buy-celgenes-otezla-for-%24134b-is-it-a-good-buy"}, {"symbol": "AMGN", "publishedDate": "2019-08-27 08:05:00", "title": "Bristol-Myers Announces Sale of Celgene's Otezla to Amgen", "image": "https://cdn.snapi.dev/images/v1/7/d/biotech13.jpg", "site": "Zacks Investment Research", "text": "Bristol-Myers (BMY) announces that Celgene will sell psoriasis drug, Otezla, to Amgen in connection with the ongoing regulatory approval process.", "url": "https://www.zacks.com/stock/news/490829/bristol-myers-announces-sale-of-celgenes-otezla-to-amgen"}, {"symbol": "AMGN", "publishedDate": "2019-08-26 16:32:00", "title": "Celgene's $13.4 Billion Deal With Amgen Is a Win-Win-Win", "image": "https://cdn.snapi.dev/images/v1/3/x/bio2-4.jpg", "site": "The Motley Fool", "text": "Here's who wins the most from the sale of Otezla.", "url": "https://www.fool.com/investing/2019/08/26/celgenes-134-billion-deal-with-amgen-is-a-win-win.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-08-26 15:32:00", "title": "5 Top Stock Trades for Tuesday: NFLX, AMGN, ACB, BMY & FL", "image": "https://cdn.snapi.dev/images/v1/s/t/sto23-4.jpg", "site": "InvestorPlace", "text": "Netflix, Amgen, Bristol-Myers Squibb, Aurora Cannabis and Foot Locker are our top stock trades for Tuesday. Here's how to trade them.", "url": "https://investorplace.com/2019/08/top-stock-trades-bmy-amgn-nflx-acb-fl/"}, {"symbol": "AMGN", "publishedDate": "2019-08-26 15:20:25", "title": "Is Amgen Overpaying For Celgene\u2019s Psoriasis Treatment?", "image": "https://cdn.snapi.dev/images/v1/3/l/biotech10.jpg", "site": "24/7 Wall Street", "text": "Both Amgen Inc. (NASDAQ: AMGN) and Celgene Corp. (NASDAQ: CELG) shares made a handy gain on Monday after it was announced that the companies had made an agreement in relation to Celgene\u2019s merger with Bristol-Myers Squibb Co.", "url": "https://247wallst.com/healthcare-business/2019/08/26/is-amgen-overpaying-for-celgenes-psoriasis-treatment/"}, {"symbol": "AMGN", "publishedDate": "2019-08-26 14:18:04", "title": "Why Amgen Thinks Celgene's Psoriasis Drug Otezla Is Worth $13.4 Billion", "image": "https://cdn.snapi.dev/images/v1/h/z/why-amgen-thinks-celgenes-psoriasis-drug-otezla-is-worth-134-billion.jpg", "site": "Bloomberg Markets and Finance", "text": "Aug.26 -- Amgen Inc.", "url": "https://www.youtube.com/watch?v=ddd01flZg-0"}, {"symbol": "AMGN", "publishedDate": "2019-08-26 10:45:33", "title": "Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion", "image": "https://cdn.snapi.dev/images/v1/d/i/m02d20190826t2i1422931549rlynxnpef7p0nmw640.jpg", "site": "Reuters", "text": "Amgen Inc will buy Celgene Corp's psoriasis drug Otezla for $13.4 billion in cash, clearing the way for Bristol-Myers Squibb to go ahead with its $74 billion deal for Celgene by the end of the year.", "url": "https://www.reuters.com/article/us-bristol-myers-divestiture-amgen/amgen-to-buy-celgene-psoriasis-drug-otezla-for-13-4-billion-idUSKCN1VG102"}, {"symbol": "AMGN", "publishedDate": "2019-08-26 10:17:43", "title": "Amgen's Proposed $13.4B Acquisition Of Celgene's Otezla: What You Need To Know", "image": "https://cdn.snapi.dev/images/v1/b/k/biotech17.jpg", "site": "Benzinga", "text": "Amgen, Inc. (NASDAQ: AMGN) is beefing up its inflammatory disease drug portfolio with a\u00a0blockbuster psoriasis drug that\u00a0Celgene Corporation (NASDAQ: CELG) is being forced to divest as a regulatory requirement for the completion of its previously announced merger agreement with Bristol-Myers Squibb Co (NYSE: BMY).", "url": "https://www.benzinga.com/general/biotech/19/08/14325840/amgens-proposed-13-4b-acquisition-of-celgenes-otezla-what-you-need-to-know"}, {"symbol": "AMGN", "publishedDate": "2019-08-26 09:01:09", "title": "Amgen Will Buy Celgene's Blockbuster Drug Otezla For $13.4 Billion", "image": "https://cdn.snapi.dev/images/v1/e/q/biotech40.jpg", "site": "Investors Business Daily", "text": "Amgen will spend $13.4 billion to acquire Celgene's blockbuster drug, Otezla,\u00a0\u2014 helping settle Federal Trade Commission concerns facing Bristol-Myers Squibb's acquisition of Celgene.\r\nThe post Amgen Will Buy Celgene's Blockbuster Drug Otezla For $13.4 Billion appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/amgen-stock-dips-deal-buy-celgene-drug-otezla/"}, {"symbol": "AMGN", "publishedDate": "2019-08-26 06:50:58", "title": "Amgen to buy Celgene's Otezla for $13.4 billion", "image": "https://cdn.snapi.dev/images/v1/s/h/biotech35.jpg", "site": "Market Watch", "text": "Shares of Amgen Inc. AMGN, -2.13% fell 1.0% in premarket trading Monday after the biotechnology company said it agreed to buy Celgene Corp.", "url": "https://www.marketwatch.com/story/amgen-to-buy-celgenes-otezla-for-134-billion-2019-08-26-6915057"}, {"symbol": "AMGN", "publishedDate": "2019-08-25 11:31:00", "title": "Should Amgen Finally Buy Alexion Pharmaceuticals?", "image": "https://cdn.snapi.dev/images/v1/p/9/hand-3632914-1920-0.jpg", "site": "The Motley Fool", "text": "One of biotech's longest-running buyout rumors is picking up steam again.", "url": "https://www.fool.com/investing/2019/08/25/should-amgen-finally-buy-alexion-pharmaceuticals.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-08-24 07:29:00", "title": "3 Reasons Why Amgen Could Actually Acquire Alexion", "image": "https://cdn.snapi.dev/images/v1/b/l/jnj-2.jpg", "site": "The Motley Fool", "text": "Rumors that Amgen plans to buy Alexion might not become reality. But a deal would make a lot of sense.", "url": "https://www.fool.com/investing/2019/08/24/3-reasons-why-amgen-could-actually-acquire-alexion.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-08-23 12:30:39", "title": "Why Alexion Makes Sense As A Target, But Amgen Doesn't As A Buyer", "image": "https://cdn.snapi.dev/images/v1/0/e/biotech22.jpg", "site": "Investors Business Daily", "text": "Alexion Pharmaceuticals is likely \"on the radar\" as a takeover candidate, but biotech company Amgen doesn't fit logically as an acquirer, an analyst said. Alexion stock dipped Friday.", "url": "https://www.investors.com/news/technology/alexion-stock-could-be-taken-over-not-biotech-company-amgen/"}, {"symbol": "AMGN", "publishedDate": "2019-08-22 12:37:36", "title": "Biotech Giant Amgen Could Be Nearing A Massive Takeover: Report", "image": "https://cdn.snapi.dev/images/v1/8/j/biotech38.jpg", "site": "Investors Business Daily", "text": "Biotech giant Amgen could be nearing a deal to buy Alexion Pharmaceuticals at a 74% premium, according to a Spanish news outlet. The deal would value Alexion stock at $200 per share.", "url": "https://www.investors.com/news/technology/biotech-company-amgen-could-near-deal-acquire-alexion-pharma/"}, {"symbol": "AMGN", "publishedDate": "2019-08-19 12:14:07", "title": "Why The 2 Biggest Biotech Stocks Were Just Hit With Downgrades", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech19.jpg", "site": "Investors Business Daily", "text": "An analyst downgraded shares of biotechs Amgen and Celgene on Monday, saying both stocks are nearing appropriate values. Amgen stock ran up after a judge sided with it in a patent battle.", "url": "https://www.investors.com/news/technology/biotech-companies-downgraded-amgen-stock-celgene-stock-fairly-valued/"}, {"symbol": "AMGN", "publishedDate": "2019-08-18 09:30:00", "title": "Is Amgen a Buy?", "image": "https://cdn.snapi.dev/images/v1/v/t/biotech1-2.jpg", "site": "The Motley Fool", "text": "The biotech's present and future might not live up to its past.", "url": "https://www.fool.com/investing/2019/08/18/is-amgen-a-buy.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-08-14 18:29:24", "title": "Final trade: LK, PEP, URI & AMGN", "image": "https://cdn.snapi.dev/images/v1/r/3/r3rfg-1.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders give you 4 trades in the banking sector after the Dow has its worst day in 2019.", "url": "https://www.youtube.com/watch?v=gFxGzAh_hVk"}, {"symbol": "AMGN", "publishedDate": "2019-08-14 09:36:23", "title": "Wednesday\u2019s Vital Data: Amgen, American Airlines and Apple", "image": "https://cdn.snapi.dev/images/v1/z/q/etf22-32.jpg", "site": "InvestorPlace", "text": "Options trading was buzzing on Tuesday, with Amgen, American Airlines and Apple all making notable moves. Here are the metrics that matter moving forward.", "url": "https://investorplace.com/2019/08/wednesdays-vital-data-amgen-american-airlines-and-apple/"}, {"symbol": "AMGN", "publishedDate": "2019-08-14 09:35:06", "title": "Amgen (AMGN) Soars to 52-Week High, Time to Cash Out?", "image": "https://cdn.snapi.dev/images/v1/0/w/biotech26.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.", "url": "https://www.zacks.com/stock/news/470231/amgen-amgn-soars-to-52-week-high-time-to-cash-out"}, {"symbol": "AMGN", "publishedDate": "2019-08-13 10:48:00", "title": "Here's Why Amgen Stock is Outperforming Its Industry Of Late", "image": "https://cdn.snapi.dev/images/v1/m/h/biotech4.jpg", "site": "Zacks Investment Research", "text": "Favorable patent ruling related to Enbrel and strong second-quarter results drive Amgen (AMGN) stock 22.6% higher in the past three months.", "url": "https://www.zacks.com/stock/news/468682/heres-why-amgen-stock-is-outperforming-its-industry-of-late"}, {"symbol": "AMGN", "publishedDate": "2019-08-13 09:50:00", "title": "Should Value Investors Choose Amgen (AMGN) Stock Now?", "image": "https://cdn.snapi.dev/images/v1/4/4/biotech39.jpg", "site": "Zacks Investment Research", "text": "Let's see if Amgen (AMGN) stock is a good choice for value-oriented investors right now from multiple angles.", "url": "https://www.zacks.com/stock/news/468539/should-value-investors-choose-amgen-amgn-stock-now"}, {"symbol": "AMGN", "publishedDate": "2019-08-13 05:26:00", "title": "Will Amgen Continue to Surge Higher?", "image": "https://cdn.snapi.dev/images/v1/e/k/biotech32.jpg", "site": "Zacks Investment Research", "text": "As of late, it has definitely been a great time to be an investor Amgen.", "url": "https://www.zacks.com/stock/news/468105/will-amgen-continue-to-surge-higher"}, {"symbol": "AMGN", "publishedDate": "2019-08-12 14:21:09", "title": "Amgen stock gets boost from Friday ruling on Enbrel", "image": "https://cdn.snapi.dev/images/v1/w/q/amgen.jpg", "site": "Market Watch", "text": "Shares of Amgen Inc. AMGN, +4.34% rose another 4.5% on Monday after gaining nearly 6% on Friday, when a U.S.", "url": "https://www.marketwatch.com/story/amgen-stock-gets-boost-from-friday-ruling-on-enbrel-2019-08-12"}, {"symbol": "AMGN", "publishedDate": "2019-08-12 13:34:32", "title": "Ride with Uber? Long term outlook for Amgen? and more..", "image": "https://cdn.snapi.dev/images/v1/g/r/grew33-1.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Uber, Amgen, Occidental and Orbcomm.", "url": "https://www.youtube.com/watch?v=8i8C16dc5pE"}, {"symbol": "AMGN", "publishedDate": "2019-08-12 11:34:06", "title": "The Biggest Biotech Stock Is Approaching A Breakout \u2014 Here's Why", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech19.jpg", "site": "Investors Business Daily", "text": "Amgen stock continued a two-day run Monday and approached a buy point after a judge upheld two key patents protecting the biotech company's blockbuster drug Enbrel against a Sandoz copycat.\r\nThe post The Biggest Biotech Stock Is Approaching A Breakout \u2014 Here's Why appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/amgen-stock-buy-point-judge-upholds-enbrel-patents/"}, {"symbol": "AMGN", "publishedDate": "2019-08-12 09:44:00", "title": "Amgen Wins Enbrel U.S. Patent Litigation Against Novartis", "image": "https://cdn.snapi.dev/images/v1/g/y/biotech17.jpg", "site": "Zacks Investment Research", "text": "Despite lower demand hurting volumes of Enbrel, it remains the largest drug for Amgen (AMGN). A district court decision prevents Novartis from launching Erelzi, its biosimilar version of Enbrel.", "url": "https://www.zacks.com/stock/news/466882/amgen-wins-enbrel-us-patent-litigation-against-novartis"}, {"symbol": "AMGN", "publishedDate": "2019-08-09 17:53:29", "title": "Final Trades: MCD, GLD, CSCO & AMGN", "image": "https://cdn.snapi.dev/images/v1/z/u/final-trades-mcd-gld-csco-amgn.jpg", "site": "CNBC Television", "text": "The Fast Money traders give their final trades heading into next week.", "url": "https://www.youtube.com/watch?v=wVCqBmRDJqM"}, {"symbol": "AMGN", "publishedDate": "2019-08-05 09:10:16", "title": "Is Amgen (AMGN) a Great Value Stock Right Now?", "image": "https://cdn.snapi.dev/images/v1/t/0/biotech14.jpg", "site": "Zacks Investment Research", "text": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.", "url": "https://www.zacks.com/stock/news/458875/is-amgen-amgn-a-great-value-stock-right-now"}, {"symbol": "AMGN", "publishedDate": "2019-08-04 15:04:00", "title": "3 Lung Cancer Stocks That Could Soar in September", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech15.jpg", "site": "The Motley Fool", "text": "These industry giants could make big moves after this year's World Conference on Lung Cancer.", "url": "https://www.fool.com/investing/2019/08/04/3-lung-cancer-stocks-that-could-soar-in-september.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-08-01 09:54:00", "title": "Amgen (AMGN) Catches Eye: Stock Jumps 5.7%", "image": "https://cdn.snapi.dev/images/v1/2/w/biotech16.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.", "url": "https://www.zacks.com/stock/news/455882/amgen-amgn-catches-eye-stock-jumps-57"}, {"symbol": "AMGN", "publishedDate": "2019-07-31 14:00:08", "title": "5 Stocks to Buy and Keep an Eye on Come Fall", "image": "https://cdn.snapi.dev/images/v1/e/t/etf13-59.jpg", "site": "InvestorPlace", "text": "Q2 earnings season rolls on and Wall Street tries to not act disappointed by the early end to the latest round of U.S.-China trade talks.", "url": "https://investorplace.com/2019/07/5-stocks-to-buy-and-keep-an-eye-on-come-fall/"}, {"symbol": "AMGN", "publishedDate": "2019-07-31 12:25:09", "title": "Amgen's Biggest Moneymakers Are Struggling \u2014 Will A Cancer Drug Fill In?", "image": "https://cdn.snapi.dev/images/v1/v/p/biotech17.jpg", "site": "Investors Business Daily", "text": "Amgen stock popped Wednesday on excitement for an experimental cancer drug\u00a0\u2014 outweighing worries new medicines won't offset continued erosion for the company's biggest moneymakers.\r\nThe post Amgen's Biggest Moneymakers Are Struggling \u2014 Will A Cancer Drug Fill In?", "url": "https://www.investors.com/news/technology/amgen-stock-pops-cancer-treatment-biotech-company-blockbuster-struggle/"}, {"symbol": "AMGN", "publishedDate": "2019-07-31 11:09:00", "title": "Are Amgen and Gilead Sciences Better Buys After Second-Quarter Earnings?", "image": "https://cdn.snapi.dev/images/v1/f/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5335812ft-celljpgw700opresize.jpg", "site": "The Motley Fool", "text": "These blue-chip biotechs delivered mixed reports Tuesday.", "url": "https://www.fool.com/investing/2019/07/31/are-amgen-and-gilead-sciences-better-buys-after-se.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-07-31 10:00:34", "title": "Why Amgen Is Up Despite Falling Product Sales", "image": "https://cdn.snapi.dev/images/v1/k/q/biotech31.jpg", "site": "24/7 Wall Street", "text": "When Amgen Inc. (NASDAQ: AMGN) released its second-quarter financial results after the markets closed on Tuesday, the firm said that it had $3.97 in earnings per share (EPS) and $5.9 billion in revenue.", "url": "https://247wallst.com/healthcare-business/2019/07/31/why-amgen-is-up-despite-falling-product-sales/"}, {"symbol": "AMGN", "publishedDate": "2019-07-31 09:51:44", "title": "Amgen Tops Forecasters on 2nd-Quarter Earnings", "image": "https://cdn.snapi.dev/images/v1/h/7/biotech35.jpg", "site": "GuruFocus", "text": "Shares of Amgen (NASDAQ:AMGN) moved 1.98% higher to $179.95 in after-hours trading on Tuesday after the U.S.", "url": "https://www.gurufocus.com/news/919156/amgen-tops-forecasters-on-2ndquarter-earnings"}, {"symbol": "AMGN", "publishedDate": "2019-07-31 09:34:00", "title": "Amgen (AMGN) Q2 Earnings & Sales Beat, New Drugs Shine", "image": "https://cdn.snapi.dev/images/v1/e/u/biotech34.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) beats estimates for earnings and sales in the second quarter. Higher demand for new growth drivers was offset by the erosion of mature brands from brand/biosimilar competition.", "url": "https://www.zacks.com/stock/news/454714/amgen-amgn-q2-earnings-sales-beat-new-drugs-shine"}, {"symbol": "AMGN", "publishedDate": "2019-07-31 06:47:00", "title": "Amgen results beat estimates, lung cancer trial planned", "image": "https://cdn.snapi.dev/images/v1/i/o/103973226-1548793652023gettyimages-563574597.jpg", "site": "CNBC", "text": "Amgen said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs.", "url": "https://www.cnbc.com/2019/07/31/amgen-results-beat-estimates-lung-cancer-trial-planned.html"}, {"symbol": "AMGN", "publishedDate": "2019-07-30 23:31:05", "title": "Amgen Inc. (AMGN) CEO Bob Bradway on Q2 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/b/k/transcript42-2.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) CEO Bob Bradway on Q2 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4279330-amgen-inc-amgn-ceo-bob-bradway-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts"}, {"symbol": "AMGN", "publishedDate": "2019-07-30 20:40:00", "title": "Amgen Manages to Tread Water for Another Quarter", "image": "https://cdn.snapi.dev/images/v1/y/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5333712fpharma-manufacturing-clean-room-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Amgen's rookie lineup continued to offset losses from the oldest members of its roster during the second quarter.", "url": "https://www.fool.com/investing/2019/07/30/amgen-manages-to-tread-water-for-another-quarter.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-07-30 17:54:33", "title": "Amgen results beat estimates, cancer drug shows wider activity", "image": "https://cdn.snapi.dev/images/v1/s/z/m02d20190730t2i1413676577rlynxnpef6t1skw640.jpg", "site": "Reuters", "text": "Amgen Inc  on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped its results exceed Wall Street forecasts.", "url": "https://www.reuters.com/article/us-amgen-results/amgen-results-beat-estimates-cancer-drug-shows-wider-activity-idUSKCN1UP2F0"}, {"symbol": "AMGN", "publishedDate": "2019-07-30 17:15:03", "title": "Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates", "image": "https://cdn.snapi.dev/images/v1/7/l/biotech21.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) delivered earnings and revenue surprises of 10.89% and 3.43%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/453980/amgen-amgn-beats-q2-earnings-and-revenue-estimates"}, {"symbol": "AMGN", "publishedDate": "2019-07-30 17:05:12", "title": "Amgen quarterly results beat estimates, but revenue dips 3%", "image": "https://cdn.snapi.dev/images/v1/q/u/m02d20190730t2i1413676577rlynxnpef6t1skw640.jpg", "site": "Reuters", "text": "Amgen Inc  on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped its results exceed Wall Street forecasts.", "url": "https://www.reuters.com/article/us-amgen-results/amgen-quarterly-results-beat-estimates-but-revenue-dips-3-idUSKCN1UP2F0"}, {"symbol": "AMGN", "publishedDate": "2019-07-30 16:28:32", "title": "Gilead beats EPS expectations by $0.10; Amgen raises low end of full-year revenue outlook", "image": "https://cdn.snapi.dev/images/v1/h/1/biotech40.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell joins \"Closing Bell\" to report the latest from Amgen's and Gilead's latest quarterly earnings.", "url": "https://www.youtube.com/watch?v=i9ReLf6jmoo"}, {"symbol": "AMGN", "publishedDate": "2019-07-30 16:13:25", "title": "Amgen Stock Jumps On Bullish Guidance Despite Mixed Report", "image": "https://cdn.snapi.dev/images/v1/1/6/biotech19.jpg", "site": "Investors Business Daily", "text": "Amgen earnings of $3.57 per share lagged by a penny, but $5.87 billion in sales beat estimates Tuesday. Amgen stock popped on bullish 2019 guidance that topped analyst expectations.", "url": "https://www.investors.com/news/technology/amgen-earnings-amgen-stock-q2-2019/"}, {"symbol": "AMGN", "publishedDate": "2019-07-30 16:09:10", "title": "Amgen shares inch up on sales, earnings beat", "image": "https://cdn.snapi.dev/images/v1/h/n/amgen.jpg", "site": "Market Watch", "text": "Amgen Inc. AMGN, +0.21% shares inched up 2% in the extended session Tuesday after the biotech company reported second-quarter results that beat analyst estimates.", "url": "https://www.marketwatch.com/story/amgen-shares-inch-up-on-sales-earnings-beat-2019-07-30"}, {"symbol": "AMGN", "publishedDate": "2019-07-29 09:18:00", "title": "Why Amgen (AMGN) Might Surprise This Earnings Season", "image": "https://cdn.snapi.dev/images/v1/a/t/biotech4.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.", "url": "https://www.zacks.com/stock/news/452755/why-amgen-amgn-might-surprise-this-earnings-season"}, {"symbol": "AMGN", "publishedDate": "2019-07-27 12:20:00", "title": "10 Biggest Cancer-Fighting Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5193592fabt-earnings-41719.jpg", "site": "The Motley Fool", "text": "The fight against cancer is a big battle. And these 10 companies are among the biggest combatants you can invest in.", "url": "https://www.fool.com/investing/2019/07/27/10-biggest-cancer-fighting-stocks.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-07-26 11:23:00", "title": "Can Newer Drugs Help Amgen (AMGN) Beat on Earnings in Q2?", "image": "https://cdn.snapi.dev/images/v1/0/x/biotech29.jpg", "site": "Zacks Investment Research", "text": "While Amgen's (AMGN) growth drugs like Prolia & Xgeva may do well, biosimilar competition and slowdown in sales of mature products are likely to put pressure on second-quarter sales.", "url": "https://www.zacks.com/stock/news/451304/can-newer-drugs-help-amgen-amgn-beat-on-earnings-in-q2"}, {"symbol": "AMGN", "publishedDate": "2019-07-26 09:27:00", "title": "5 Drug/Biotech Stocks Set to Beat Earnings Estimates in Q2", "image": "https://cdn.snapi.dev/images/v1/9/5/952.jpg", "site": "Zacks Investment Research", "text": "We take a look at the overall drug/biotech sector's performance and five stocks that are poised to beat on earnings in the second quarter of 2019.", "url": "https://www.zacks.com/stock/news/450905/5-drug-biotech-stocks-set-to-beat-earnings-estimates-in-q2"}, {"symbol": "AMGN", "publishedDate": "2019-07-23 10:32:36", "title": "Amgen (AMGN) Expected to Beat Earnings Estimates: Should You Buy?", "image": "https://cdn.snapi.dev/images/v1/n/r/biotech5.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/447492/amgen-amgn-expected-to-beat-earnings-estimates-should-you-buy"}, {"symbol": "AMGN", "publishedDate": "2019-07-12 16:59:22", "title": "More bad news for Alzheimer's patients", "image": "https://cdn.snapi.dev/images/v1/z/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5174042falzheimers-disease-chalkboard.jpg", "site": "The Motley Fool", "text": "Novartis (NYSE:NVS) and Amgen (NASDAQ:AMGN) announced the failure of a candidate drug treatment for Alzheimer's disease.", "url": "https://www.fool.com/investing/2019/07/12/what-happened-in-the-stock-market-today.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-07-12 10:24:00", "title": "Amgen & Novartis' Alzheimer Studies End in Another Failure", "image": "https://cdn.snapi.dev/images/v1/n/4/biotech27.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) and Novartis (NVS) discontinue two Alzheimer's disease studies. Alzheimer's has always been a highly challenging area with many studies failing.", "url": "https://www.zacks.com/stock/news/441627/amgen-novartis-alzheimer-studies-end-in-another-failure"}, {"symbol": "AMGN", "publishedDate": "2019-07-12 10:19:16", "title": "Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug", "image": "https://cdn.snapi.dev/images/v1/a/m/brain-1787622-1920-13.jpg", "site": "Benzinga", "text": "A drug to treat Alzheimer's disease is increasingly proving elusive, despite billions of dollars spent on research and development.", "url": "https://www.benzinga.com/general/biotech/19/07/14067050/novartis-amgen-scrap-pivotal-study-of-alzheimers-prevention-drug"}, {"symbol": "AMGN", "publishedDate": "2019-07-11 16:51:41", "title": "Amgen and Novartis drop Alzheimer's-prevention study after patients worsened", "image": "https://cdn.snapi.dev/images/v1/p/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5263662famgen-scientistsjpgw700opresize.jpg", "site": "Market Watch", "text": "Amgen Inc. AMGN, -2.34% and Novartis AG NVS, -1.15% announced Thursday afternoon that they will discontinue a study into a potential Alzheimer's disease prevention therapy after patients in the study showed worsening conditions.", "url": "https://www.marketwatch.com/story/amgen-and-novartis-drop-alzheimers-prevention-study-after-patients-worsened-2019-07-11"}, {"symbol": "AMGN", "publishedDate": "2019-07-11 09:50:10", "title": "Short Sellers Run for Cover From Major Biotechs", "image": "https://cdn.snapi.dev/images/v1/1/3/13shs-1.jpg", "site": "24/7 Wall Street", "text": "The short interest data are out for the most recent settlement date, June 28. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.", "url": "https://247wallst.com/healthcare-business/2019/07/11/short-sellers-run-for-cover-from-major-biotechs-13/"}, {"symbol": "AMGN", "publishedDate": "2019-07-11 09:20:00", "title": "Trump's Order on Kidney Care Lifts These Dialysis Stocks", "image": "https://cdn.snapi.dev/images/v1/h/o/biotech13.jpg", "site": "Zacks Investment Research", "text": "Dialysis stocks move north after Trump signs an executive order designed to reform the nation's kidney treatment industry.", "url": "https://www.zacks.com/stock/news/440950/trumps-order-on-kidney-care-lifts-these-dialysis-stocks"}, {"symbol": "AMGN", "publishedDate": "2019-07-10 13:16:00", "title": "The 10 Biggest Healthcare Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5301712fbusinessman-pointing-to-healthcare-iconsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "How big does a company's market cap need to be to make the top 10 list of healthcare stocks? $111 billion.", "url": "https://www.fool.com/investing/2019/07/10/the-10-biggest-healthcare-stocks.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-07-10 11:24:00", "title": "Court Ruling Topples Trump Order, No Price Display in TV Ads", "image": "https://cdn.snapi.dev/images/v1/6/0/608.jpg", "site": "Zacks Investment Research", "text": "The recent ruling by a federal court against the Trump regime's decree to disclose the price labels of drugs in TV adverts resumes the spotlight on drug pricing.", "url": "https://www.zacks.com/stock/news/440524/court-ruling-topples-trump-order-no-price-display-in-tv-ads"}, {"symbol": "AMGN", "publishedDate": "2019-07-10 08:14:00", "title": "Will Patent Woes Boost Pharma Stock Megamergers Further?", "image": "https://cdn.snapi.dev/images/v1/8/7/873.jpg", "site": "Zacks Investment Research", "text": "With key drugs losing exclusivity, key drug makers are poised to face deep trouble since their sales are mostly dependent on a single drug.", "url": "https://www.zacks.com/stock/news/440310/will-patent-woes-boost-pharma-stock-megamergers-further"}, {"symbol": "AMGN", "publishedDate": "2019-07-08 18:40:00", "title": "US judge halts Trump administration rule requiring drug prices in TV ads", "image": "https://cdn.snapi.dev/images/v1/1/0-3/106001692-1562170322294gettyimages-1153138238r.jpg", "site": "CNBC", "text": "A federal judge on Monday blocked the Trump administration from implementing a new rule that would force pharmaceutical companies to include the wholesale prices of their drugs in television advertising.", "url": "https://www.cnbc.com/2019/07/08/us-judge-halts-trump-hhs-rule-requiring-drug-prices-in-tv-ads.html"}, {"symbol": "AMGN", "publishedDate": "2019-07-06 10:00:00", "title": "Here's Why Amgen Stock Gained 10% in June", "image": "https://cdn.snapi.dev/images/v1/a/2/sc33.jpg", "site": "The Motley Fool", "text": "The biotech's shares perked up for two unrelated reasons last month.", "url": "https://www.fool.com/investing/2019/07/06/heres-why-amgen-stock-gained-10-in-june.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-07-05 20:09:15", "title": "The Top 10 Biotechnology Companies (JNJ, ROG.VX)", "image": "https://cdn.snapi.dev/images/v1/k/t/drugs11.jpg", "site": "Investopedia", "text": "Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational biotechnology corporations.", "url": "https://www.investopedia.com/articles/markets/122215/worlds-top-10-biotechnology-companies-jnj-rogvx.asp"}, {"symbol": "AMGN", "publishedDate": "2019-07-05 14:30:06", "title": "5 Stocks to Buy as You Rebalance Your Portfolio", "image": "https://cdn.snapi.dev/images/v1/e/t/etf25-27.jpg", "site": "InvestorPlace", "text": "Investors who are feeling a little gutsy should consider these 5 stocks to buy to take advantage of the market's weariness right now.", "url": "https://investorplace.com/2019/07/5-stocks-to-buy-as-you-rebalance-your-portfolio/"}, {"symbol": "AMGN", "publishedDate": "2019-07-01 23:12:22", "title": "How to Invest in Biotech Stocks", "image": "https://cdn.snapi.dev/images/v1/l/c/biotech40.jpg", "site": "The Motley Fool", "text": "Seven simple steps to improving your chances of success in this part of the market.", "url": "https://www.fool.com/investing/2019/07/01/how-to-invest-in-biotech-stocks.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-06-29 06:00:00", "title": "3 Cancer-Treatment Stocks to Buy", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5296792fgettyimages-972885682jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These three businesses are a great way for investors to support the war on cancer.", "url": "https://www.fool.com/investing/2019/06/29/3-cancer-treatment-stocks-to-buy.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-06-28 11:14:41", "title": "Stocks With Low Price-Sales Ratios", "image": "https://cdn.snapi.dev/images/v1/a/s/asset-management13-8.jpg", "site": "GuruFocus", "text": "According to the GuruFocus All-in-One Screener, the following companies look cheap since they are trading with low price-sales ratios.", "url": "https://www.gurufocus.com/news/901562/5-stocks-with-low-pricesales-ratios"}, {"symbol": "AMGN", "publishedDate": "2019-06-28 09:56:00", "title": "Amgen's Osteoporosis Drug Evenity Gets Adverse CHMP View", "image": "https://cdn.snapi.dev/images/v1/m/8/biotech34.jpg", "site": "Zacks Investment Research", "text": "The CHMP provides an unfavorable feedback to Amgen's (AMGN) marketing application for Evenity to treat severe osteoporosis in postmenopausal women with risk of fracture.", "url": "https://www.zacks.com/stock/news/435489/amgens-osteoporosis-drug-evenity-gets-adverse-chmp-view"}, {"symbol": "AMGN", "publishedDate": "2019-06-25 11:02:00", "title": "The 10 Biggest Biotech Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5295332fbiotech-conceptjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's how these biotech stocks became the biggest on the market -- and how their future prospects look.", "url": "https://www.fool.com/investing/2019/06/25/the-10-biggest-biotech-stocks.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-06-24 09:33:00", "title": "Trump to issue executive order to increase transparency in health-care prices", "image": "https://cdn.snapi.dev/images/v1/1/0-3/105984506-1561380360659gettyimages-1151430132.jpeg", "site": "CNBC", "text": "President Trump issues an executive order that would pressure insurers, doctors and other providers to disclose more information about health-care prices.", "url": "https://www.cnbc.com/2019/06/24/trump-to-issue-executive-order-increasing-transparency-in-health-prices.html"}, {"symbol": "AMGN", "publishedDate": "2019-06-19 16:12:17", "title": "Amgen and University of Washington\u2019s Institute for Protein Design team up to build better cancer drugs", "image": "https://cdn.snapi.dev/images/v1/p/a/190416-baker-king-768x509.jpg", "site": "GeekWire", "text": "Biotech giant Amgen is putting up the money to fund three research projects in partnership with the University of Washington\u2019s Institute for Protein Design (IPD).", "url": "https://www.geekwire.com/2019/amgen-university-washingtons-institute-protein-design-team-build-better-cancer-drugs/"}, {"symbol": "AMGN", "publishedDate": "2019-06-19 11:49:28", "title": "3 Large-Cap Biotech Stocks to Buy for Massive Gains", "image": "https://cdn.snapi.dev/images/v1/b/i/biotechmsn-2.jpg", "site": "InvestorPlace", "text": "If you\u2019re looking for the next big thing in investing, these three down but not out biotech stocks are the way to go.", "url": "https://investorplace.com/2019/06/3-large-cap-biotech-stocks-to-buy-for-massive-gains/"}, {"symbol": "AMGN", "publishedDate": "2019-06-19 10:29:00", "title": "Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data", "image": "https://cdn.snapi.dev/images/v1/3/8/386-2.jpg", "site": "Zacks Investment Research", "text": "Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.", "url": "https://www.zacks.com/stock/news/431676/biotech-stock-roundup-amgen-gets-fda-nod-for-kanjinti-regeneron-presents-data"}, {"symbol": "AMGN", "publishedDate": "2019-06-19 09:06:00", "title": "Big Drugmakers That May Tread the M&A Path After Pfizer", "image": "https://cdn.snapi.dev/images/v1/3/8/383-3.jpg", "site": "Zacks Investment Research", "text": "There has been a flurry of M&A deal announcements this year in the drug industry. Here we discuss three big drug/biotech companies, which may make the next M&A move.", "url": "https://www.zacks.com/stock/news/431504/big-drugmakers-that-may-tread-the-ma-path-after-pfizer"}, {"symbol": "AMGN", "publishedDate": "2019-06-18 08:00:00", "title": "3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech34-6.jpg", "site": "The Motley Fool", "text": "Pfizer could be only the first of several to spend billions buying smaller biotech.", "url": "https://www.fool.com/investing/2019/06/18/3-big-drugmakers-most-likely-to-make-acquisitions.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-06-16 07:00:00", "title": "Thee Stocks to Buy and Hold for the Next 50 Years.", "image": "https://cdn.snapi.dev/images/v1/v/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5288282f19-06-05-a-street-sign-that-reads-where-to-invest-gettyimages-808812132jpgw700opresize.jpg", "site": "The Motley Fool", "text": "When your time frame is decades, you need to look differently at an investment. Here are three that can stand the test of time.", "url": "https://www.fool.com/investing/2019/06/16/3-stocks-to-buy-and-hold-for-the-next-50-years.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-06-14 15:06:30", "title": "Drugmakers sue to prevent disclosure of drug prices in TV ads", "image": "https://cdn.snapi.dev/images/v1/m/q-5/drugmakers-sue-to-prevent-disclosure-of-drug-prices-in-tv-ads.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on a new lawsuit from drugmakers against having to disclose prices in television graphics.", "url": "https://www.youtube.com/watch?v=fSI0a2gMb7c"}, {"symbol": "AMGN", "publishedDate": "2019-06-14 08:34:00", "title": "Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti", "image": "https://cdn.snapi.dev/images/v1/e/o/drugs50.jpg", "site": "Zacks Investment Research", "text": "FDA approves Amgen (AMGN) and Allergan's Kanjiniti, a biosimilar version of Roche's (RHHBY) breast cancer drug, Herceptin.", "url": "https://www.zacks.com/stock/news/429548/amgen-allergan-get-fda-nod-for-herceptin-biosimilar-kanjinti"}, {"symbol": "AMGN", "publishedDate": "2019-06-06 17:50:16", "title": "Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/w/r/biotech1-2.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Amgen (AMGN) closed at $174.45, marking a -0.06% move from the previous day.", "url": "https://www.zacks.com/stock/news/425899/amgen-amgn-stock-sinks-as-market-gains-what-you-should-know"}, {"symbol": "AMGN", "publishedDate": "2019-06-06 15:13:05", "title": "5 Healthcare Stocks to Pick Up From the Wreckage", "image": "https://cdn.snapi.dev/images/v1/h/e/healthcaremsn4.jpg", "site": "InvestorPlace", "text": "These beaten-down healthcare stocks still have plenty of long-term potential. Here's what investors need to know about each.", "url": "https://investorplace.com/2019/06/5-healthcare-stocks-to-pick-up-from-the-wreckage/"}, {"symbol": "AMGN", "publishedDate": "2019-06-06 10:23:16", "title": "Amgen Breaches Hurdle For Decades Of Research To Bring A New Drug To Reality", "image": "https://cdn.snapi.dev/images/v1/4/u/amgen.jpg", "site": "Seeking Alpha", "text": "Amgen announced positive results from a phase 1 study using AMG 510 to treat patients with KRASG12C mutant solid tumors.", "url": "https://seekingalpha.com/article/4268678-amgen-breaches-hurdle-decades-research-bring-new-drug-reality?source=feed_tag_long_ideas"}, {"symbol": "AMGN", "publishedDate": "2019-06-06 09:09:00", "title": "Was ASCO Quieter for Big Drug/Biotech Stocks This Year?", "image": "https://cdn.snapi.dev/images/v1/s/c/sc33.jpg", "site": "Zacks Investment Research", "text": "The annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago sees cancer data presentations from several drug/biotech companies about the latest developments in treating cancer.", "url": "https://www.zacks.com/stock/news/425444/was-asco-quieter-for-big-drug-biotech-stocks-this-year"}, {"symbol": "AMGN", "publishedDate": "2019-06-05 07:32:09", "title": "Amgen's early-stage study of cancer treatment had 'adverse events' in nearly half of its patients", "image": "https://cdn.snapi.dev/images/v1/t/d/biotech19.jpg", "site": "Market Watch", "text": "Amgen Inc. AMGN, +1.38% said Wednesday data from phase 1 studies of an investigational bispecific T cell engager (BiTE) molecules, updated with investigational AMG 420 results for the treatment of refractory multiple myeloma (R/R MM) showed that serious adverse events were reported in 19 of 42 patients (45%), with 16 requiring hospitalization.", "url": "https://www.marketwatch.com/story/amgens-early-stage-study-of-cancer-treatment-had-adverse-events-in-nearly-half-of-its-patients-2019-06-05"}, {"symbol": "AMGN", "publishedDate": "2019-06-04 18:45:59", "title": "Amgen Drug Breaks New Ground", "image": "https://cdn.snapi.dev/images/v1/z/q/biotech15.jpg", "site": "GuruFocus", "text": "Amgen Inc. (NASDAQ:AMGN) has accomplished something cancer researchers have failed to do for decades.", "url": "https://www.gurufocus.com/news/889634/amgen-drug-breaks-new-ground"}, {"symbol": "AMGN", "publishedDate": "2019-06-04 11:10:03", "title": "Credit Suisse Calls Out Amgen as Its Key Cancer Winner From ASCO", "image": "https://cdn.snapi.dev/images/v1/d/3/biotech10.jpg", "site": "24/7 Wall Street", "text": "It has been a tough year for many members of the so-called big pharma and big biotech.", "url": "https://247wallst.com/healthcare-business/2019/06/04/credit-suisse-calls-out-amgen-as-its-key-cancer-winner-from-asco/"}, {"symbol": "AMGN", "publishedDate": "2019-06-04 10:53:28", "title": "How Does Mirati's Lung Cancer Candidate Stack Up Against Amgen's?", "image": "https://cdn.snapi.dev/images/v1/f/k/anatomical-2261006-1920-4-0.jpg", "site": "Benzinga", "text": "Mirati Therapeutics Inc (NASDAQ: MRTX)'s shares have been on a tear, advancing over 50 percent\u00a0since Amgen, Inc.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/19/06/13857819/how-does-miratis-lung-cancer-candidate-stack-up-against-amgens"}, {"symbol": "AMGN", "publishedDate": "2019-06-04 10:19:00", "title": "Amgen's KRAS Inhibitor Shows Impressive Anti-Tumor Activity", "image": "https://cdn.snapi.dev/images/v1/n/b/biotech9.jpg", "site": "Zacks Investment Research", "text": "At ASCO, Amgen (AMGN) presented encouraging initial data set for AMG 510, its novel investigational KRAS inhibitor for solid tumor.", "url": "https://www.zacks.com/stock/news/424587/amgens-kras-inhibitor-shows-impressive-anti-tumor-activity"}, {"symbol": "AMGN", "publishedDate": "2019-06-04 09:21:00", "title": "3 Cancer Stocks Given a Lift by Amgen", "image": "https://cdn.snapi.dev/images/v1/n/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5183412fbiotech-stocks-to-own.jpg", "site": "The Motley Fool", "text": "Success with an experimental new oncology treatment that scratches a 35-year itch is good news for more than one biotech stock.", "url": "https://www.fool.com/investing/2019/06/04/3-cancer-stocks-given-a-lift-by-amgen.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-06-03 15:00:00", "title": "Biogen vs. Amgen", "image": "https://cdn.snapi.dev/images/v1/a/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5275312fbiotechjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which of these elite biotechs is the better buy right now?", "url": "https://www.fool.com/investing/2019/06/03/better-buy-biogen-vs-amgen.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-06-03 13:32:30", "title": "Amgen, Mirati stocks climbing on innovative cancer treatments", "image": "https://cdn.snapi.dev/images/v1/b/j/amgen-mirati-stocks-climbing-on-innovative-cancer-treatments.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports from the American Society of Clinical Oncologists conference on which biotech stocks are moving.", "url": "https://www.youtube.com/watch?v=M0W6Xp-00uc"}, {"symbol": "AMGN", "publishedDate": "2019-06-03 11:13:57", "title": "Did This Biotech Giant Just Find The Key To An 'Undruggable' Protein?", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech35-2.jpg", "site": "Investors Business Daily", "text": "Amgen stock popped Monday after its experimental drug showed promise in hard-to-treat lung and colon cancers. The FDA granted the drug, AMG 510, orphan drug designation in both caners.", "url": "https://www.investors.com/news/technology/amgen-stock-promising-results-lung-colon-cancer-treatment/"}, {"symbol": "AMGN", "publishedDate": "2019-05-30 15:11:49", "title": "Ranking the Top 10 Stock Buybacks of Last Year", "image": "https://cdn.snapi.dev/images/v1/b/u/buybackmsn.jpg", "site": "InvestorPlace", "text": "The top ten stock buybacks by S&P 500 companies in 2018 totaled $252 billion. Here are the best stocks to buy of the bunch.", "url": "https://feedproxy.google.com/~r/InvestorPlace/~3/F5xMjrc12d4/"}, {"symbol": "AMGN", "publishedDate": "2019-05-30 09:31:36", "title": "Amgen (AMGN) Down 4% Since Last Earnings Report: Can It Rebound?", "image": "https://cdn.snapi.dev/images/v1/m/f/biotech36.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/422260/amgen-amgn-down-4-since-last-earnings-report-can-it-rebound"}, {"symbol": "AMGN", "publishedDate": "2019-05-26 09:00:00", "title": "3 Charts Every Amgen Investor Needs to See", "image": "https://cdn.snapi.dev/images/v1/k/9/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5263662famgen-scientistsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These charts show there's a new Amgen emerging.", "url": "https://www.fool.com/investing/2019/05/26/3-charts-every-amgen-investor-needs-to-see.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-05-24 13:22:48", "title": "Final Trades: Amgen, Costco, ArQule, XAR & XLC", "image": "https://cdn.snapi.dev/images/v1/f/t/ft6a.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders give their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=Ihd56WK4_Hk"}, {"symbol": "AMGN", "publishedDate": "2019-05-23 11:40:04", "title": "Citigroup Sees Big Upside for 2 of the Largest Biotechs", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech13-5.jpg", "site": "24/7 Wall Street", "text": "After quite some time of muted or negative performance, big biotech may be worth a look again.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/eCG8PacuTs4/"}, {"symbol": "AMGN", "publishedDate": "2019-05-23 10:38:00", "title": "Amgen (AMGN) Offers to Acquire Drug Discovery Platform", "image": "https://cdn.snapi.dev/images/v1/e/z/biotech8.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) looks to acquire Nuevolution in an all-cash deal. Nuevolution focuses on discovering small molecule drugs partnering its proprietary platform.", "url": "https://www.zacks.com/stock/news/418558/amgen-amgn-offers-to-acquire-drug-discovery-platform"}, {"symbol": "AMGN", "publishedDate": "2019-05-22 10:14:10", "title": "Amgen To Buy Danish Collaborator Nuevolution For $167M", "image": "https://cdn.snapi.dev/images/v1/z/w/amgenheadquarters.jpg", "site": "Benzinga", "text": "Amgen, Inc. took a logical step forward in buying a preclinical biotech it has been collaborating with since 2016.", "url": "https://feeds.benzinga.com/~r/benzinga/~3/3Q0zU-XRWuU/amgen-to-buy-danish-collaborator-nuevolution-for-167m"}, {"symbol": "AMGN", "publishedDate": "2019-05-16 09:22:50", "title": "Final Trades: Amgen, Cisco, eBay & XRT", "image": "https://cdn.snapi.dev/images/v1/f/r/frt5.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders share their final trades of the day including AMGN, CSCO, and more.", "url": "https://www.youtube.com/watch?v=ryiKFeTGxX4"}, {"symbol": "AMGN", "publishedDate": "2019-05-07 06:00:00", "title": "3 Top Biotech Stocks  to Buy in May", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5239242ftest-tubes-with-arrow.jpg", "site": "The Motley Fool", "text": "These three biotech stocks could be prime comeback candidates.", "url": "https://www.fool.com/investing/2019/05/07/3-top-biotech-stocks-to-buy-in-may.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-05-03 15:28:00", "title": "Migraine drugs cause pain for investors", "image": "https://cdn.snapi.dev/images/v1/m/q-4/migraine-drugs-cause-pain-for-investors.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on a group of migraine drug manufacturers that missed expectations on earnings.", "url": "https://www.youtube.com/watch?v=JPBZEAI91e8"}, {"symbol": "AMGN", "publishedDate": "2019-05-01 13:07:37", "title": "Amgen Earnings Beat Forecasts \u2014 But Here's The Caveat You Need To Know", "image": "https://cdn.snapi.dev/images/v1/e/d/biotech30.jpg", "site": "Investors Business Daily", "text": "Amgen stock toppled to a year-low Wednesday after first-quarter competition snagged a key blockbuster drug. Further, sales of key drugs Aimovig and Repatha lagged analyst expectations.", "url": "https://feedproxy.google.com/~r/BusinessRss/~3/0Jn3pOei5PQ/"}, {"symbol": "AMGN", "publishedDate": "2019-05-01 09:05:00", "title": "Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure", "image": "https://cdn.snapi.dev/images/v1/y/x/biotech34.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) earnings beat estimates in the first quarter while sales come in line with the same.  The company raises the lower end of its previously issued sales and earnings guidance for 2019.", "url": "https://www.zacks.com/stock/news/406447/amgen-amgn-q1-earnings-top-sales-hurt-by-pricing-pressure"}, {"symbol": "AMGN", "publishedDate": "2019-04-30 23:51:39", "title": "Amgen Inc. (AMGN) CEO Bob Bradway on Q1 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/j/c/transcript43.jpg", "site": "Seeking Alpha", "text": "Amgen Inc. (AMGN) CEO Bob Bradway on Q1 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4258358-amgen-inc-amgn-ceo-bob-bradway-q1-2019-results-earnings-call-transcript?source=feed_sector_transcripts"}, {"symbol": "AMGN", "publishedDate": "2019-04-30 19:37:00", "title": "Amgen Reports an Unusual Slide Backward", "image": "https://cdn.snapi.dev/images/v1/a/m/amg-2.jpg", "site": "The Motley Fool", "text": "The first three months of the year weren't nearly as positive as investors had hoped for.", "url": "https://www.fool.com/investing/2019/04/30/amgen-reports-an-unusual-slide-backward.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-04-30 16:34:09", "title": "Amgen beats on top and bottom lines", "image": "https://cdn.snapi.dev/images/v1/m/q-4/amgen-beats-on-top-and-bottom-lines.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on Amgen's first-quarter earnings.", "url": "https://www.youtube.com/watch?v=frppo16UXh0"}, {"symbol": "AMGN", "publishedDate": "2019-04-30 16:18:07", "title": "Biotech Giant Amgen Tops First-Quarter Earnings Forecast, Sales In Line", "image": "https://cdn.snapi.dev/images/v1/a/m/amg7-2.jpg", "site": "Investors Business Daily", "text": "Amgen earnings of $3.56 per share beat expectations from Wall Street analysts when it reported late Tuesday, though sales were just in line. Amgen stock advanced in after-hours trading.", "url": "https://feedproxy.google.com/~r/BusinessRss/~3/7PhpokzWmzI/"}, {"symbol": "AMGN", "publishedDate": "2019-04-30 16:15:04", "title": "Amgen stock rises on company's earnings beat, Neulasta sales fall 12%", "image": "https://cdn.snapi.dev/images/v1/b/i/biogen-3.jpg", "site": "Market Watch", "text": "Shares of Amgen Inc.  rose more than 1% in the extended session Tuesday after the drug company reported adjusted first-quarter profit and sales above expectations.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/ILokv3Y2EME/story.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-04-29 21:43:00", "title": "4 More Healthcare Earnings Reports to Watch This Week", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech24-5.jpg", "site": "The Motley Fool", "text": "If you thought Monday was exciting, wait until you see what's on the slate for the rest of the week.", "url": "https://www.fool.com/investing/2019/04/29/4-more-healthcare-earnings-reports-to-watch-this-w.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-04-26 14:19:28", "title": "FDA approves biosimilar to Amgen's Enbrel", "image": "https://cdn.snapi.dev/images/v1/a/m/amgen-3.jpg", "site": "Market Watch", "text": "The Food and Drug Administration has approved Samsung Bioepis's drug Eticovo as a biosimilar to Amgen Inc.'s  Enbrel, the regulatory agency announced Friday.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/qjG5xfPvUs0/story.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-04-24 12:55:51", "title": "Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain", "image": "https://cdn.snapi.dev/images/v1/b/i/bio2-4.jpg", "site": "24/7 Wall Street", "text": "When the stock market is hitting record highs, it\u2019s important to remember that it\u2019s really a market of stocks rather than a stock market. Not all companies are created equal. Nor are all sectors.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/WAtE6F9bYKY/"}, {"symbol": "AMGN", "publishedDate": "2019-04-23 07:40:34", "title": "Why 5 Lagging Health Care Giants May Be Incredible Buys Now", "image": "https://cdn.snapi.dev/images/v1/h/c/hc2-3.jpg", "site": "24/7 Wall Street", "text": "While the overall stock market has been very strong year to date, with sectors like technology outperforming, the health care sector, which encompasses everything from pharmaceuticals to biotech to medical devices and more, has been absolutely wretched, lagging the S&P 500 by a huge 9%.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/_dbktYH2jm0/"}, {"symbol": "AMGN", "publishedDate": "2019-04-22 14:33:57", "title": "Two investors make the case for why now is the time to invest in health care stocks", "image": "https://cdn.snapi.dev/images/v1/m/q-3/two-investors-make-the-case-for-why-now-is-the-time-to-invest-in-health-care-stocks.jpg", "site": "CNBC Television", "text": "Michael Yee, Jefferies Biotech analyst, and Les Funtleyder, E-Squared Capital Management, join 'The Exchange' to discuss the health care sector and why investors are taking their bets off the stocks.", "url": "https://www.youtube.com/watch?v=C95nFfG5VRA"}, {"symbol": "AMGN", "publishedDate": "2019-04-18 10:36:34", "title": "Amgen Evenity Approval Just Makes It A Hold", "image": "https://cdn.snapi.dev/images/v1/a/m/amgen-2.jpg", "site": "Seeking Alpha", "text": "Evenity for building bone mass was approved on April.", "url": "https://seekingalpha.com/article/4255211-amgen-evenity-approval-just-makes-hold?source=feed_tag_long_ideas"}, {"symbol": "AMGN", "publishedDate": "2019-04-13 12:28:00", "title": "Better Buy:  Amgen vs. Gilead Sciences", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech4-5.jpg", "site": "The Motley Fool", "text": "Which biotech giant is the smarter choice for investors today?", "url": "https://www.fool.com/investing/2019/04/13/better-buy-amgen-vs-gilead-sciences.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-04-12 13:45:00", "title": "Amgen: Top Analyst Report", "image": "https://cdn.snapi.dev/images/v1/a/m/amge2.jpg", "site": "Zacks Investment Research", "text": "Shares of Buy-ranked Amgen have declined -1.3% year to date, underperforming the Zacks Biomedical and Genetics industry's increase of +9.3%.", "url": "https://www.zacks.com/research-daily/379778/top-analyst-reports-for-bank-of-america-amgen-nextera-energy"}, {"symbol": "AMGN", "publishedDate": "2019-04-10 09:44:26", "title": "Second Time's The Charm For Amgen As FDA OKs Bone-Building Osteoporosis Drug", "image": "https://cdn.snapi.dev/images/v1/k/n/knee-2253047-1920-3.jpg", "site": "Benzinga", "text": "Amgen announced late Tuesday the FDA approved Evenity, for treating osteoporosis in postmenopausal women.", "url": "https://feeds.benzinga.com/~r/benzinga/~3/ItO7fesGH5A/second-times-the-charm-for-amgen-as-fda-oks-bone-building-osteoporosis-drug"}, {"symbol": "AMGN", "publishedDate": "2019-04-09 16:09:42", "title": "FDA approves Amgen's Evenity for treatment of osteoporosis in postmenopausal women", "image": "https://cdn.snapi.dev/images/v1/o/s/os7.jpg", "site": "Market Watch", "text": "The U.S. Food and Drug Administration on Tuesday approved Amgen Inc's drug Evenity for the treatment of osteoporosis in postmenopausal women who are at high risk of bone fractures.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/qfc-EImBvTY/story.aspx"}, {"symbol": "AMGN", "publishedDate": "2019-04-09 10:23:00", "title": "Why Amgen Can Deliver Medical and Financial Miracles", "image": "https://cdn.snapi.dev/images/v1/a/m/amg.jpg", "site": "The Motley Fool", "text": "Its size, catalog, and pipeline give it strengths that are hard to beat.", "url": "https://www.fool.com/investing/2019/04/09/why-amgen-can-deliver-medical-and-financial-miracl.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-04-07 18:31:00", "title": "Why Amgen's Giving Novartis a Headache", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5183412fbiotech-stocks-to-own.jpg", "site": "The Motley Fool", "text": "These two are intertwined in a legal tango that could get messy.", "url": "https://www.fool.com/investing/2019/04/07/why-amgens-giving-novartis-a-headache.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-04-05 10:14:00", "title": "Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig", "image": "https://cdn.snapi.dev/images/v1/a/m/amg6.jpg", "site": "Zacks Investment Research", "text": "Novartis sues Amgen as the latter issues termination notice for migraine drug.", "url": "https://www.zacks.com/stock/news/371493/novartis-amgen-in-legal-dispute-over-migraine-drug-aimovig"}, {"symbol": "AMGN", "publishedDate": "2019-04-05 10:10:17", "title": "Why Amgen is Poised to Beat Earnings Estimates Again", "image": "https://cdn.snapi.dev/images/v1/a/m/amg7.jpg", "site": "Zacks Investment Research", "text": "Amgen has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.", "url": "https://www.zacks.com/stock/news/371457/why-amgen-amgn-is-poised-to-beat-earnings-estimates-again"}, {"symbol": "AMGN", "publishedDate": "2019-04-04 12:46:38", "title": "Novartis Lawsuit Accuses Amgen Of Trying To Welsh On Migraine Deal", "image": "https://cdn.snapi.dev/images/v1/m/t/mt6-2.jpg", "site": "Investors Business Daily", "text": "Novartis reportedly sued its partner Amgen on Thursday, accusing the biotech of trying to welsh on their agreement to sell migraine treatment Aimovig. Novartis stock fell more than 1%.", "url": "https://feedproxy.google.com/~r/BusinessRss/~3/wnnrRJOSvO4/"}, {"symbol": "AMGN", "publishedDate": "2019-03-30 12:00:00", "title": "3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5174042falzheimers-disease-chalkboard.jpg", "site": "The Motley Fool", "text": "Biogen threw in the towel with once-promising Alzheimer's disease drug aducanumab. But these three late-stage pipeline candidates could potentially still emerge as winners.", "url": "https://www.fool.com/investing/2019/03/30/3-leading-alzheimers-disease-drugs-in-development.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-03-15 12:20:22", "title": "Can Amgen Leapfrog A Key Rival And Add Millions Of New Patients?", "image": "https://cdn.snapi.dev/images/v1/a/m/amgen-1.jpg", "site": "Investors Business Daily", "text": "Leading biotech Amgen could expand the market for Repatha by 4.5 million patients with high cholesterol if the PCSK9 inhibitor proves its mettle in a new study, an analyst said Friday.", "url": "https://feedproxy.google.com/~r/InternetTechnologyRss/~3/cxXBtJgFNjg/"}, {"symbol": "AMGN", "publishedDate": "2019-03-11 11:20:36", "title": "Is Amgen (AMGN) a Profitable Pick ForValue Investors Now?", "image": "https://cdn.snapi.dev/images/v1/a/m/amgen.jpg", "site": "Zacks Investment Research", "text": "Amgen (AMGN) stock may be a good choice for value-oriented investors right now from multiple angles.", "url": "https://www.zacks.com/stock/news/358656/is-amgen-amgn-a-profitable-pick-forvalue-investors-now"}, {"symbol": "AMGN", "publishedDate": "2019-03-10 17:53:34", "title": "Better Buy: Amgen vs. Biogen", "image": "https://cdn.snapi.dev/images/v1/b/i/biogen.jpg", "site": "The Motley Fool", "text": "These cash-flow monsters are trading on the cheap. Which is the better bet for new money today?", "url": "https://www.fool.com/investing/2019/03/10/better-buy-amgen-vs-biogen.aspx?source=iedfolrf0000001"}, {"symbol": "AMGN", "publishedDate": "2019-03-05 19:00:00", "title": "Stocks that are trading at a discount: Amgen, Inc.", "image": "https://cdn.snapi.dev/images/v1/j/i/ji37x-y7-ou-1.jpg", "site": "CNBC Television", "text": "Tony Scherrer, director of research at Smead Capital Management, joins \"Squawk Box\" by phone to explain which stocks he's buying.", "url": "https://www.youtube.com/watch?v=jI37X_y7_OU&t=129s"}, {"symbol": "AMGN", "publishedDate": "2019-02-24 19:00:00", "title": "Technician: It's time to fade the biotech rally", "image": "https://cdn.snapi.dev/images/v1/h/x/hxjmd43j4nq.jpg", "site": "CNBC Television", "text": "Cornerstone Macro's Carter Worth on whether there's a biotech breakdown ahead. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Brian Kelly, Dan Nathan and Guy Adami.", "url": "https://www.youtube.com/watch?v=hXJMD43j4NQ"}, {"symbol": "AMGN", "publishedDate": "2019-01-29 19:00:00", "title": "What Boeing's Report Means for U.S. Companies With China Exposure", "image": "https://cdn.snapi.dev/images/v1/u/1/u13kumvf7pi.jpg", "site": "The Street", "text": "Kate Warne, investment strategist at Edward Jones, spoke to TheStreet about what the Boeing earnings mean for companies with exposure to China, how the tech sector is doing after Apple's AAPLearnings and how healthcare is looking now that Amgen, Pfizer and Allergan have reported.", "url": "https://www.youtube.com/watch?v=u13kUMVf7pI"}, {"symbol": "AMGN", "publishedDate": "2019-01-28 19:00:00", "title": "These are the key biotech stocks to watch this week", "image": "https://cdn.snapi.dev/images/v1/n/w/nw2vb8dmtao.jpg", "site": "CNBC Television", "text": "Brian Skorney, senior research analyst with Baird, joins CNBC's \"Power Lunch\" to break down what investors should look for as biotech companies release earnings reports this week.", "url": "https://www.youtube.com/watch?v=nW2VB8dmtAo"}, {"symbol": "AMGN", "publishedDate": "2019-01-07 19:00:00", "title": "Amgen CEO: Unmet Medical Needs | Mad Money | CNBC", "image": "https://cdn.snapi.dev/images/v1/r/h/rhgmer7tiqa.jpg", "site": "CNBC Television", "text": "It's Jim Cramer's favorite biotechnology company, and the CEO joined him for the first time ever. Don't miss his exclusive with Amgen chief Robert Bradway.", "url": "https://www.youtube.com/watch?v=rhGMer7TiQA"}, {"symbol": "AMGN", "publishedDate": "2018-12-19 19:00:00", "title": "Drug companies don't hear anything Congress on drug prices, says analyst", "image": "https://cdn.snapi.dev/images/v1/o/b/obk-lw13pn8.jpg", "site": "CNBC Television", "text": "Wells Fargo Senior Analyst David Maris joins \"Power Lunch\" to discuss drug companies raising prices in the new year and what a new Congress could mean for the industry.", "url": "https://www.youtube.com/watch?v=obk-Lw13Pn8"}, {"symbol": "AMGN", "publishedDate": "2018-11-07 19:00:00", "title": "The future of the health-care industry", "image": "https://cdn.snapi.dev/images/v1/u/6/u6rlgkkgeoe.jpg", "site": "CNBC Television", "text": "Fred Hassan, former Shering-Plough CEO, and Bill George, former Medtronic CEO, join 'Squawk on the Street' to discuss the impact on health-care stocks after news that the sector was the top issue for midterm voters.", "url": "https://www.youtube.com/watch?v=U6rLgKKgeOE"}, {"symbol": "AMGN", "publishedDate": "2018-11-06 19:00:00", "title": "Elections is more about the health care sector, and less drug prices, says pro", "image": "https://cdn.snapi.dev/images/v1/q/h/qhp0-wnd4ci.jpg", "site": "CNBC Television", "text": "Ipsita Smolinski of Capitol Street and Jared Holz of Jefferies join 'Closing Bell' to discuss the health care sector and how drug pricing could be changed following the midterm elections.", "url": "https://www.youtube.com/watch?v=qhp0_wnd4cI"}, {"symbol": "AMGN", "publishedDate": "2018-10-23 20:00:00", "title": "Amgen cutting price for cholesterol drug by 60 percent", "image": "https://cdn.snapi.dev/images/v1/y/m/ymqwz73d-eq.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports that Amgen is slashing the price of its cholesterol drug Repatha by 60 percent.", "url": "https://www.youtube.com/watch?v=Ymqwz73D-eQ"}, {"symbol": "AMGN", "publishedDate": "2018-08-02 20:00:00", "title": "Health-care pharma stocks are on fire, here's how to trade them", "image": "https://cdn.snapi.dev/images/v1/a/t/attzn1wmao0.jpg", "site": "CNBC Television", "text": "Michael Farr of Farr, Miller and Washington, Joe Terranova of Virtus Investment Partners, Steve Weiss of Short Hills Capital and Jim Lebenthal of HPM Partners join CNBC's Scott Wapner to discuss what sectors you should be watching in the market.", "url": "https://www.youtube.com/watch?v=AttZN1wmaO0"}, {"symbol": "AMGN", "publishedDate": "2018-07-25 20:00:00", "title": "Wall Street reacts to Amgen earnings", "image": "https://cdn.snapi.dev/images/v1/s/o/sov5go75vtc.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell breaks down Wall Street's reaction to Amgen earnings.", "url": "https://www.youtube.com/watch?v=SoV5gO75Vtc"}, {"symbol": "AMGN", "publishedDate": "2018-07-08 20:00:00", "title": "Bullish options traders target Amgen, this energy ETF", "image": "https://cdn.snapi.dev/images/v1/s/w/swwymkpht0k.jpg", "site": "CNBC Television", "text": "\"Halftime Report\" trader Pete Najarian and Mad Money's Jim Cramer discuss unusual options activity in Amgen and the XOP energy ETF.", "url": "https://www.youtube.com/watch?v=sWwymKpht0k"}]